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Abstract 
The use of nanomaterials (NMs) in orally ingestible products raises concerns about 
potential hazards. Titanium dioxide (TiO2) particles (of which some are incidentally 
produced at the nanoscale) are used in cosmetics, biological remediation (photo-
catalysis), toothpastes, ingestible pharmaceuticals and food products. The increased 
surface area to mass ratio of nanoparticles (NPs) potentially makes them more 
biologically reactive than their coarser (bulk) material counterparts. There is limited 
data available on the uptake kinetics across the mammalian gastrointestinal tract, 
and the potential hazard posed to humans. In this study, the uptake and 
accumulation of TiO2 (nano and bulk) into and across the human intestinal cell line, 
the isolated perfused rat jejunum and the whole rat were evaluated. Caco-2 
monolayers exhibited time-dependent, accumulation, uptake and transport of Ti/TiO2 
from TiO2 exposures of 1 mg L
-1 over 24 h, which was influenced by the crystal type, 
irrespective of cell maturity and growth substrate (Chapters 2-3). Electron 
micrographs of the Caco-2 monolayer showed the presence of particles inside the 
cells within vesicles and energy dispersive spectroscopy (EDS) confirmed the 
composition as TiO2. Addition of pharmacological inhibitors altered the Ti 
concentration in the cells suggesting diffusion is not the primary mechanism of 
uptake, rather, an active process is responsible (Chapter 2). Whole gut sacs 
exposures of 1 mg L-1 bulk or nano TiO2 demonstrated the primary regions of the gut 
associated with accumulation are the small and large intestine, with 70 % or more of 
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the TiO2 accumulating in the mucosa rather than the underlying muscularis. 
Perfused intestines exposed to 1 mg L-1 bulk or nano TiO2 for 4 h showed a time-
dependent accumulation of Ti in the serosal perfusate with the initial rates of Ti flux 
from the nano exposures being 5 fold higher than the bulk form. Addition of 
pharmacological inhibitors caused increases in tissue Ti concentration and 
significantly reduced Ti serosal flux rates for NP exposures. Overall, the data 
suggests an active absorption mechanism is responsible for Ti uptake from both bulk 
and nano TiO2 exposures across the perfused rat intestine that is drug sensitive 
(Chapter 4). In vivo work demonstrated feed status and rat age effected Ti tissue 
concentrations. Critically, Ti tissue concentrations reduced with increasing age and 
removal of Ti containing feed caused transient decreases in Ti tissue concentrations 
in 23 day old rats. Transient decreases in Ti tissue concentration following feed 
removal were not observed in older rats suggesting young rats may be more 
sensitive to the uptake hazards presented by titanium (Chapter 5).  
Overall, the findings presented in this thesis demonstrate Ti/TiO2 from both bulk and 
nano TiO2 exposures are accumulated and transported across intestinal epithelium 
and these processes are drug sensitive and affected by crystal structure and particle 
size. The results in this thesis have contributed to a better understanding of the 
uptake kinetics and sub-lethal hazards presented by bulk and nano forms of TiO2 
exposed to intestinal epithelium which could be used to partially inform policy makers 
on human dietary risk assessments. 
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Chapter 1: General Introduction 
 
 
1.1 Introduction  
Nanomaterials (NMs) which include nanoparticles (NPs) have existed naturally since 
the beginning of Earth’s history (Handy et al. 2008). The size range of the nano scale, 
as suggested by the scientific committee on emerging and newly identified health 
risks (SCENIHR), is from the atomic level (around 0.2 nm) up to 100 nm (SCENIHR 
2006). This definition is not absolute and more recent existing working definitions 
have stipulated materials can be regarded as ‘nano’ when the material is 
approximately between 1 and 200 nm in at least one dimension, and in the case of 
the UK (DEFRA) in two or more dimensions (Lovestam et al. 2010). These 
definitions fail to account for NM agglomerates/ aggregates with dimensions of a few 
hundred nanometres although current EU definition has stipulated that a NM is ‘A 
natural, incidental or manufactured material containing particles, in an unbound state 
or as an aggregate or as an agglomerate and where, for 50 % or more of the 
particles in the number size distribution, one or more external dimensions is in the 
size range 1 nm - 100 nm’ (European-Commission, 2011). Moreover, the generic 
term of NM can be used to describe a NP whilst the term NP implies the particle has 
a spheroidal like morphology. 
Of central concern for materials within the nano scale is the idea that they can have 
substantially different properties compared to the same substances larger size (e.g., 
micrometre scale and above). NMs have much larger surface area to mass ratios 
than courser materials. Since biological and chemical reactions often occur on the 
surface of materials there is an expectation that NMs will be much more reactive 
than the same mass of material made from larger particles (Sutariya and Pathak, 
2014). Furthermore, as a result of reduced size, NMs may be able to cross biological 
barriers such as the lung and gut more easily than coarser materials and 
consequently cause unexpected effects. In addition, quantum behaviours appear at 
the nanoscale. These effects prevail at sizes below 30 nm and alter basic material 
characteristics, including optical, magnetic and electrical properties (Lovestam et al. 
2010). 
Naturally occurring NMs can be broadly characterized into two areas, organic and 
inorganic compounds. Inorganic NMs include clays (aluminosilicates), metal 
sulphides, amorphous silica, iron oxyhydroxides; organic NMs include proteins, 
humic aggregates, viruses etc. (Lead and Wilkinson 2006). These naturally occurring 
NMs are generally found as colloidal dispersions; which can broadly be defined as 
substances in which microscopically dispersed insoluble particles are suspended 
throughout another material/solution which does not settle or takes a long time to 
settle appreciably (Lead and Wilkinson 2006). 
NM production can occur through natural geological processes such as volcanic 
activity, authigenesis/neoformation and weathering of rocks (Handy et al. 2008). 
There are also biological degradation mechanisms, which typically comprise of the 
chemical disintegration of organic material from plant or microorganisms (Boyle et al. 
2005). In the last decade, anthropogenic activity has become a source of NMs and 
intentional engineered nano material (ENM) production has occurred. Unintentional 
creation of NMs occurs as an incidental part of many industrial processes involving 
the combustion of fossil fuels, the use of diesel in vehicles, welding or smelting, 
polymer fabrication, and even cooking (Gwinn and Vallyathan 2006).  
ENMs are deliberately manufactured with an application in mind, and ‘how the 
product is used’ may be more important for exposure aspects of risk assessment 
than the physico chemical characteristics of the material (Hansen et al. 2008). Given 
that with no exposure there is no risk. In light of this, there is an argument that the 
classification of ENMs can be considered according to the industry they are used in. 
For example, medical prosthetics, drug delivery vehicles, cosmetics, food, water 
treatment and environmental remediation are likely to increase NM exposure to 
humans and therefore increase potential risk (Aitken et al. 2006). Hansen et al. 
(2007) have also suggested another method of classification based on how the ENM 
is incorporated into the product. For example, whether ENMs comprise the bulk of 
the product, whether they exist on the surface of the product, or whether they are 
incorporated within the product (Hansen et al. 2007), the material composition would 
likely effect exposure kinetics. For example surface bound ENMs are more likely to 
become freely detached in an organism in comparison to ENMs incorporated within 
the material matrix. 
Traditionally risk assessment of new materials is based on a chemical approach, and 
there is debate about how to chemically classify ENMs because there is currently 
insufficient knowledge about the mechanisms of toxicity. However, a number of 
researchers involved in the NanoImpactNet environmental workshop have agreed on 
generally similar classifications of ENMs based on the broad chemical categories 
they occupy with regards to environmental studies (Stone et al. 2010) (although 
similar ideas would be useful from a human toxicological perspective). Chemical 
categories include, carbon-based, mineral-based, organic and composite (see Stone 
et al. (2010) and Hansen et al. (2014). Classification of composites is particularly 
problematic, (possibly due to synergistic interactions of materials that make up the 
composite); however, current suggestions include an initial strategy of ENM 
classification based on the individual classes that make up the material (Stone et al. 
2010).  
There is a growing body of literature demonstrating that respiratory exposure to 
NMs/ENMs can cause adverse effects to lungs. For example respiratory exposure to 
TiO2 NPs have been shown to elicit lung injury, inflammation and tumour formation in 
murine models (Heinrich et al. 1995; Chen et al. 2006; Kobayashi et al. 2009; Rossi 
et al. 2010). Moreover, a number of studies have illustrated the role of particle size in 
relation to toxicity, with smaller TiO2 particles causing increased inflammatory effects 
compared to courser particles of the same material following acute or chronic 
respiratory exposure (Oberdorster et al. 1994; Renwick et al. 2004; Sager et al. 
2008). Less is known about the risks and hazards associated with dietary exposure 
to NMs or ENMs. Knowledge gaps include how ENMs interact with food components; 
the effect of NM/food matrix on gastro intestinal tract (GIT) epithelium and gut 
microflora; the fate and behaviour of ENMs or NMs in the gastrointestinal tract; 
uptake and accumulation rates for different ENMs; the effect of ENMs or NMs on 
absorption and bioavailability in comparison to coarser material equivalents; and 
whether these changes are of toxicological significance and require lowering of the 
permissible limits in food (Chaudhry et al. 2008). 
The overall aim of this review is to give a broad overview of ENMs used in the food 
industry with a particular focus on TiO2 NP absorption mechanisms at the apical 
membrane of intestinal cells following oral exposures. The issue of hazard is 
approached from the view point of mammalian body systems physiology. In order to 
characterise mechanism of apical uptake and potential toxicity, in vitro, ex vivo 
techniques are discussed and contextualised with regard to researching NM uptake 
and transport in mammals. 
 1.1.1 The global nanotechnology market 
Nanotechnology is the application of ENMs in products and processes. Early 
estimates of the global nanotechnology market in 2015 range from about $27 billion 
to $2.4 trillion (Roco and Bainbridge 2001; Global-Industry-Analysts 2012). Some of 
the higher estimates suggest the market may be worth more than $2.4 trillion by 
2015 (Roco 2007). The variability in the estimates of global value of the market can 
be attributed to different analytical methods and assumptions made during each 
forecast, but also due to different definitions of the ‘nanotechnology market’ (e.g. 
whether to include old technologies such as carbon black, rubber reinforces and 
photographic silver, or whether to base the market value on nanotechnology inputs 
alone, as opposed to the total value of products containing NMs) (McWilliams 2010). 
Examples of the areas in which nanotechnology is being developed 
include,manufacturing, electronics, healthcare, pharmaceuticals, chemical plants, 
transportation, the agri-food sector, water treatment and environmental sustainability 
(Roco and Bainbridge 2001). 
Most applications of nanotechnology in the food industry (packing and food) are 
outside the UK (or EU) with the majority of them in countries such as the USA, 
Australia, New Zealand, Taiwan, and China (Chaudhry et al. 2008). According to the 
Helmut Kaiser Consultancy,  nano technology in the food market has increased from 
a value of $2.6 billion in 2003 to $5.3 billion in 2005; and it is expected to soar to 
$20.4 billion in 2015 (Helmut-Kaiser-Consultancy 2011). However, a report by the 
Innovative Research and Products Inc. has estimated a lower forecast growth rate to 
$7.30 billion by 2014, at a compound annual growth rate (CAGR) of 11.65% 
(Innovative-Research-Products-Inc 2009). Nevertheless, this industry is growing, and 
with the increased use of ENMs in food applications the avenues of exposure and 
potential hazard likely to increase.  
 
1.1.2 Current applications of nanomaterials in the food sector 
The term ‘nanofood’ describes food which has been developed, manufactured, 
processed or packaged using nanotechnology techniques, or to which ENMs have 
been added (Joseph and Morrison 2006). A selection of ENMs already being used in 
the nanofood sector are listed in Table 1-1. Technologies are emerging aimed at 
improved traceability (to hold appropriate manufacturers accountable in the event of 
a food contaminant issue) and food nutritional value (with a view to addressing food 
related illness, e.g. obesity, diabetes). For example, lipid micelles, liposomes or 
nanospheres are used to encapsulate and protect bioactive ingredients from acid 
hydrolysis in the stomach with a view to improving bioavailability, increasing 
residence time in the GI tract and promoting efficient nutrient absorption into cells 
(Chen et al. 2006) (Table. 1-1). Another area undergoing significant research and 
development is smart food packaging. Such packaging can respond to changing 
environmental conditions such as moisture and temperature and can alert the 
customer via a visual cue if food is contaminated or starting to decay (Joseph and 
Morrison 2006). There are also some agricultural applications of nanotechnology 
(pesticides, fertilisers, herbicides) that could be a source of residues in the human 
food chain (Miller and Senjen 2008; Frewer et al. 2011). 
It is difficult accurately estimate the amount and types of ENMs in food due to 
commercial confidentiality on food recipes and the absence of labelling laws that 
specifically necessitate manufacturers to disclose nano forms of existing additives in 
food (Miller and Senjen 2008). Moreover, manufacturers of nanofood products self-
promote the ‘nano’ nature of their products and it is unknown whether products 
advertised as ‘nano’ do in fact contain NMs. Legislators and manufacturers need to 
work together to ensure that claims about products are true.  
There are between 150 and 600 putative nanofoods and nanofood packaging 
products currently available (Cientifica 2006; Miller and Senjen 2008; Helmut-Kaiser-
Consultancy 2011; Woodrow-Wilson-Institute 2014). Examples of packaging 
incorporating ENMs include using NMs or nanocomposites (e.g., titanium dioxide, 
silicon dioxide, nano clay and silver) to improve the protection of food by altering the 
permeation behaviour of the packaging. This can include deodorising, blocking UV, 
scavenging ROS, improving mechanical and heat resistant properties and 
developing antimicrobial/antifungal surfaces (Xiao et al. 2004; Chau et al. 2007).  
ENMs in food are generally either in suspension (colloidal) or an emulsion (two liquid 
phases; e.g., colloidal particles suspended in a gelatine matrix) (Bouwmeester et al. 
2009). Currently available products include, synthetic lycopene (Table 1-1), which is 
used as an additive in soft drinks and food products aimed at promoting absorption 
of synthetic lycopene, which research suggests is an effective antioxidant (Vance et 
al. 2013). NovaSOL (Table1-1) from Aquanova (Aquanova 2006; Chaudhry et al. 
2008) is a nano-based carrier system which is comprised of 30 nm (diameter) 
micelles that are able to solubilise hydrophobic molecules contained within them in 
the hope of making them more bioavailable (Aquanova 2006). By reducing the size 
of the encapsulate to the nano scale, opportunities for greater surface coverage, 
increased retention time in the GI tract and improved bio adhesion to the mucus 
covering the intestinal epithelium may be achieved (Medina et al. 2007; 
Bouwmeester et al. 2009). Examples of solubilised substances include functional 
food ingredients such as vitamins A and E, omega 3 fatty acids and coenzyme Q10 
(Chaudhry et al. 2008). 
Table ‎1-1: A summary of currently available ENMs used in the food sector 
Type of 
Product 
Product name Manufacturer Nano Content Purpose/ Claim Reference 
Beverage Nano tea Ph Pure health Nanized green tea  Green tea that has been "nanized" extremely 
bio-available. Even those with poor digestion 
can rapidly absorb the "nanized" green tea 
 
http://www.phpure.c
om/nutrition_produc
ts/green_tea.htm 
Beverage “Daily Vitamin 
Boost” 
Jamba Juice 
Hawaii 
300 nm iron 
(sunactive Fe) 
 
22 essential vitamins and minerals and 100 % 
or more of your daily needs of 18 of them 
 
http://jambajuice 
Hawaii.com/vita-
boost.asp 
Food 
additive 
Nano-self 
assembled 
structured liquids 
(NSSL) 
Nutralease Nano micelles for 
encapsulation of 
nutraceuticals 
 
Improved bioavailability means nutraceuticals 
are released into membrane between the 
digestive system and blood 
 
http://www.nutraleas
e.com/technology.a
sp 
Food 
additive 
Synthetic lycopene BASF LycoVit 10% 
(<200nm synthetic 
lycopene) 
 
60 nm particle encapsulated in a colloid case http://www.humann
utrition.basf.com 
Food 
additive 
AquaNova 
Novasol 
Aquanova Product micelle 
(capsule) 30 nm in 
diameter  
An optimum  carrier system for hydrophobic 
substances for a higher and faster intestinal 
and dermal reabsorption and penetration of 
active ingredients 
 
http://www.aquanov
a.de/product-
micelle.htm 
 
Food 
additive 
E171 Shijiazhuang 
Tianqiu Chemicals 
Co.,Ltd 
TiO2 TiO2 is a food additive that is used in over 100 
products. Some of which is nano 
 
Weir et al. (2012) 
Food 
Storage 
Food container NS A-Do Global Nano silver 99.9 % anti bacterial nanotechnology http://www.adox.info
/?doc=shop/list.php
&ca_id=110 
 
Food 
storage 
DuPont Light 
Stabilizer 210 
DuPont Nano TiO2 U.V.-protected plastic food packaging http://www2.dupont.
com/titanium_techn
ologies/en_us/produ
cts/dls_210/dls_210
_landing.html 
 Food 
storage 
Adhesive for 
McDonald’s burger 
containers 
 
Ecosynthetix 50-150 nm starch 
nano-spheres 
The adhesive requires less water and less 
time to dry 
http://www.physorg.
com/new71748835.
html 
Plant 
Growth 
treatment 
Primo MAXX plant 
growth regulator 
Syngenta 100 nm particle 
size emulsion  
The extremely small particle size allows Primo 
MAXX to mix completely with water and not 
settle out in a spray tank 
http://www.syngenta
p.com/prodrender/in
dex.asp?nav=CHE
MISTRY&ProdID=7
47 
 
Regulation and legislation relating to food safety  
Currently there are many different areas of legislation that apply to the food sector in 
which ENMs in food may be covered. For a detailed overview see (FSA 2007) 
Chaudhry et al. (2008) who performed a regulatory gap study assessing existing 
regulatory frameworks relevant to food and food packaging using nanotechnologies. 
The study concluded that existing models for risk assessment are generally 
applicable to ENMs, but there are major gaps in information on hazard exposure. For 
example: 
• ‘Current legislation does not differentiate between microscale and nano 
forms of food additives already approved for use in food’.  
• ‘There is a lack of clarity in the definition of novel foods under relevant 
regulations that may lead to uncertainty as to whether a food processed at 
the nano scale should be considered a novel food’ 
• There is a lack of knowledge of the effects of processes and products of 
nanotechnologies in food to enable adequate risk assessment’.  
(Chaudhry et al. 2008) 
 ‘Of concern are existing additives such as TiO2 that are already approved for use in 
food and legislation does not prescribe criteria associated with particle size which 
can be considered a principle issue in terms of risk and hazard presented by ENMs 
and NMs (Chaudhry et al. 2008). According to the food and drug administration (FDA) 
‘Any substance that is reasonably expected to become a component of food is a 
food additive that is subject to premarket approval by FDA, unless the substance is 
generally recognized as safe among experts qualified by scientific training and 
experience to evaluate its safety under the conditions of its intended use, or meets 
one of the other exclusions from the food additive definition’ (FDA 2014). 
Manufacturers do not need to include TiO2 on food labels (in most circumstances) 
because it meets the prescribed exclusion criteria with regards to additive labelling. 
For example, labelling is not required when additives perform no additive function in 
or make up less than 25% of the final product (Jovanović 2014). Given that TiO2 
does not have any known nutritional value and has been recognised as safe 
following the initial toxicological assessment performed in 1969 (JECFA 1969), it is in 
some cases considered a manufacturing aid rather than a food ingredient, making it 
exempt from labelling (Jovanović 2014). 
 
Generic routes of exposure to ENMs and NMs 
Exposure routes to ENMs and NMs, and sites of systemic accumulation are 
summarised in Fig. 1-1. Exposure to NMs is multifaceted and while exposure 
modelling for NMs has been researched (Weir et al. 2012; Shi et al. 2013), there is 
less information on exposure modelling from a nanofood focused perspective. 
Essentially, there are four modes of exposure which may result in the uptake and 
accumulation of NMs into systemic circulation. Inhalation/aspiration of powders 
aerosols and vapours; dietary exposures through eating and drinking (covered below 
from a nanofood related perspective); intra-body (prosthetics, IV medicines) and 
dermal exposures (creams, face scrubs). For example, intra-body exposures of 
ENMs can occur though intravenously administered ENMs for therapeutic purposes 
(Nazir et al. 2014) or through degradation of prosthetic implants. TiO2 has long been 
used as a component for articulating prosthetic implants for hips and knees (Jacobs 
et al. 1991; Sul 2010). These implants can fail due to degradation of material or 
through chronic inflammation in response to the implant resulting in the release of 
particles into the systemic circulation.  
Dermal exposure studies suggest NMs contained in sunscreens and face scrubs 
(TiO2) can penetrate the stratum corneum (the skin) and hair follicles (Lademann et 
al. 1999), although subsequent studies have failed to corroborate this result (Senzui 
et al., 2010, Pflucker et al., 2001). In more recent times research has demonstrated 
that hair follicles represent important routes into the skin for drugs and chemicals 
(Otberg et al. 2008). A study done on the percutanous absorption of caffeine showed 
that hair follicles are considerable weak spots of the skin against penetration of 
hydrophilic substances (Otberg et al. 2008). Past research has shown the potential 
for effective uptake of vitamins through topical application. The study concluded that 
topical application of a vitamin A emulsion was almost as effective in overcoming 
vitamin A deficiency in rats as when the vitamin was given orally (Schaefer et al. 
1955). This route of exposure may become more relevant for manufacturers of 
nutritional supplements looking for novel ways to ensure vitamin exposure. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. ‎1-1: Routes of exposure to ENMs and NMs 
Adapted from Shi et al. (2013) 
 
1.1.3 Routes of exposure to nanomaterials in the human food chain 
ENMs and NMs can enter the food chain through a variety of processes (Fig. 1-1). 
ENMs in household products or in pesticides and fertiliser end up in sewage. This 
sewage is then processed by wastewater treatment plants. Studies have shown that 
particles of TiO2 between 4 and 30 nm can be found in treated effluent from 
wastewater treatment facilities (WWTP) (Kiser et al. 2009; Westerhoff et al. 2011). 
These particles are then re-released into the environment where they can interact 
with living organisms (Fig. 1-1). Exposure via ingestion is likely to occur through the 
consumption of food containing ENMs (TiO2 - additive E171) in conjunction with the 
potential migration of ENMs into food and drinks from packaging containing ENMs 
(Chaudhry et al. 2008) (Fig. 1-1). Moreover, food and beverages containing ENMs 
such as herbal teas will have vapours which create NP aerosols which can be 
inhaled and or swallowed with mucus. 
 
1.1.4 Occupational exposures and respiratory exposure 
Historically it has been well documented that occupational exposure to food stuffs 
comprised of fine powders and dusts are known to be respiratory irritants. For 
example, ‘bakers asthma’ is an allergic asthma caused by cereal flour. In several 
countries baker’s asthma is reported to be one of the most frequent forms of 
occupational asthma (Houba et al. 1998; Zuskin et al. 1998). The addition of 
powdered additives could also be another risk of inhalation exposure. Diacetyl, a 
butter flavouring used as a liquid, paste or powder has been associated with fixed 
obstructive lung disease resembling bronchoilitis obliterans in microwave popcorn 
workers. The vapours and dust associated with diacetyl have been shown to be of 
respirable size with only 100 ppm (379 mg m-3) required to cause acute airway injury, 
but diacetyl vapours have been shown to reach 1230 ppm (4.6 x 103 mg m-3) in the 
production plants (Boylstein et al. 2006; Kanwal 2008; Hubbs et al. 2008). The food 
industry has routinely used fine particles of TiO2 as a colorant in many products; with 
TiO2 accounting for 70% of the total production volume of pigments worldwide (Baan 
et al. 2006) of which 36% is incidentally produced at the nano scale (Weir et al. 
2012). An elevated exposure risk and subsequent internalisation of TiO2 may occur 
in people involved in its large scaled production. 
In the general population, a common route of exposure is likely to occur through 
inspiration of vapours associated with cooking foods which contain ENMs or through 
the use of powdered sweeteners which could create dusts. Exposure of ENMs or 
NMs via the lungs can result in translocation across pulmonary epithelium to extra 
pulmonary sites such as the liver, heart, and brain in mammals (Kreyling et al. 2002; 
Nemmar et al. 2002; Oberdörster et al. 2004). 
 
1.1.5 Oral/dietary exposure 
Another route of direct exposure is through the gastro intestinal tract (GIT).  
Estimated oral doses in the form of food and drinking water for nano TiO2 range from 
5 mg day-1 through to 1 mg kg-1 bw (Lomer et al. 2000; Weir et al. 2012). In 2013 the 
European Commission’s scientific committee on consumer safety concluded that the 
oral exposure lowest observed adverse effect level (LOAEL) of 5 mg kg-1 bw day-1 
may be derived for nano TiO2 (European-Commission 2013), which is close to 
estimated levels of consumption.  
A human exposure analysis study conducted by Weir et al. (2012) indicated that 
American children between the ages of 3 and 15 years are exposed to the largest 
concentrations of nano TiO2 because elevated levels occur in confectionary products 
in comparison to other food products (Weir et al. 2012) (Table 1-2). In extreme cases, 
just one portion of a salad dressing (225 mg TiO2) (Table 1-2) could exceed the nano 
LOAEL for TiO2 by > 2-fold for a 30 kg child. Moreover, no allowable daily intake 
(ADI) for TiO2 has been set given that the initial toxicological assessment implied low 
solubility, toxicity and absorption of TiO2 (JECFA 1969). 
Existing risk assessment procedures for metals assume 100% absorption and these 
procedures may be used for products containing ENMs. However, assessment 
estimates may be over zealous considering 100% absorption is unlikely for many 
substances. Moreover, to my knowledge there is no information on the level of 
absorption and the rates of uptake for TiO2 in mammalian models.  
 
Table ‎1-2: TiO2 concentration in a selection of food products 
Food group Food product Portion size 
(g) 
TiO2 
(mg/portion) 
Nano 
component 
/portion 
(mg)* 
Company 
Confectionery Cake Icing  30 55 19.8 Cadbury Ltd 
Supercook; 
Good and plenty 
candy 
30 81 29 Hershey 
foods 
Hostess 
powdered 
Donettes 
2 6 2 Hostess 
Mentos 
Freshmint Gum 
30 90 32 Perfetti Van 
melle 
corporation 
Sauces Dickinsons 
coconut curd 
30 (1tbs) 120 43 Dickinsons 
family 
Mustard (min) 
Italian Dressing 
(max) 
 
30 (1tbs) 225 81 Colman’s of 
Norwich 
Hellmann’s 
Non-dairy 
creamers 
Teamate (max) 4·5 (1tsp) 3·5 1.3 Nestlé 
*Assumed nano component based on Weir et als (2012) estimate that 36% of TiO2 in food products is 
within the nano size range.  
Adapted from (Lomer et al. 2000; Weir et al. 2012) 
 
 
1.2 Titanium dioxide physico – chemical considerations 
Titanium dioxide (TiO2) powder has been used in commercial and industrial 
applications since 1918 (Barksdale 1950). TiO2 naturally exists as three distinct 
crystalline phases, anatase, rutile and brookite (Sayes et al. 2006). Pure rutile and 
anatase are commercially synthesised and used as a white pigment base (mostly 
rutile) in paints, plastics, rubber and paper, as catalysts (anatase); and as food 
additives (E171 anatase) (Powell et al. 1996).  
Food grade TiO2 in its microparticle form is widely used as a food additive for 
whitening and brightening food, in white sauces and dressings, powdered foods, 
confectionary and many ingestible pharmaceuticals (Lomer et al. 2000; Weir et al. 
2012). United States (US) regulations authorize its use as a colour additive in foods 
at levels not exceeding 1% w/w. The EU permits its use in foods, with some 
specified exceptions, at quantum satis levels if used in accordance with good 
manufacturing practices (GMP) (FAO 2006). 
Food grade bulk TiO2 is generally regarded as a poorly soluble low toxicity material 
(JECFA 1969; Jovanović 2014). Research into the properties of bulk TiO2 
demonstrate that the mean diameter of manufactured particles are 200 nm (Lomer et 
al. 2002), although research has shown that up to 36% of ‘Bulk’ (food grade, E171) 
TiO2 is below 100 nm in at least 1 dimension (Weir et al. 2012). This research has 
been corroborated by Yang et al. (2014) who assessed five different powders or 
paste samples of E171 from around the world by analysing primary particle size and 
hydrodynamic radius. The results showed average primary particle diameter was 
between 106 nm and 132 nm with at least 17-35% of the particles being < 100 nm in 
diameter (Yang et al. 2014). Food grade TiO2 (E171) is composed of the anatase 
polymorph which in the nano form has been shown to be the most reactive in terms 
of generating reactive oxygen species (ROS), and in human lung epithelial cell lines 
has been demonstrated to be 100 times more toxic than rutile TiO2. Specifically, the 
calculated LC50 for nano anatase was 3.6 µg ml-1 compared to 550 µg ml-1 for nano 
rutile (Sayes et al. 2006). Nano (anatase) TiO2 (10 nm diameter at a concentration of 
15 mg ml-1) has been shown to generate 6 times more ROS than rutile alone when 
irradiated by U.V through electron transfer at the surface of the TiO2 crystal (Sayes 
et al. 2006).  
The mechanisms involve the dissociative adsorption of water to titania surfaces 
(Sayes et al. 2006) and the subsequent ROS (˙OH- and ˙.O2
-) react with cell 
constituents. It is unclear why anatase (TiO2) is considerably more efficient at ROS 
production through the catalyses of water on the crystal surface compared to the 
other TiO2 phases.  Selloni et al. (1998) and Vittadini et al. (1998) theoretically 
demonstrate with first principle calculations that water molecules would dissociate to 
H+ and OH-, and then adsorb to anatase crystal surfaces; but undissociated water 
molecules (i.e., H2O) adsorp to rutile surfaces (Selloni et al. 1998; Vittadini et al. 
1998) (Fig.1-2). The chemistry at the surface of metal oxides are relatively unknown. 
The general approach to determining surface chemistry is to assume that metal 
oxides are ideal crytals where the atomic arrangement is maintained up to the 
surface plane (Diebold, 2003). This assumption is flawed considering crystals are 
imperfect. Crystals often contain defects (Koodali and Klabunde 2006). Defects are 
much more abundant at surfaces than within the lattice (Feltz 1987), and when 
particles become smaller, the surface area to volume ratio becomes progressively 
larger, increasing the likelihood of encountering a chemically reactive defect. On 
oxide surfaces, defects can be either cation or anion vacancies, or adatoms (Koodali 
and Klabunde 2006) (atoms attached at the surface of the lattice structure – Fig. 1-2). 
The most predominant type of defect on metal oxide surfaces is oxygen vacancies 
(see review by Barteau 1996). When a metal oxide (MO) surface is exposed to water, 
adsorption of water molecules takes place at cationic sites through a combination of 
ion dipole attraction and orbital overlap (Koodali and Klabunde 2006) (Equation 1: 
Fig.1-2). Subsequent protonation and deprotonation of the surface hydroxyls 
produce a charged oxide surface (Equations 2 - 3) (Koodali and Klabunde 2006). 
The Gibbs free energy of adsorbative disassociation per molecule of water at TiO2 
crystal surface ranges between +0.02 and -1.56 eV; depending on the orientation 
and coordination of the atoms at the crystals surface. The latter is strongly influenced 
by crystal phase, with rutile having the lowest hydroxylation potential and anatase 
the greatest (Vittadini et al. 2010). 
  
 
  
 
Adapted from Brown et al. (1998). 
Fig.  1-2:Idealised diagram of a metal oxide (MO) crystal surface. Water adsorbs to the surface 
through dipole attraction. Cationic vacancy acts to break apart the water molecule to form hydrogen 
gas and a hydroxyl radical (Equation 1). Oxygen molecule scavenges the electron in an anionic 
vacancy to form superoxide anion. 
(Eq 1)   *MOsurf + H2O       MO.H2Osurf MOH
+.OH- surf 
(Eq 2)     MOHsurf + H
+  MOH2
+
 surf 
(Eq 3)     MOHsurf        MOsurf + H
+ 
*Metal oxide surface (MOsurf). 
(Koodali and Klabunde 2006). 
It is important to note that equations 2 and 3 occur when TiO2 is in an environment 
where the pH is below (more H+) that of its ‘point of zero charge’ (PZC). Depending 
on the experimental method used the PZC of TiO2 at normal body temperature is 
Hydroxyl radical                Superoxide anion 
between pH 5.97 – 5.9 (Chou and Liao 2005). Moreover, much of these 
hypothesised surface reactions assume the crystal is surrounded by an ideal 
medium (e.g. ultra pure water) which is unlikely to occur in vivo. 
Sayes et al (2006) compared the ROS generation of different crystal structures 
(phase) of TiO2. The results showed that anatase (TiO2) did not require an 
illumination source to produce reactive oxygen species (orally ingested products will 
have no access to light). A higher rate of ROS production occurred when anatase 
(TiO2) was sonicated (probably due to cavitation processes) (Luche 1996) and 
exposed to UV light (Sayes et al. 2006). The authors concluded that the fundamental 
differences between the anatase and rutile surfaces is responsible for the differences 
in adsorbative dissociation of water (Sayes et al. 2006), rather than the larger 
surface area associated with NMs. Chemical reactivity is fundamental to toxicity and 
therefore, hazard of a chemical substance. From a regulatory perspective it may be 
prudent to not simply extrapolate chemical reactivity of one form of TiO2 to another. 
 
1.3 In vivo toxicity of TiO2 NPs 
The toxicity of TiO2 NPs has been the subject of a number of in vivo laboratory 
studies. Several studies (in rodents) have demonstrated TiO2 toxicity following 
respiratory exposures (Table 1-3). Respiratory exposures to TiO2 NPs have been 
shown to elicit lung injury, inflammation and tumour formation (Heinrich et al. 1995; 
Chen et al. 2006; Kobayashi et al. 2009; Rossi et al. 2010). Moreover, studies have 
illustrated the role of particle size in relation to toxicity, with smaller particles eliciting 
greater inflammatory responses in comparison to bulk counterparts following acute 
or chronic exposure (Oberdörster et al. 1994; Renwick et al. 2004; Sager et al. 2008; 
Kobayashi et al. 2009). For example, Oberdörster et al. (1994) reported that TiO2 
NPs (21 nm) caused a greater pulmonary inflammatory response than bulk TiO2 of 
the same mass burden. The crystal structure of TiO2 has also been shown to play a 
role in the magnitude of detected bronchoalveolar lavage (BAL) inflammatory 
parameters related to lung tissue and cell damage (Warheit et al. 2007; Liu et al. 
2009; Sayes et al. 2006). Moreover, P25 Degussa TiO2 NPs (a mix of anatase and 
rutile 80/20) have been shown to induce greater pulmonary inflammation, cytotoxicity 
and adverse lung tissue effects than rutile NPs alone in rats (Warheit et al. 2007) 
supporting the idea that crystalline phase plays a role in toxicity. Given the 
respiratory toxicity demonstrated by TiO2 of different sizes and crystal structures 
there is concern that oral and dietary exposures to TiO2 NPs (predominantly anatase) 
could also elicit pathological responses.  
The literature reporting the impact of TiO2 on the GIT is scant, with the majority 
reporting systemic toxicity associated with intra gastric administration of TiO2 (Table 
1-3). A handful of studies have shown changes in gut morphology or parameters that 
are deemed to be pathological following exposures to TiO2 NPs. For instance, 
Federici et al. (2007) demonstrated injuries to the intestine of trout, such as fusion 
and erosion of the villi and vacuolation of the mucosa following aqueous exposures 
of 1 mg L-1 P25 TiO2 NPs. Wang et al. (2007) demonstrated an increase in 
inflammatory cells in the chorion and mucosa of the stomach (which he ascribed to 
overload of particles to the stomach) following single oral gavage of 5 g kg-1 TiO2 
NPs to mice. There are considerable knowledge gaps on the effects of TiO2 NP 
exposures on the major physiological functions of the gut (e.g. motility secretion 
digestion and absorbtion) and the non-nutritional functions of the gut (e.g. endocrine 
and immunological functions).  
 1.3.1 Internal organ toxicity 
The toxicity of TiO2 NPs on internal organs of vertebrates has been well researched 
following many different modes of exposure (oral, intravenous, intraperitoneal 
intratracheal) and these pathological responses to TiO2 exposure are described 
below.   
 
1.3.2 Liver 
The toxicity of TiO2 NPs on liver function and morphology has been demonstrated in 
numerous studies e.g. Wang et al. (2007), Chen et al. (2009) and Wu et al. (2009). 
Hepatic injury has been demonstrated with a number of crystal phases of TiO2 NPs 
at differing doses (Chen et al. (2009) - anatase; Nemmar et al. (2011) - rutile; Wu et 
al. (2009) - P25; irrespective of administration route (intragastric 5 g kg-1 bw: Wang 
et al. (2007); intraperitoneal between 324, and 2592 mg kg-1: Chen et al. (2009); 
intratracheal between 4 and 20 mg kg-1: Meng Tang et al. (2011); intraarticular 
between 2 and 20 mg kg-1: Wang et al. (2009)) and size and shape of NPs. 
Significant increases in biomarkers found in the blood plasma such asaspartate 
aminotransferase–alanine aminotransferase (ALT/AST) ratios have been 
demonstrated following high doses of TiO2 NPs (unknown crystal form) (500 mg kg
-1 
bw) via intraperitoneal injections (lower doses 200mg kg-1 had no effect) (Guo et al. 
2009). Increases in the ALT/AST ratio above the upper limit of normal are indicative 
of hepatocellular injury (Gopal and Rosen, 2000). This result was supported by 
previous studies by Wang et al. (2007, 2009). Moreover, several experiments have 
demonstrated histopathological changes and hepatocyte ultrastructural changes 
which would lead to impaired liver function, such as the fatty degeneration of 
hepatocytes, central vein infiltration of inflammatory cells in the portal area and 
apoptotic and necrotic cells (Wang et al. 2007; Duan et al. 2010; Cui et al. 2011). In 
contrast, some studies have reported no effects on liver function and morphology 
(Fabian et al. 2008; Liang et al. 2009). Fabian et al. (2008) demonstrated no toxic 
effects in a range of organs following one intravenous administration of TiO2 (70/30 
anatase rutile: 20-30 nm diameter at 5 mg kg-1 bw) even though detected TiO2 levels 
were highest in the liver. Direct comparison between studies is problematic, although 
a possible explanation for the lack of effect observed in the studies by Fabian et al. 
(2008) and Liang et al. (2009) may be due to the dosages of TiO2 administered (a 
function of concentration and time). Both studies performed single exposures whilst 
Wang et al. (2007) administered a very high dose and Guo et al. (2009) performed 
repeated exposures over a given time frame.  
 
1.3.3 Kidneys 
The literature on renal pathology following exposure to TiO2 NPs is contradictory. 
Several in vivo studies have identified changes in renal markers such as increases in 
blood urea nitrogen (BUN), e.g. Wang et al. (2007) and Guo et al. (2009) following 
exposure to TiO2 NPs, whilst some studies have reported the opposite (Liu et al. 
2009). The same pattern emerges when comparing renal histopathology of animals 
exposed to TiO2 NPs. Fabian et al. (2008) demonstrated no NP-induced 
nephrotoxicity following intravenous administration of anatase (< 100 nm, one dose 
of 5 mg kg-1) and this was also demonstrated by Liang et al. (2009) (intratracheal 
installation of anatase and rutile NPs 0.5, 5, or 50 mg kg-1 (one dose)). In contrast, a 
number of studies have observed histopathological changes in the kidneys, such as 
glomerula swelling, deposition of proteinic liquid in proximal tubules, apoptosis or 
vacuolization of the renal epithelieum, cell abscission, fatty degeneration or cell 
necrosis, and increased concentrations of inflammatory cells following intragastric, 
intrarticular and interperitonel administration of TiO2 NPs (Wang et al. 2007- 
intragastric; Wang et al. 2009: intraarticular; Gui et al. 2013: intragastric). The 
aforementioned studies that demonstrate renal histopathology used repeated 
exposures of TiO2 (chronic exposure) or extremely high single doses (Wang et al. 
2007) suggesting excretion through the kidneys can become overloaded following 
chronic exposure or high doses of TiO2 NPs.  
1.3.4 Immune effects 
 
TiO2 NPs have been shown to interact with immune cells such as macrophages, 
monocytes, platelets, leukocytes and dendritic cells, and can trigger inflammatory 
responses (Skocaj et al., 2011, Vamanu et al., 2008, Palomäki et al., 2010). TiO2 NP 
exposure to human monoblastoid cell line (U937) induced apoptosis and necrosis at 
concentrations similar to those found in tissues surrounding Ti implants (Vamanu et 
al., 2008). Moreover, TiO2 NP exposure has been shown to induce the enhanced 
expression of a variety of pro inflammatory cytokines in murine macrophages and 
dendritic cells (Palomäki et al., 2010). For example Palomaki et al. (2010) reported 
nano TiO2 led to an up regulation of maturation markers and activated the NLRP3 
inflammasome leading to significant IL 1 B- secretion (Palomäki et al., 2010).  
In vivo immunodulating effects have also been demonstrated. For example Larsen et 
al. (2010) that intraperitoneal exposure to TiO2 NPs promoted a T-Helper type 2 cell 
mediated response.Moon et al. (2011) demonstrated the intraperitoneal exposure of 
mice to TiO2 NPs enhanced the growth of subcutaneously implanted B16F10 
melanoma through immunomodulation of B- and T- lymphocytes, macrophages and 
natural killer cells. Airway inflammation and increased immune activity has also been 
demonstrated after intranasal exposure to TiO2 NPs (Larsen et al., 2010, De Haar et 
al., 2006) evidenced by an increases in eosinophils, neutrophils and lymphocytes in 
BAL fluid. Whether these responses are TiO2 specific or simply inflammatory 
responses mediated by ROS or mechanical irritation is subject to debate and needs 
more research. 
 
1.3.5 Spleen 
The main functions of the spleen are to filter the blood, recycle blood cells and play a 
role in immunity. These functions are performed in two anatomically distinct regions, 
red pulp and white pulp. There is a concern that NP exposure may affect the 
composition and relative distribution of red and white pulp (Mebius and Kraal 2005).  
The toxicity of TiO2 NPs to the spleen following acute or chronic exposure has been 
demonstrated (Chen et al. 2009; Rossi et al. 2010; Sang et al. 2013; Tassinari et al. 
2014). Tassinari et al. (2014) orally exposed female mice to 0, 1 and 2 mg kg-1 
anatase TiO2 per day for 5 days and showed TiO2 aggregates in the spleen and an 
increase in white pulp area. Similar results were demonstrated by Sang et al. (2013) 
who exposed mice to 2.5, 5 or 10 TiO2 NPs mg kg
-1 body weight for 90 days via 
intragastric administration and demonstrated NP accumulation in the spleen and 
histopathological changes such as splenocyte apoptosis. In contrast Wang et al. 
(2007) administered one dose of (oral gavage) 5 g kg-1 TiO2 NPs and no 
histopathological changes were observed, even though substantial concentrations of 
Ti were detected in the spleen. Fabian et al. (2008) showed that Ti persisted in the 
spleen for 28 days following one intravenous administration of 5 mg kg-1 TiO2 NPs 
although there were no obvious health effects and organ function remained normal 
(Fabian et al. 2008). It appears that acute exposure is fairly well tolerated by the 
spleen, but chronic exposures appear to cause more pathologies (Chen et al. 2009; 
Rossi et al. 2010; Sang et al. 2013; Tassinari et al. 2014). The reasons are unclear, 
although some researches attribute this to prolonged oxidative stress in overload 
conditions (Li et al. 2010; Wang et al. 2011). Changes in red pulp may be due to 
respiratory stress (Stewart and McKenzie, 2002), whilst immune responses to NMs 
may be responsible for changes in white pulp and the processing and mobilisation of 
white blood cells therein (Swirski et al. 2009). 
 
1.3.6 Nervous system 
The potential for NMs to elicit toxic response in the brain and nervous system is a 
cause for concern. From a dietary perspective the concern is whether there may be 
a neurological hazard following chronic exposure to TiO2 in food and water. 
Studies have demonstrated an increase in Ti concentration in the brain, suggesting 
Ti or TiO2 from TiO2 exposures can circumvent the blood brain barrier regardless of 
the exposure route (intranasal: Wang et al. (2008), intratracheal : Li et al. (2010), 
intragastric: Hu et al. (2010),intraabdominal: Ma et al. (2010) and aerosol: 
Oberdorster et al (2004)) and induce histological and biochemical changes. Wang et 
al. (2007; 2008) have demonstrated that bulk and nano TiO2 can translocate to the 
central nervous system via the olfactory system in mice; and accumulate in the brain, 
mainly in the hippocampal regions (Wang et al. 2008). Fatty degeneration of the 
hippocampal tissue was observed in mice exposed to 80 nm and 150 nm particles 
but not 25 nm particles following a single oral administration of 5 g kg-1 (Wang et al. 
2007). In another study by Wang et al. (2007) (Table 1-3), changes in neurological 
biochemistry were demonstrated following exposure to TiO2 (25 nm, 80 nm (rutile), 
155 nm (anatase; intranasal instillation of 50 mg kg-1 every other day for 30 days). In 
all mice there was a significant elevation in brain Ti content, (Table 1-3) but, 
biochemical changes were only induced by 80 nm and 150 nm TiO2 particles (25 nm 
had no significant effect). These changes included a significant increase in 
norepinephrine (NE) and 5-hydroxytryptamine (5-HT). The authors were unsure of 
why the 25 nm particles had no obvious toxicological effect (Wang et al. 2007). In 
contrast, Hu et al. (2010) showed a decrease in NE and 5-HT following intragastral 
instillation of 5 nm anatase NMs (5, 10 and 50 mg kg-1 every day for 60 days) (Table 
1-3). Interestingly, TiO2 exposure caused significant disturbances in electrolyte 
homeostasis in mouse brain (Ca2+, Mg2+, Na+, K+, Fe and Zn) and inhibition of 
activities of Na/K ATPase, Ca2+ ATPase, Ca2+/Mg2+ ATPase (Hu et al. 2010). These 
conflicting reports maybe a function of the mode of particle administration (intranasal 
(Wang et al 2007) instead of intragastral Hu et al. (2010)). Nevertheless, changes in 
electrolyte homeostasis in brain tissue following repeated oral exposure, as 
demonstrated by Hu et al. (2010), should be a cause for concern even if the 
exposures used in this study are 10 fold higher than predicted human exposure 
scenarios. 
 
 
1.3.7 Cardiovascular toxicity 
 
The translocation of TiO2 NPs into systemic circulation suggests that they would be 
free to interact with the cardiovascular system. A handful of in vivo studies have 
demonstrated pathological effects to the cardiovascular system following oral or 
intraperitoneal exposure to TiO2 NPs (Wang et al., 2007, Liu et al., 2009, Bu et al., 
2010). For example, oral gavage of rats with a mixture of anatase and rutile NPs (50 
nm diameter) demonstrated increased levels of urine metabolites such as Aspartate 
aminotransferase (AST), creatine kinase (CK) and lactate dehydrogenase (LDH) in 
conjunction with mitochondrial swelling in heart tissue relative to control animals (Bu 
et al., 2010). Similar changes to biochemical serum parameters have been 
demonstrated by Wang et al. (2007) although histology of heart tissue demonstrated 
no visual pathologies. Other studies have also demonstrated pathological effects to 
blood vessels. For example, Nurkiewicz et al. (2008) observed systemic micro vessel 
dysfunction attributed to the adherence of polymorphonuclear leukocytes to micro 
vessel walls and the production of ROS following airborne exposures (1.5 -12 mg m-3 
for 240-720 mins) of nano TiO2 (crystal form unknown) . 
 
1.3.8 Reproductive and developmental toxicity 
A handful of studies have investigated reproductive and developmental toxicity 
following exposure to TiO2 NPs. Takeda (2009) demonstrated that subcutaneous 
exposure of pregnant mice to TiO2 NPs (25 and 70 nm; 16 mg kg
-1) at days 3, 7, 10 
and 14 can damage the genital and cranial nerves by altering gene expression 
associated with development (Table 1-3), indicating foetal development is sensitive 
to TiO2 administrations during pregnancy. Shimizu et al. (2009) supported this data 
by demonstrating that subcutaneous injection of anatase TiO2 NPs in pregnant mice 
alters a variety of genes associated with development and function of the CNS in 
male pups (Table 1-3). Furthermore, Yamashita et al. (2011) demonstrated that 
intravenously injected TiO2 NPs in pregnant mice were found in the placenta, foetal 
liver and brain, indicative of the transplacental transfer of TiO2 NPs. Moreover the 
female mice had smaller uteri and smaller foetuses than controls that were injected 
with the vehicle (saline) alone. There may be also be a risk of NP transfer to the GIT 
of the young through breast feeding, although to my knowledge no such research 
has explored this topic. There is limited research in this area and more needs to be 
performed with a view to understanding the processes underpinning maternal NP 
transfer to pre and post natal offspring.  
The effects of TiO2 NPs on the male reproductive system are not well understood 
although some experimental evidence suggests TiO2 NPs exert some toxic effects 
(Guo et al. 2009). Guo et al. (2009) showed reductions in sperm density and motility 
and increases in sperm abnormalities and germ cell apoptosis following 
intraperitoneal injections of TiO2 NPs. Interestingly histology of the testes and 
epididymis did not show any pathological changes.  
The TiO2 NP in food issue can best be thought of as a chronic exposure scenario. 
Therefore the central theme from a toxicological perspective is whether children 
chronically exposed to TiO2 NP containing food will demonstrate pathological health 
effects in 20 years’ time. Only time will tell. 
 
Table ‎1-3: Selection of studies assessing the toxicity of TiO2 NPs to in vivo murine models 
Type of 
exposure 
Organ/ System 
effected 
Crystal Phase 
composition 
Organism Results References 
 
Inhalation:  
Dose:10 mg m
-3
 for 
18 h a day for 2 
years 
 
 
Respiratory 
 
P25 Degussa TiO2 (15-
40 nm) 
 
100 female 
wistar rats. 
NMRI mice 
 
Rats: adenocarcinomas, squamous cell 
carcinomas increased 
Mice: no effect on tumour rates 
 
 
(Heinrich et al. 
1995) 
Inhalation: 
Dose:10, 50 and 
250mg/m
3
 for 2 
years 
 
Respiratory Fine TiO2 (< 2.5 µm) Rats Bronchioloalveolar adenomas and cystic 
keratinizing squamous cell carcinomas 
occurred at 250 mg m
-3
 exposure 
 
(Lee et al. 1985) 
Intracheal instillation: 
Dose: 1 – 5 mg kg
-1
  
Time: 3 months 
Respiratory 136, 150, 382 nm (rutile) 
25 nm (80% anatase/ 
20% rutile) 
Rats Pure rutile only produced transient 
inflammation. Anatase/rutile TiO2 produced 
pulmonary inflammation, cytotoxicity and 
adverse lung effects. 
 
(Warheit et al. 
2007) 
Intranasal instillation: 
500 µg kg
-1
 every 
other day  
Time: 30 days 
Nervous system / 
Kidney 
 80 nm (rutile) 155 nm 
(anatase) 
Female mice Pathological changes were observed in the 
hippocampus and olfactory bulb. The group 
exposed to anatase showed higher 
inflammation responses. Rutile group 
showed severe atrophy of the renal 
glomerus. 
 
(Wang et al. 2008) 
Intragastric 
administration: 5-50 
mg kg
-1
 every day for 
60 days 
Nervous system Anatase (5 nm) 20 female mice 
per group. 
Changes in neurotransmitters (Increase; 
NE, DA, 5-HT, Dopac. 
Decreased Na
+
/K
+
, Ca
2+
, Ca
2+
/Mg
2+
 
ATPase 
 
(Hu et al. 2010) 
Oral administration: 
(single gavage,   
Dose: 5 g kg
-1
 body 
weight 
Time: 2 weeks 
GIT/liver/ Kidney 25, 80, 155 nm (type 
unknown) 
Mice 
 
25 nm and 80nm particles caused liver and 
kidney damage in female mice. TiO2 
accumulated in liver, spleen kidneys. 
inflammation of cells in the chorion and 
mucosa of the stomach. 
 
(Wang et al. 2007) 
Intragastric 
administration: 2.5, 
5, 10 mg kg
-1
 bw 
every day for 90 
days 
Kidney Anatase (5 nm) 120 male mice Apoptosis, infiltration of inflammatory cells, 
tissue necrosis or disorganization of renal 
tubules, coupled with decreased body 
weight. 
Changes in gene expression: suppression 
of Birc5,Crap2, and Tfrc  
(Gui et al. 2013) 
  
Intragastric 
administration:  
Dose: 5-150 mg kg
-1 
for 30 days 
 
 
Spleen 
 
Anatase  
 
20 female mice 
per group 
 
Spleen O2, H2O2 levels increased. 
Histology indicated lymph nodule 
proliferation 
 
(Wang et al. 2011) 
Intraperitoneal 
injections: 200 and 
500 mg kg
-1
 every 
other day for 5 days  
Reproductive/Liver/Ki
dney  
5 nm (type unknown) 15 male mice 
per group 
Reduced sperm density and motility, germ 
cell line apoptosis. Liver: Increased 
ALT/AST ratio 
Kidney: Increase in BUN 
(Guo et al. 2009) 
 
1 Intraperitoneal 
injection :324 – 2592 
mg kg
-1
 bw 
 
Liver/Kidney 
 
Anatase (5 nm) 
 
10 male and 
female mice 
 
High dose groups- Liver: ALT and AST ratio 
increased. Fibrosis, necrotic and apopotic 
cells were detected. 
Kidney: severe lesions 
 
(Chen et al. 2009) 
 
Subcutanous 
injections: 100 µl of 1 
mg mL
-1
 at days 3, 7, 
10 and 14 
 
Reproductive / 
developmental 
 
Anatase (25 - 70 nm) 
 
6 pregnant 
mice per group 
 
Altered gene expression in cranial and 
genital nerve systems. Disorganised and 
disrupted seminiferous tubules, decreased 
sperm motility in male offspring 
 
(Takeda et al., 
2009) 
 
Subcutanous 
injections: 100 µg 
mouse
-1
 day
-1
 at 
days 3, 7, 10 and 14 
 
Reproductive 
 
Anatase (25 - 70 nm) 
 
14-15 mice per 
group 
 
Changes in gene expression related to 
development and function of the CNS in 
male pups 
 
(Shimizu et al., 
2009) 
1.3.9 Genotoxicity and Carcinogenicity 
 
In vivo genotoxicity studies are limited and there is a lack of agreement in the 
literature. For example, Trouiller et al. (2009) reported that TiO2 NPs administered in 
drinking water for 5 days, induced DNA damage and genetic instability in bone 
marrow and white blood cells of C57Bl/6J pun/pun mice. This was supported by 
Sycheva et al. (2011) who exposed mice to bulk and nano TiO2 (40, 200 and 
1000mg kg-1 daily for 7 days) via oral gavage and demonstrated genetic damage in 
the cells of bone marrow, fore stomach, colon and testis for both treatments. In 
contrast Bernard et al. (1990) fed rats diets containing 1 2 or 5% TiO2 (assuming 
adult rats eat 6 g of food per day 5% is equivalent to 300 mg day-1 per rat) coated 
mica for 130 weeks. They found no evidence that TiO2 coated mica elicited 
toxicological orbiologically important changes in survival, body weight gains, 
hematologic or clinical chemistry parameters or histopathology.. This could simply be 
down to surface properties of the material considering reactions generally take place 
at the surface of materials. Nevertheless, there are large knowledge gaps 
concerning the genotoxicity of TiO2 at physiologically relevant doses via oral 
exposures. The genotoxicity of a material does not necessarily imply carcinogenicity 
considering genetic damage can be repaired. Nevertheless a threshold level of 
genotoxicity is usually required carcinogenicity to occur. 
In vivo TiO2 NP induced carcinogenicity has been investigated by a number of 
researchers ((Bernard et al. 1990 and Borm et al. 2004), reviewed by Shi et al. 
(2013)). Lee et al. (1985) demonstrated that high concentrations of bulk TiO2 
particles (< 2.5 µm diameter: dose, 250 mg m-3 for 2 y; aerosol) have been shown to 
cause respiratory tract cancer in rats, whilst Heinrich et al. (1995) demonstrated 
chronic exposure to TiO2 NPs (15 - 40 nm diameter; exposure of 10 mg m
-3 for 2 ye 
followed by a 6- month holding period) were more tumorgenic in rats than bulk TiO2 
on an equal mass dose basis. A review of the aforementioned studies by Dankovic 
et al. (2007) suggested that TiO2 induced cancers are due to a secondary genotoxic 
mechanism associated with persistent inflammation.  
 
1.3.10 Mechanisms of toxicity 
Studies that demonstrate TiO2 toxicity generally attribute the mechanism to oxidative 
stress mediated by free radical formation leading to persistent inflammation, and 
subsequent DNA damage and mutations. Oxidative stress is essentially an 
imbalance between the production of free radicals (ROS) and the ability of the body 
to counteract their harmful effects through neutralization by antioxidants (Winston 
and Di Giulio, 1991). ROS consist of a group of partially reduced forms of molecular 
oxygen, such as hydroxyl radicals (.OH-), superoxide anion (.O2
-), hydrogen peroxide 
(H2O2) and lipid peroxides (Buechter 1988) which are free to react with cell 
constituents.  
Ashwood et al. (2007) proposed an alternative idea which suggested that TiO2 on its 
own is not particularly toxic. However TiO2 avidly binds lipopolysaccharides (LPS) 
with bridging calcium cations (see below). This may mimic bacterial cell surfaces 
thereby triggering proinflammatory responses (Ashwood et al., 2007). Hirayama et al. 
(2011) demonstrated this in macrophages using real time PCR. Exposures to 
TiO2/LPS increased expression of proinflammatory cytokines compared to TiO2 
alone or LPS alone implying a synergistic effect of TiO2/LPS in triggering 
proinflammatory responses.  
Wang et al. (2007) suggests another mechanism of toxicity in conjunction with 
oxidative stress. The aggregation of rutile TiO2 NPs observed in the kidney indicates 
an inability of the kidney to excrete these NPs leading to atrophy of the glomerus 
(Wang et al. (2007). Sayes et al (2006) showed that the aggregation of rutile TiO2 is 
severe in comparison to the other crystal forms. If these aggregates can form easily 
in the organism than the total aggregate size may supersede the renal filtration 
threshold resulting in atrophy and blockage of the tissue. 
Recently studies have demonstrated interference of TiO2 NPs with electrolyte 
homeostasis in cells and tissue (Hu et al. 2010; Koeneman et al. 2010; Simon et al. 
2010; Al-Jubory and Handy 2012). Exposure and internalization of anatase or P25 
TiO2 NPs appears to increase levels of intracellular calcium in various cell types 
(Human keratoncytes; Simon et al. (2010); Trout GIT tissue; Al-Jubory and Handy 
(2012); Mouse brain; Hu et al. (2010)). The mechanisms are unclear although Hu et 
al. (2010) demonstrated a reduction in activity of Ca2+ ATPase and Ca2+/Mg2+ 
ATPase. Inhibition of calcium efflux ATPases would result in an increase of 
intracellular calcium down the concentration gradient. Simon et al. (2010) suggested 
TiO2 interacts with the Golgi  and this interaction is responsible for increases in 
intracellular free calcium considering the Golgi is thought to play an important role in 
calcium pool regulation (Missiaen et al. 2007). More research is required on the 
mechanism(s) of TiO2 NP induced changes on electrolyte homeostasis. 
One of the limitations of research into the adverse effects of microparticles and NPs 
is that in vivo and in vitro studies are usually carried out on healthy tissues. Diseased 
tissue may allow for a greater absorption of NMs. This has implications for people 
with compromised GIT function. Research suggests that micro particles in the diet 
exacerbate the symptoms in conditions such as irritable bowel syndrome (IBS) and 
Crohn’s disease (Lomer et al. 2000; Powell et al. 2000). The effects are attributed to 
luminal constituents  adsorbing to particles (which form a corona surrounding the NP) 
such as LPS and calcium, mimicking bacterial cell surface and triggering an 
inflammatory response (Powell et al. 2000; Ashwood et al. 2007; Hirayama et al. 
2011). Perhaps TiO2 may act to aggravate Crohn’s and IBS (Lomer et al. 2000; 
Powell et al. 2000; Chaudhry et al. 2008). The assumption that these particles are 
inert may not be correct and further work is required to prove beyond doubt that TiO2 
is acceptable for human consumption. With increasing applications of TiO2 NPs in 
the food industry, there is an urgent need to evaluate the risk posed by chronic oral 
exposure to these particles, considering the demonstrated carcinogenic effects in 
rats following long term respiratory exposures and the toxicological responses to 
systemic body sites mentioned above.  
1.4 Absorption, Distribution and Excretion of NMs 
For systemic distribution and toxicity to occur via oral exposures, TiO2 NPs need to 
be absorbed or diffuse through the GIT and into the capillaries or lymphatic networks. 
The usual mechanism of metal uptake across biological membranes involves carrier 
mediated transport on metal ion transporters (Campbell 1995). Chemically stable 
NMs such as TiO2 that undergo limited dissolution are likely to be too large to use 
ion transporters and paracellular diffusion pathways, suggesting the most likely route 
of uptake will be by an endocytic mechanism at the apical membrane (Handy et al. 
2008; Fig. 1-3, 1-4). For small NMs (< 20 nm) that have a hydrophobic surface either 
through their surface chemistry or through incidental binding of anions found in the 
mucus (Handy and Maunder 2009) it remains possible that these NMs could 
passively diffuse through the cell membrane. For example Xia et al (2008) 
demonstrated that NMs with alternating surface attached hydrophilic and 
hydrophobic ligands could pass directly through the cell membrane and into the main 
cell compartment without causing membrane disruption (Xia et al. 2008). Given this 
evidence, a diffusional component for NP uptake that is both a function of particle 
size and particle surface hydrophobocity should be considered in particle uptake 
models.  
For particles that undergo dissolution in the gastric environment, bioavailability is 
assumed to be a function of metal speciation, since only certain metals will fit 
relevant transport pathways (Campbell 1995), although, there are some generic 
metal transporters that are known to transport more than one metal as long as 
oxidation state remains the same e.g. divalent metal transporter 1 (DMT 1).  
The absorption, systemic distribution and toxicity to systemic body sites following 
oral exposure to TiO2 NPs have been demonstrated in in vivo studies (Table 1-3, 1-4) 
e.g. Jani et al. (1994); Wang et al. (2007) and Tassinari et al. (2014). Organs that 
have increased Ti levels following  oral TiO2 exposures are the mesentery and 
lymphatic networks (MLN), liver, kidney, spleen, brain lungs and reproductive organs 
(Jani et al. (1994) Liver, spleen, lung, MLN; Wang et al. (2007)- liver, kidney, spleen, 
lung, brain; Tassinari et al. (2014)- spleen, thyroid, ovaries, uterus, testes). 
 
1.4.1 Distribution  
Aside from basolateral exocytosis from enterocytes into the lymph and capillary 
networks within the lamina propria, NP distribution may occur via M-cell 
macrophages which are transported to draining lymph nodes (LeFevre et al. 1978). 
When macrophages become full of inorganic particles they make their way to the 
spleen and liver to be recycled (apoptotic mechanisms) (Powell et al. 2010) and it is 
during this process that the NMs enter systemic circulation where particles are free 
to interact with plasma proteins (Deng et al. 2009) and/or bind to the surface of 
erythrocytes (Rothen-Rutishauser et al. 2006). The coronal environment of NMs 
could have substantial effects on the distribution of NMs (Hagens et al. 2007) (see 
below – Gut lumen environment).  
The liver receives blood directly from the GIT and can be considered the first internal 
target organ aside from the GIT itself. Following liver processing, blood will end up in 
the inferior vena cava (systemic circulation) where it will be redistributed to systemic 
body sites. Nutrient rich blood from the small intestine flows into the liver via the 
hepatic portal vein. Large microparticles could get stuck in hepatocytes removing 
them from circulation. Research by Jani et al. (1994) investigated the translocation of 
intra gastrically administered TiO2 microparticles (500 nm diameter) and showed that 
accumulation of particles in the liver and spleen was elevated compared to different 
body sites (Table 1-4) (interestingly no particles were found in the kidneys)et al. 
Systemic distribution and retention of particles will occur if the organism is unable to 
excrete the dietary load fast enough. 
Fabian et al. (2008) investigated the tissue distribution of intravenously administered 
(100% bioavailability) TiO2 NPs (70/30 anatase/rutile 20-30 nm, 5 mg kg
-1) with 
tissue Ti content being determined at days 1, 14 and 28 post exposure. Ti levels 
were highest in the liver > spleen > lung and kidneys at day 1 post exposure. Ti was 
retained in the liver and spleen for the duration of the experiment, whilst the Ti 
concentration of the lung and kidneys returned to control levels by day 14 and there 
was no detectable Ti in blood cells, plasma, brain, or lymph nodes following 
exposure, suggesting a rapid clearance of TiO2 from the blood into the liver spleen 
lungs and kidneys. Interestingly Wang et al. (2007) orally exposed mice to TiO2 and 
showed a small accumulation of NMs in the blood and significant accumulations in 
the brain (Table 1-4), suggesting route of administration (possibly coronal 
environment) impacts systemic distribution of particles. 
 
1.4.2 Excretion 
NMs in systemic circulation could be excreted in a number of ways. The most 
common/likely routes are expulsion through the urine, faeces and bile, although the 
possibility exists that any uptake routes may also act as excretory pathways (with the 
exception of injected exposures) (Fig. 1-1). Jani et al. (1994) calculated that 6.5% 
(12.5 mg kg-1 TiO2 per day for 10 days 500 nm diameter primary particle size) of an 
oral dose is absorbed in rat small intestine whilst the rest is excreted through the 
bowel (Jani et al. 1994). In contrast to these findings, the international program on 
the chemical safety for TiO2 suggests that most ingested TiO2 is excreted with the 
urine (WHO 1982).  
Cho et al. (2013) investigated and compared the distribution and excretion of TiO2 
and ZnO NPs following repeated daily oral exposures for 13 weeks in rats. had low 
absorption and Ti was almost entirely excreted via the faeces. None was found in the 
urine. In contrast Zn was detected in the urine at high concentrations. The authors 
concluded absorption of Zn from ZnO exposure was much higher due to increased 
dissolution rates of ZnO in the acidic gastric environment in comparison to TiO2. The 
maximum molecular weight for glomerular filtration is around 60 kDa (Handy et al. 
2008) indicating that NMs only a few nano metres across would pass in to the urine.  
Particles accumulated in the liver (Wang et al. 2007; Fabian et al. 2008) could 
migrate through hepatocytes to the gall bladder where they are re-released into the 
small intestine, or the particles may drain into the liver sinusoids into the hepatic vein 
whereby excretion through the kidneys becomes viable route. Clearance of particles 
from the liver via the bile duct into the small intestine is well known in pharmaceutics 
(Huggins and Froehlich 1966). Whether this happens in the case of insoluble NMs is 
subject to debate. Presumably material that is not absorbed following oral exposures 
will be expelled in the faeces as has been demonstrated by Jani et al. (1994) and 
Cho et al. (2013). 
Table ‎1-4: Organ Ti concentrations following in vivo oral TiO2 exposures in murine models 
 
 
 
Organism Dose (oral 
administration) 
Liver  Kidney Spleen Lung MLN Brain Blood 
(µg/ml) 
Reference 
Rat- Female 
Sprague 
Dawley  
(n = 6) 
500 nm diameter 
TiO2- 12.5 mg kg
-1
  d
-
1
 for 10 days. 
Samples on day 11 
 
87.34 0.005 8.09 273.17 545.92 Not 
measured 
5.25  Jani et al 
(1994) 
 
Controls Not stated Not stated Not stated Not stated Not stated Not stated Not 
measured 
Not stated 
Mice 80 nm diameter TiO2 
one dose of 5 g kg
-1
 
sampled 2 weeks 
post exposure 
 
19.85  2.25  2.4 3.15 Not 
measured 
0.85 0.65 Wang et al 
(2007)*** 
Controls Distilled water 
control 
0.45  0.75 0.63 1.00 Not 
measured 
0.15 0.4 
Rats (n = 8) 25 nm diameter 
anatase - 2 mg kg
-1
 
for 5 consecutive 
days. Sampled on 
day 6 
  
Not 
measured 
 
Not 
measured 
 
0.23 Not 
measured 
 
Not 
measured 
 
Not 
measured 
 
Not 
measured 
 
Tassinara et 
al (2013)*** 
Controls Distilled water control Not 
measured 
Not 
measured 
0.18 Not 
measured 
Not 
measured 
Not 
measured 
Not 
measured 
Rats-
Female 
Sprague 
Dawley 
(n = 11) 
26 nm (Anatase/ 
rutile – 80/20 
mix).1041.5 mg kg
-1
d
-
1
 for 13 weeks. 
Sampled one day 
after final gavage 
  
0.60 1.40 3.25 Not 
measured 
 
Not 
measured 
 
4.00 0.50 Cho et al 
(2013)*** 
Controls Distilled water control 0.60 2.00 2.00 Not 
measured 
 
Not 
measured 
 
3.25 0.45 
Wistar Rats 
9 weeks old 
200 nm diameter 
anatase 
Below LOD Below LOD Below LOD Below LOD 1.0 Below LOD Below LOD Geraets et al 
(2014)*** 
(n = 6) 10.9-12.0 mg kg
-1
 bw 
d
-1
 for 5 days.  
Sampled 24 h after 
last exposure 
 
Controls Distilled water control Below LOD Below LOD Below LOD Below LOD 0.5 Below LOD Below LOD 
1.4.3 Gut lumen environment 
Ambient chemistry has been shown to affect fate and bioavailability of NMs in all 
environmental and biological compartments. The behaviour and interaction of ENMs 
with the gut is influenced by a number of factors. Similar to metal chemistry, ENMs 
(colloids) behaviour (e.g. aggregation) are affected by abiotic factors such as pH, the 
presence of divalent ions, ionic strength of the surrounding matrix, concentration, 
collision frequency and temperature (Handy et al. 2008). Metal speciation models 
can be described as equilibrium models, whereas NP behaviour in ionic solutions 
can be described as a dynamic process where predicted behaviour is modelled 
using Derjaguin, Landau, Verwey and Overbeek (DLVO) theory (See Handy et al. 
(2008)). Factors that need to be accounted for when using DLVO to predict colloidal 
dispersion behaviours are particle physico-chemical properties, such as particle size, 
shape, surface area, concentration, surface charge (measured as zeta potentials) 
and surface coatings (Oberdorster et al. 2005; Abbott and Maynard 2010). Of 
primary significance to NP behaviour is surface charge and at what pH the point of 
zero charge (PZC) occurs for the NP in question. Outside the pH range of the PZC 
the electrical double bilayer will influence particle behaviour. In the context of the gut, 
pH changes dramatically from the oesophagus through to the colon and it can be 
expected, just from the view point of pH, that particle behaviour will be considerably 
altered.  
Further complicating particle behaviour is the environment surrounding the NMs. For 
example, viscosity of the matrix the NMs are in, the presence of peptides (e.g. 
enzymes, bacterial exudates) and macromolecules (e.g. humic substances, proteins) 
in the gut may synergistically interact to promote or hinder particle-particle 
interactions. There is limited information on the interactions of NMs with food matrix 
components and the effect this may have on intestinal epithelium, GIT microflora and 
the fate and behaviour of particles in the gastrointestinal tract. 
The gut lumen can contain a myriad of different types of natural particles, including 
viruses, organic matter/colloids, and metal particles, which will likely influence 
particle behaviour. As NMs enter the luminal environment they may become covered 
in a corona of biomolecules which gives the NM a biological identity and differing 
surface chemistry which can ultimately determine the impact and fate of the particle 
(Hellstrand et al. 2009).  
NP contact with the apical membrane of cells within the GIT will initially be subject to 
successful diffusion/migration of NMs through the mucus layer. Mucus is 
predominantly water (97%). The remaining constituent is composed of mucoproteins 
(principally the glycoprotein mucin) which contain sialic acid, carboxylic acid and 
sulphated residues (Creeth 1978; Handy et al. 2008). The mucoproteins are 
composed of mainly negatively charged ligands, and therefore mucus can be 
considered as a gel containing a fixed polyanionic matrix (Creeth 1978; Handy et al. 
2008). The diffusion of NMs through the mucus layer has been demonstrated e.g. 
Saltzman et al. (1994); Norris and Sinko (1997); Szentkuti (1997) and Olmsted et al. 
(2001). For example, Szentkuti et al. (1997) demonstrated that polystyrene 
microspheres (14 and 415 nm diameter) placed in the distal colon of rats could be 
observed adjacent to the mucosa, whereas larger microspheres (1.1 µm) remained 
in the mucus layer and the colon. This effect of particle size on diffusion has been 
supported by Norris and Sinko (1997) who calculated translocation permeabilities of 
polystyrene NMs in purified GIT pig mucin under steady-state conditions using a 
modified Ussing-type diffusion chamber. They showed that diffusion of particles over 
0.5 µm in size were hindered by the mucin layer. Nevertheless, the authors 
concluded that although mucin may be a significant barrier to the oral absorption of 
particles, the rate-limiting barrier for the absorption of NMs is ultimately the intestinal 
mucosa (Norris and Sinko 1997). The inability of larger particles to diffuse through 
the mucus is likely related to the mesh spacing between mucin fibres which has 
been shown to be between 20 and 200 nm (Olmsted et al. 2001). Smaller particles 
would diffuse unhindered through the mucus. NMs that do become trapped in the 
mucus through steric hinderence by mucoproteins may agglomerate. However, this 
would improve residence time and possible contact with the GIT epithelium through 
endogenous peristaltic movements.  
Food grade TiO2 (anatase) will have an electrical double layer (EDL) following 
consumption due to the ionic strength and varying pH in the GIT. The surface charge 
of TiO2 will change from positive (in the stomach) to negative in the intestine (due to 
the PZC of TiO2 at body temperature – see above). Similar surface charge changes 
will also occur in the mucus lining the GIT. Assuming absorption of NMs occurs in 
the small intestine in mammals as demonstrated in fish (Al-Jubory and Handy 2012), 
TiO2 NPs will have a negative surface charge in the small intestinal gut lumen and so 
will the mucoproteins lining the epithelial cells which would (from a purely chemical 
perspective) result in repulsive force. However, as the luminal pH increases there will 
be a reduction in cationic species within the mucus thereby creating larger gaps 
within the mucin fibres via electrostatic repulsion which in turn may facilitate direct 
TiO2 NP contact with the apical membrane (Handy and Maunder 2009) 
The changing pH along the GIT will act on the zeta potential (a measurement of the 
net charge contained within the electrical double layer (EDL)) of TiO2 NPs. Cho et al. 
(2013) demonstrated at pH 2 (gastric pH) that the zeta potential of TiO2 was 54.4 ± 
0.7 mV and at pH 8 decreased to 7.9 ± 2.7 mV suggesting particles would be more 
dispersed in the stomach and have a greater tendency to agglomerate in the 
intestine (assuming no other factors are involved\ this is unlikely because food matrix 
constituents and gut lumen environment will have an effect on particle behaviour). 
Nevertheless, more research is required to assess the PZC of the mucus 
constituents and the diffusion coefficients of metal oxide NMs through the mucus 
lining the epithelium. 
 
1.5 The molecular mechanisms of uptake 
The GIT has been exposed to natural NMs throughout evolution and has evolved 
mechanisms to take up nano scale particulates (Powell et al. 2010). For example, 
the ingestion of red meat exposes the GIT to ferritin particles which are 12 nm in 
diameter (including the protein shell) and contain an iron oxide core which is 6- 8 nm 
in diameter (Pan et al. 2009). Kalgaonkar and Lonnerdale (2009) showed that ferritin 
may be taken up by endocytosis into intestinal epithelial cells (enteryocytes). 
Insoluble NMs are too large to be taken up by ion or other transporters on the cell 
membranes (Fig. 1-3, 1-4) thereby pointing towards vesicular transport as the 
mechanism underpinning NP translocation (Handy et al. 2008). 
Endocytic mechanisms at the apical membranes of cells are generally categorised 
into two types, broadly according to the size of the endocytic vesicle; phagocytosis 
and pinocytosis. In phagocytosis, large particles are ingested. In pinocytosis fluid 
and solutes are ingested via small pinocytic vesicles. Pinocytosis is a constitutive 
process; it occurs continuously, regardless of the needs of the cell (Alberts et al. 
2008). Under the generic label of pinocytosis other endocytic process should be 
mentioned, such as clathrin-mediated endocytosis (CME), caveolae mediated 
pinocytosis and macropinocytosis. There are also pathways that are clathrin/caveolin 
independent (Kirkham and Parton 2005; Cheng et al. 2006). Surface chemistry and 
particle size will influence which endocytic process is utilised for NP internalisation. 
Rejman et al. (2004) demonstrated that uptake pathways of microspheres and 
nanospheres (50 – 1000 nm) in non-phagocytic murine melanoma B16 cells was 
strongly influenced by particle size. Internalization of microspheres with a diameter < 
200 nm involved clathrin-coated pits. With increasing size, a shift to a mechanism 
that relies on caveolae-mediated internalization occurred and became the 
predominant pathway of entry for particles of 500 nm in size (Rejman et al. (2004). 
The authors concluded that that particle size (ligand-devoid) can determine entry 
pathway. Whether different crystal phases of similar sized particles (such as anatase, 
rutile and brookite TiO2) also influences route of uptake is unknown and more 
research is required on this topic. 
 
1.5.1 Movement of NMs inside gut epithelium cells 
Little is known about the intracellular fate of endocytosed NMs in intestinal epithelial 
cells. However, immunofluorescence techniques have demonstrated endocytosed 
NMs co-localise with a number of different organelles at different times following 
vesicular uptake, such as early endosomes, late endosomes, lysosomes, Golgi 
apparatus and the endoplasmic reticulum (ER) (Cartiera et al. 2009). 
Depending on the endocytic process, NMs end up in endosomes, caveosomes, free 
floating in the cytosol or in another unlabelled type of vesicle. All the different 
endocytic pathways require a deformation (invagination) of the cell membrane 
followed by pinching off to form a vesicle. Once formed, the vesicle (dependent on 
uptake pathways) merges with an early endosomes or caveosome (just beneath the 
plasma membrane (Fig. 1-3). If particles are not retrieved from the early endosomes 
and returned to the membrane by transport vesicles (or passed on to basolateral 
excretory transport vesicles) they are passed on to the lysosomal pathway (Alberts 
et al. 2008). NMs endocytosed by the caveolae pathway are thought to be delivered 
to caveosomes (similar to endosomes except they avoid lysosomal degradation 
(Kiss and Botos 2009)). This pathway has been shown to be targeted by small 
viruses such as SV40 and polyoma virus (around 45 nm in diameter) (Soldati and 
Schliwa 2006) which allows virus genetic material proximal access to the nucleus. 
NMs taken up through caveolae may be subsequently released near the nucleus 
where NMs co-localise with the ER and the Golgi (Cartiera et al. 2009). Caveosomes 
are thought to have some sorting properties (Parton and Simons 2007). For instance, 
when cholera toxin is within caveosomes it is sorted to carriers that are destined for 
the Golgi complex (Torgersen et al. 2001). It is plausible that NMs may exploit this 
pathway and once in the Golgi could undergo basolateral exocytosis via the Golgi 
excretion pathway. It is well known that copper is basolaterly excreted via this 
pathway and that metals such as mercury can hijack this transport pathway (Handy 
et al. 2000; Hoyle and Handy 2005). Whether this can happen for insoluble NMs is 
subject to debate and requires more research. 
1.5.2 Alternative routes to transcellular uptake: Persorbtion and paracellular 
transport 
NP uptake from the intestinal lumen may also occur through the villus tip in a 
process known as persorbtion (Powell et al. 2010). Persorbtion is described as a 
passive process which occurs at a low frequency (O’Hagen 1996). The life span of 
an enteryocyte is between 3 and 6 days (Saladin 2009). During this time the 
epithelial cell migrates from the crypt up to the tip of the villus (much like an escalator) 
where it is sloughed leaving a hole in the villus tip allowing particles of up to 150 µm 
direct access to capillary and lymphatic networks (O'Hagan 1996). This method of 
uptake has been demonstrated in mice following exposures through drinking water 
containing 2 parts per billion (ppb) gold NPs for 7 days ad libitum (4, 10, 28 and 58 
nm diameter) (Hillyer and Albrecht 2001).  
Small NMs (< 3 nm) may translocate via the tight junctions of the epithelial cell layer 
(paracellular diffusion). Diffusion of solutes and presumably small NMs through tight 
junctions are a function of the innate permeability relating to the structure of the 
junction and osmotic environment (salt effect on aggregation) (Handy et al. 2008). 
NMs are generally too large to diffuse through the paracellular route although this 
route cannot be excluded for lipophilic NMs. The Ca2+ and Mg2+ rich environment in 
the tight junctions imply that NMs would aggregate rather than diffuse. However, if 
tight junction integrity is compromised then diffusion through the paracellular route 
may increase (Handy et al. 2008). 
Disorders of the gut epithelium that result in excessive inflammation (e.g. Chron’ s or 
ulcerative colitis) could reduce tight junction integrity (see review by Arrieta et al. 
(2006)) promoting paracellular diffusion. Studies have shown that citrate can 
increase the permeability of the tight junctions (Powell et al. 2010). Citrate is 
commonly used in oral food preparations (E331) and as a NP dispersant. Increasing 
tight junction permeability with citrate in small bowel tissue has been demonstrated 
by Froment et al. (1989). Froment et al. (1989) showed, under short circuit conditions, 
exposed tissue in the presence of citrate demonstrated a prolonged reduction in 
transepithelial electrical resistance (TEER), which is indicative of a reduction in tight 
junction integrity (Froment et al. 1989). Ussing (1982) put forward the idea that 
sodium-coupled solute transport (e.g., glucose and some amino acids) triggers 
contraction of the cytoskeletal elements of the enterocyte, resulting in the loosening 
of tight junctions (Ussing 1982; Sanderson and Walker 1993). Taken together this 
would suggest that both genetic and external dietary factors could alter tight junction 
permeability and potentially increase paracellular diffusion of NMs. 
 
1.5.3 Immunological tissue types 
Cells and tissues involved in GIT immune surveillance (M-cells of Peyer’s patches) 
have been implicated as areas where uptake of NMs is greatest (Hillery et al. 1994; 
Jani et al. 1994; Janer et al. 2014) (Fig. 1-4). M-cells are areas which sample the 
contents of the lumen and present endocytosed particles to immune cells. 
Macrophages will phagocytose a variety of inanimate particles such as glass or latex 
beads, asbestos fibres and TiO2, amongst others (Alberts et al. 2008), and drain into 
mesenteric lymph nodes where they could enter systemic circulation. The fate of 
macrophages within Peyer’s patches is unknown. 
Dietary studies in rats and mice have shown that TiO2 NP uptake occurs principally 
in the Peyer’s patches (Jani et al. 1994; Brun et al. 2014; Janer et al. 2014). This is 
supported by in vitro work on Caco-2 intestinal cells that had been differentiated to 
express M-cell characteristics. Rieux et al. (2005) showed that uptake of 200 nm to 
500 nm (diameter) latex particles was increased 1000 fold in comparison to normal 
Caco-2 cells (control) (Rieux et al. 2005). However, an in vivo (mice) study 
performed by Hillery et al. (1994) using 60 nm polystyrene spheres orally 
administered to mice showed that 40% of non-excreted particles (composed of 10% 
of total particle administered) in the small bowel were in non Peyer’s patch locations 
(Hillery et al. 1994) suggesting immune sampling is not entirely responsible for 
particle uptake in the intestine. 
 
 Fig. ‎1-3:Magnified epithelial cell highlighting possible mechanism of NP 
endocytosis and transport through a cell.  
NP entry into the cell may be mediated by many processes. 1-2) NMs in the extracellular space could 
adsorb a corona of biological molecules allowing NP’s to be endocytosed through receptor mediated 
processes (1) calveolae and 2) clathrin) (Hellstrand et al. 2009). 1) Particles taken up through 
calveolae dependent mechanisms end up in caveosomes (CV) (Alberts et al. 2008) which are ferried 
towards the endoplasmic reticulum (ER) and Golgi or (through an unknown mechanism) enter the 
nucleus (Alberts et al. 2008). Particles endocytosed through clathrin dependent processes end up in 
endosomes (E) where they are either transported to the Golgi or passed on to the Multivesicular 
bodies (MV) and either passed on to lysosomes, golgi, or recycled in vesicles destined for the apical 
membrane (4) pathway. Larger aggregates of Np’s (<500nm) can be endocytosed through 
macropinocytosis ending up in macropinosomes (MP). These vesicles then mature down the 
degradative pathway and become multivesiclar bodies (MV) which may fuse with lysosomes be 
recycled or passed on to the Golgi excretory pathway. 
 Adapted from Handy et al. (2008) 
Fig. ‎1-4: Idealised diagram of intestinal epithelium 
Substances in the gastric secretions must first diffuse into an unstirred layer comprising of 
water/mucus prior to transfer to the gut epithelium. NP’s may aggregate to organic matter in the gut 
and be trapped by mucus. Metal ions usually move through the cell using ion transport pathways. In 
contrast, small lipophilic organic chemicals can diffuse through the cells (transcellular diffusion), or 
between the cells via the tight junctions (paracellular diffusion). NMs are too large to be taken up by 
ion or other transporters on the cell membranes, and although diffusion cannot be excluded for 
lipophilic NMs. The Ca
2+ 
and Mg
2+
 rich environment in the tight junctions suggest that NMs would 
aggregate rather than diffuse through the paracellular route. If tight junction integrity is compromised 
then diffusion through the paracellular route may increase (Handy et al. 2008). Active M-cell uptake is 
likely to play a role in absorbing NP aggregates and when the phagocytes undergo recycling their NP 
contents may be released into systemic circulation.                                                       
1.6 In vitro techniques for studying metal uptake across GIT 
In order to comply with the 3 Rs regulatory testing is moving towards the use of 
alternative screening methods for assessing toxicity (see European-Commission 
(2014)). 
1.6.1 Caco-2 cell culture 
Monolayers of Caco-2 cells, derived from human colorectal adenocarcinoma, have 
been widely accepted as an effective and efficient in vitro model to predict intestinal 
metal permeability (e.g. Copper - Arredondo et al. 2000; Zerounian and Linder 2002) 
and more recently for NMs (e.g. TiO2 - Koeneman et al. 2010; Brun et al. 2014) 
(Table 1-5).   
The Caco-2 cell line differentiates into polarized cells that exhibit similar 
morphological and functional characteristics to intestinal enterocytes such as tight 
junctions and well differentiated apical brush borders (Peterson and Mooseker 1992). 
While Caco-2 cells are a useful proxy for exploring mechanism(s) of uptake, 
transport, accumulation and toxicity of metals and NMs, they do not accurately 
represent in vivo uptake rates in the human gut. Primarily, monolayers do not 
accurately represent the whole structure of the gut. Rather, they can be viewed as 
just one cell type in the mucosa (enterocytes). There is no mucus on the apical side 
of these cells which would likely increase NP contact with the apical membrane and 
subsequent uptake. Moreover, Caco-2 cells were originally immortalized from colon 
adenocarcinoma cells. Carcinoma cells have been shown to have high trace metal 
uptake rates due to increased cell proliferation, membrane turnover and higher 
concentrations of apical membrane metal transporters, which are characteristic of 
carcinoma cells rather than gut cells (Brookes et al. 2006). 
1.6.2 Isolated intestinal preparations 
An important aspect of research into metal uptake is the precise location of where 
these processes take place in the gut. The isolated whole gut sac technique 
(oesophagus through to colon) can be used to determine which sections of the gut 
are involved in metal uptake (Handy et al. 2000; Al-Jubory and Handy 2012). 
According to Handy et al. (2000) gut sacs are prepared by quickly removing them 
from the experimental animal and filling them with the test substance for up to 4 h. 
Subsequent analysis of tissue metal concentration serves as a useful proxy for 
determining the primary regions of the gut involved in metal uptake. Further 
experiments using the isolated perfused intestine can be performed on the GIT 
section that demonstrated increased metal accumulation with a view to ascertaining 
metal uptake rates and potential mechanisms. 
Historically the perfused intestine preparation has been used to study the uptake of 
water and solutes (Ando et al. 1986) (Table 1-5) in vertebrate gut and has also been 
used for measuring uptake of toxic metals (Handy et al. 2000; Hoyle and Handy 
2005). The technique involves removing a section of intestine, carefully everting it so 
that the mucosal epithelium is facing outward and placing it in a physiological gut 
saline (Fig. 1-5). The serosal part of the gut (now on the inside) is then perfused with 
gut saline via a peristaltic pump. This set up allows for manipulation of either the 
mucosal or serosal solution (e.g., temperature, addition of NMs, addition of 
pharmacological inhibitors etc.) to ascertain rates of metal/particle uptake or the 
mechanisms involved. The viability criteria of this type of preparation are confirmed 
by observing normal morphology, steady perfusate flow rate, low lactate 
dehydrogenase (LDH) leak into the mucosal and serosal solution, normal pH 
fluctuations and negligible leak of Na+ and K+ leak into the mucosal solution. Taken 
together these criteria are a robust indicator of a successful preparation. The utility of 
this preparation with NMs has been successfully demonstrated by Al-Jubory and 
Handy (2012) using trout intestine at 15°C, although it is unclear whether this 
preparation will work for NMs when the mucosal/ serosal solutions are heated to 
37°C for mammalian preparations.  
The benefits of intestinal perfusions preparations relative to cell culture models are 
preparations use healthy physiologically and morphologically normal tissues which is 
more representative of the in vivo situation; the quality of the data (e.g. 
representative uptake rates) is more relevant, assuming appropriate care has been 
taken during the preparation and suitable physiological saline(s) are used (species 
specific, isotonic solution). A weakness of the preparation is it is not particularly high 
throughput (in comparison to culture models) and the tissue has been removed from 
the animal which will effect autonomic nervous system activity.   
 
 
 
 
 
 
 
Fig. ‎1-5: Schematic of isolated everted intestinal perfusion 
This set up allows for easy manipulation of the serosal and mucosal solutions. In this study the test 
material was is in the mucosal solution. Pharmacological inhibitors can be placed in the serosal 
perfuste or the mucosal solution to investigate pharmacological effects on uptake accumulation and 
transport.
Everted intestinal segment 
Gassed and stirred mucosal 
solution 
Table ‎1-5: In vitro techniques for studying metal uptake and toxicity 
Technique Chemical Concentration Measured factors Results Author(s) 
Caco-2 cell culture 
(Flat plates) 
Iron, copper and zinc 5, 10, 20, and 50 µm 
Fe, Cu, Zn for 60 min 
Effect of increasing intracellular 
concentrations of iron zinc and copper 
on iron and copper uptake 
 
Fe uptake was reduced 
in the presence of high 
extracellular Cu and visa 
versa. 
Arredondo et al. 
(2006) 
Caco-2 cell culture 
(Hanging inserts) 
Copper chloride, Iron 
sulphate 
0.1-2 µm for 90 min The effect of cellular copper availability 
on uptake transport and absorption of 
Iron 
 
Removal of cellular Cu 
caused a doubling of 
iron uptake. 
Zerounian and 
Linder (2002) 
Caco-2 cell culture 
(Hanging inserts) 
 
Iron, Manganese, 
Copper 
0-15 µmol L
-1
 for 60 -90 
min 
Mechanism of iron absorption 
(vesiculare and ion transport across 
DMT1). 
Endocytosis is a 
fundamental aspect of 
intestinal iron 
absorbtion. Excess 
extracellular 
concentration of Mn and 
Cu reduced uptake of 
Fe across DMT1.  
 
Linder et al. 
(2006) 
Caco-2 cell culture 
(Hanging inserts) 
Anatase/ rutile mix 
TiO2 NPs. 
10, 100, 1000 µg mL
-1
 24 
h (acute) or 10 days 
(chronic). 
Trans epithelial resistance, uptake and 
transport of TiO2.  
 
1000 µg mL
-1
 TiO2 
caused a significant 
reduction in 
transepithelial 
resistance at 7 days. 
Relatively more TiO2 
accumulated in cells at 
lower concentrations 
 
Koeneman et al. 
(2010) 
Caco-2 cell culture 
(Hanging inserts) 
TiO2 NPs (12 nm) 
Anatase  
50 µg mL
-1
 48 h exposure Trans epithelial resistance 
Paracellular permeability, cell viability 
 
TiO2 accumulated in 
cells but was not 
present in the serosal 
compartment. Cell 
viability remained 
unaffected. 
 
Brun (2014) 
Perfused intestine 
(Rat) 
Calcium/ Mannitol 0.4 mM calcium chloride 
and 0.025 µCi mL
-1 
 
45
Ca. 60 mins exposure 
Active transport and passive  
transport of calcium, transport of 
labelled mannitol was taken as a 
measure of passive permeability 
 
High calcium increased 
passive transport of 
mannitol and calcium 
whilst reucing active 
transport of calcium. 
 
Rao (2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Perfused intestine 
(Rat) 
Copper and sodium Cu 31.5 µmol L
-1
 in 
isotonic solutions 
Effect of Na
+
 addition on Cu retention, 
effects of amiloride and furosemide 
 
Cu retention higher in 
the absence of Na
+
. 
Amiloride reduced 
copper uptake. 
 
Wapnir (1991) 
Perfused intestine 
Fish; African walking 
(Catfish) 
Copper 10, 50, 100 µmol L
-1
 for 2 
h at 22
0
C 
Intestinal Cu uptake, effects of ion-
transport inhibitors and manipulation of 
Cl
-
 gradient 
Water flux 
 
Cu tissue accumulation 
showed a dose- 
dependent elevation. 
Inhibition of anion 
transport caused a 3 
fold increase in copper 
absorption.  
 
Handy et al 
(2000) 
Perfused intestine 
(Fish; Rainbow trout) 
Inorganic mercury 0-100 µmol L
-1
 for 4 h Regional intestinal uptake of Hg, effects 
of amiloride and Ca
2+
 chelators 
 
Luminal exposure to 
[Hg] between 0 and 100 
μmol L
−1 
for 4 h showed 
a non-linear dose-
dependent accumulation 
with a maximum Hg 
uptake rate of about 103 
nmol g
−1 
h
−1 
 
Hoyle and Handy 
(2005) 
Perfused intestine 
(Fish; Rainbow trout) 
TiO2 NPs (P25) and 
Bulk 
1 mg L
-1 
for 4 h Intestinal Ti uptake 
Effects of inhibitors on uptake 
Water flux 
Overall mucosal to 
serosal uptake of Ti was 
0.85 ± 0.32 and 2.38 ± 
0.68 nmol g
-1
 h
-1 
for bulk 
and nano respectively. 
Vanadate abolished the 
serosal appearance of 
Ti. 
Al-Jubory and 
Handy (2012) 
1.7 Hypotheses 
The hypothesis of this study is that TiO2 particles are bioavailable and can 
translocate through gut epithelial cells and enter the serosal compartment mediated 
via vesicular energy dependent processes (Fig. 1-3, 1-4). It is hypothesised that the 
physico-chemical properties of NPs such as particle size and crystal structure will 
alter uptake rates and exert different physiological effects on tissues relative to bulk 
versions of the same material. However, it is possible that any ‘nano’ effect could be 
offset by the propensity of NPs to form agglomerates in high ionic strength solutions, 
so the cells and tissues may not be exposed to primary NPs but larger agglomerates.  
The following hypotheses will be tested: 
i. Bulk and nano TiO2 is taken up through intestinal cells via active processes, 
the rates of which are influenced by particle size and crystal structure. 
Pharmacological inhibitors will be used to investigate the mechanism(s) 
responsible (Chapters 2, 3 and 4).  
ii. Uptake of bulk or TiO2 NPs occurs without compromising epithelial layers. 
Viability will be assessed using LDH, histology and tight junction integrity 
(Chapters 2, 3 and 4). 
iii. NPs will exert different physiological effects in comparison to bulk versions of 
the same material (Chapters 2, 3 and 4). 
iv. TiO2 uptake occurs in the mammalian small intestine (Chapter 4). 
v. TiO2 uptake occurs in vivo at physiologically relevant doses following normal 
murine eating behaviour (Chapter 5). 
 
1.8 Aims of the Thesis 
The overall aim of this research is to explore NP uptake and effects of TiO2 on the 
GIT of mammals using Caco-2 cells, the perfused rat intestine and the whole rat. 
There is a lack of information on the effect of crystal structure on uptake processes, 
the mechanisms underpinning uptake processes and the rates of uptake across the 
GIT. There are currently large knowledge gaps on the absorption, and distribution of 
TiO2 following normal eating behaviour (physiologically relevant administrations of 
TiO2). This thesis will contribute to filling these knowledge gaps as well as informing 
the evaluation of hazards posed to humans following oral exposure to different 
crystal types of TiO2 NPs at physiologically relevant concentrations. 
The specific objectives of the study are: 
i. To determine the effect of crystal structure and size on uptake rates and 
accumulation in Caco-2 cells; 
ii. to assess the effect of cell maturation on uptake and accumulation; 
iii. to investigate; which part of the mammalian gut is responsible for uptake of 
TiO2 using the isolated whole gut sac preparation and explore the rates of 
particle (bulk and nano TiO2) uptake in the perfused intestine and the 
mechanisms of uptake in the perfused intestine; 
iv. to determine whether dietary TiO2 can be detected in vivo following normal 
murine eating patterns; and 
v. to compare the different methods of determining uptake and accumulation 
rates with a view to informing hazards presented to humans following 
exposure to physiologically relevant doses. 
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Chapter 2: Apical uptake and 
accumulation of different crystal 
structures of TiO2 nanoparticles by 5 
day old Caco-2 intestinal cells 
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2.1 Abstract 
The gastrointestinal uptake of different crystal structures of TiO2 was investigated 
using Caco-2 intestinal cells. The approach involved exposing cells to medium 
containing 1 mg L-1 of different forms of TiO2. Caco-2 monolayers exhibited time-
dependent uptake of Ti from TiO2 exposures of 1 mg L
-1 over 24 h, which was 
influenced by crystal type. Initial accumulation rates were 3.01, 2.75, 2.11 and 3.26 
nmol mg-1 protein h-1 for bulk, P25, anatase and rutile forms respectively. All 
exposures caused elevations of total Ti metal in the cells relative to the control 
(ANOVA P < 0.05). Electron micrographs of the Caco-2 monolayer showed the 
presence of particles inside the cells, and energy dispersive spectroscopy (EDS) 
confirmed the composition as TiO2. Incubating the cells with 120 IU mL
-1 nystatin 
(putative endocytosis inhibitor) or 100 µmol L-1 sodium orthovanadate (vanadate) 
(ATPase inhibitor) caused a large increase in Ti accumulation for all crystal types 
relative to the controls (ANOVA P < 0.05), except for the rutile form with vanadate. 
Incubating the cells with 90 µmol L-1 genistein (tyrosine kinase inhibitor) or 27 µmol 
L-1 chlorpromazine (clathrin-mediated endocytosis inhibitor) caused a large decrease 
in Ti accumulation relative to the controls (ANOVA P < 0.05). Cell viability measures 
were generally good (low LDH leak, normal cell morphology), but changes were 
observed in the electrolyte composition (K+, Na+, Ca2+, Mg2+) of exposed cells 
relative to controls. A rise in total Ca2+ concentration in the cells was observed for all 
TiO2 crystal type exposures. Overall, the data shows that Ti accumulation for TiO2 
NP exposure in Caco-2 cells is crystal structure-dependent, and that the 
mechanism(s) involves endocytosis of intact particles.       
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2.2 Introduction 
There is growing interest in the use of engineered nanomaterials (ENMs) in the food 
sector with suggested applications including the encapsulation of essential nutrients, 
the inclusion of nano minerals in food; and the use of ENMs as antibacterial agents 
to improve the shelf life or packaging of perishable goods (Aitken et al. 2006; 
Chaudhry et al. 2008; Tiede et al. 2008). ENMs are also used in oral personal care 
products (e.g., tooth pastes); in drinking water technology (Handy and Shaw, 2007); 
and have been proposed for medicines that are intended for ingestion (Garnett and 
Kallinteri 2006), It is therefore clear that humans are likely to be exposed to ENMs 
via an oral route, but current understanding of the bioavailability and uptake 
mechanisms of ENMs across the gut epithelium is limited (Panessa-Warren et al. 
2006; Bouwmeester et al. 2009).  
Bulk forms of titanium dioxide (TiO2) have been used in foods as a whitening agent 
(E171) for many years, and estimates of daily ingestion rates collectively for all 
forms of TiO2 are between 5 and 50 mg in Europe and the USA (Lomer et al. 2000; 
Weir et al. 2012). It is likely that a fraction of the traditional ingested bulk TiO2 was 
incidentally at the nano scale (estimated at around 35%, Weir et al. 2012), and with 
engineered TiO2 nanoparticles (NPs) now being available, it seems likely that 
increased ingestion of nano forms of TiO2 will occur (Weir et al. 2012). Studies with 
ultrafine (< 100 nm) TiO2 particles have shown respiratory toxicity and epithelial 
inflammation of the lung in rodents (e.g., Ferin and Oberdörster 1985; Ferin et al. 
1992; Bermudez et al. 2004; Warheit et al. 2007). Like the lung, the gut also 
consists of mucous epithelia and there are concerns that TiO2 NPs may be toxic to 
the gastrointestinal tract.  
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In vivo exposures using gut gavage to administer salines containing TiO2 NPs have 
confirmed oral toxicity in rodents. Wang et al. (2007) exposed mice to ultrafine (25 
or 80 nm) or fine (155 nm) TiO2 particles by single oral gavage. Although no clear 
acute mortality occurred, changes to serum biochemical parameters indicating some 
loss of liver function and liver pathology (inflammation, necrosis) was observed 
(Wang et al., 2007). In vivo studies with other metals have also shown toxicity to the 
internal organs with oral gavage (Cu NPs, Chen et al. 2006; Zn NPs, Wang et al. 
2008). In the latter, the symptoms also included gastrointestinal tract irritation 
(vomiting and diarrhoea) for the first few days (5 g kg-1 body weight of nano scale Zn, 
58 nm diameter NPs). However, the few studies where the TiO2 has been 
incorporated into animal feed show little systemic toxicity (e.g., fish, Ramsden et al. 
2009) indicating that the bioavailability of Ti in food is low.  
There is some evidence for the uptake of Ti and/or TiO2 NPs across the gut. Al-
Jubory and Handy (2012) recently reported nystatin-sensitive transepithelial uptake 
of Ti from TiO2 NPs across the isolated perfused intestine of trout, and found resting 
Ti uptake rates of around 1 - 2.4 nmol g-1 h-1; similar to that of other non-essential 
divalent metals (e.g., Cu, Handy et al. 2002). In humans, particle size and dose-
dependent increase of blood total Ti concentration following oral ingestion of 
anatase TiO2 has been observed (Bockman et al. 2000), providing some evidence 
for a particle size-effect on dietary uptake. Studies using cultured monolayers of 
Caco-2 cells suggest some Ti uptake, possibly of intact particles, without disruption 
to the epithelium (Koenman et al. 2010; Janer et al. 2014).  
However, the exact mechanism of TiO2 NPs uptake by the gut epithelium is unclear. 
The possibilities include uptake of dissolved metal ions by dissolution of the particles 
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in the gut lumen or in the mucus layer on the epithelial surface; and/or direct uptake 
of NPs by endocytosis-related pathways at the mucosal membrane (see review by 
Shaw and Handy 2011 on nano metals). It is also unclear if the bulk material uses 
the same uptake pathway as the equivalent nano form. The situation is further 
complicated by the existence of several different crystal structures of TiO2 including 
brookite, anatase and rutile (the latter two being more commonly produced; Chen 
and Mao 2007). Although cell culture studies have suggested some differences in 
the toxicities of the rutile and anatase forms (mostly in lung epithelial cells, Sayes et 
al. 2006; Singh et al. 2007), it is not clear if crystal structure influences the rate of 
uptake of Ti from TiO2 NPs by gut cells, or if the different forms have different 
uptake mechanisms.  
The overall aims of this research were to demonstrate the utility of the nascent 
Caco-2 cell line for Ti metal accumulation studies with TiO2 NPs and then to 
compare the uptake of Ti from the bulk and nano forms (size effect), as well as the 
effects of different crystal structures (anatase and rutile). The approach used 
electrically tight, confluent monolayers of Caco-2 cells at 4 - 5 days old to enable 
fundamental metal uptake studies without the confounding factor of incidental 
nutritional uptake by non-specific processes in the aged epithelium (e.g., absorptive 
food vacuoles). The experiments included detailed pharmacological investigations 
into solute transport pathways for metals using sodium orthovanadate ( a tyrosine 
phosphatase inhibiter and P-type ATPase inhibitor which blocks active ion transport 
(Cantley et al. 1978) and has been successfully demonstrated as an ion transport 
inhibitor in trout intestine (Al-Jubory and Handy 2012), as well as pharmacological 
studies to establish whether the different sizes or forms of TiO2 were using different 
pathways to enter the cells and whether there is a cholesterol dependent component 
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to uptake and accumulation. For example; nystatin which sequesters cholesterol to 
prevent the initiation of the non-specific lipid raft formation needed for membrane 
invagination during calveolae-based endocytosis (Ros-Baro et al. 2001; Le and Nabi. 
2003; Silva et al. 2006); chlorpromazine, which has been shown to inhibit clathrin 
mediated endocytosis; genistein which has been demonstrated to inhibit caveolae 
mediated endocytosis in vitro (Dos Santos et al., 2011); and amiloride which has 
been successfully used as a macropinocytosis inhibitor in vitro for NP uptake 
investigations (Koivusalo et al., 2010). Finally, measurements of electrolytes in the 
cells, biochemical measurements of cell integrity, and electron microscopy 
investigations were carried out to understand the physiological basis of any 
differences observed.  
2.3 Materials and methods 
Several experiments were performed using confluent monolayers of Caco-2 cells in 
culture medium (see below). The first series determined the total Ti metal 
accumulation in Caco-2 cells exposed to 1 mg L-1 of different forms of TiO2 (bulk, 
nano P25 which was a mix of 25% rutile and 75% anatase, nano anatase, or nano 
rutile) over 24 hours. Effects on cell viability (LDH activity in the media, cell 
morphology) and electrolyte concentrations were also measured. The second series 
of experiments involved pharmacological investigations to determine whether or not 
the observed Ti metal accumulation involved either solute transport or endocytosis-
related pathways for uptake at the mucosal (apical) membrane. In the third series of 
experiments, after having pharmacologically identified both solute transport and 
likely endocytosis components to Ti accumulation, pathways were probed using 
specific inhibitors of the possible routes involved for the different forms of TiO2. In 
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the present study, the authors adopt the same precise terminology for metal 
accumulation as used by Al-Jubory and Handy (2012). All data on Ti accumulation 
were normalized as a total Ti metal concentration in the cells, expressed as nmol Ti 
metal mg-1 cell protein (not TiO2 compound), and are distinguished from the mg L
-1 
of TiO2 compound added to the cell culture media when confirming the exposure. 
The phrase “total Ti metal concentrations” refers to the total mass concentration of 
Ti (not TiO2 compound) in the cells or relevant media determined by inductively 
coupled plasma optical emission spectroscopy (ICP-OES, Varian 725 ES, see 
below). It does not infer whether the Ti was present as particulate TiO2 or as a 
dissolved Ti species. The term “Ti accumulation” signifies a net increase in the total 
Ti metal concentration in the cells over time, determined by ICP-OES of the digested 
cells.  
2.3.1 Cell culture 
A human intestinal cell line, Caco-2 (brush border expressing, European collection of 
cell cultures; catalogue no: 86010202; the supplier indicated that these cells were of 
the same origin as the ATCC HTB-37 Caco-2 cell line) was routinely incubated in 75 
cm2, 200 mL flasks (Iwaki T75, Japan) containing 15 mL of Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% 
glutamine and 1% penicillin-streptomycin (100 IU penicillin and100 μg mL-1 
streptomycin), at 37 ºC and gassed with 95% air: 5% CO2. The DMEM, FBS, 
glutamine and penicillin-streptomycin was obtained from Lonza (Verviers, Belgium). 
For routine maintenance, the medium was changed every 48 h and the cells were 
sub-cultured by trypsinization. Experiments were conducted on cells between 
passage 60 and 75 (cells were purchased at passage 45) and antibiotics were 
withdrawn to avoid possible interference with ion transport ≥ 2 passages before 
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seeding the cells into 6-well plates (Iwaki microplates, Japan) for experiments. 
Preliminary trials were conducted to determine the optimum seeding density and 
time to confluence of the cells in 6-well plates by measuring the electrical resistance 
of the monolayer using an xCelligence real time label free cellular analysis system 
(Real-Time Cell Analyzer (RTCA), Roche Applied Science). In brief, the instrument 
monitors the change in electrical impedance associated with the electrical coupling 
of the epithelium during cell growth. Cells were grown on gold-coated wells 
(electrode), as cells adhered and spread across the well surface, increases in 
impedance were recorded. When confluence is reached, the impedance value (cell 
index) remains constant. A seeding density of 5 x 104 cells cm-2 produced confluence 
by 24 h ( Fig.2-1). Subsequently for all experiments, cells were seeded at 5 x 104 
cells cm-2 in the 6-well plates and, after an initial 24 h growth, the cells were left for a 
further 72 h to ensure both 100% confluence and that the cells were rested. The 
cells were also visually inspected (Phase contrast microscope, Olympus/CK30-F200, 
Japan) each day until they became confluent. Cell viability was checked by Trypan 
blue exclusion prior to seeding the flasks and 6-well plates. Briefly, 0.1 mL of a 0.4% 
solution of trypan blue in buffered isotonic salt solution (PBS) (pH 7.2 to 7.3) was 
added to 1 mL of cells and the mixture was immediately loaded onto a 
haemocytometer. Cells were counted and % viable cells were calculated as follows. 
% viable cells = [1.00 – (Number of blue cells ÷ Number of total cells)] × 100. 
Flasks with less than 90% cell viability were discarded. Lactate dehydrogenase leak 
(LDH) was also checked (see section 2.3.7). 
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Fig.  2-1 : Change in cell index over time for Caco-2 cells seeded at a density of 5 x 10
4
 cells cm
-2
. Cell 
index is a surrogate measure of impedance. Steady resistance is achieved at around 35 h post 
seeding. Plots are means ± SEM (n = 6) from the replicate data. 
 
2.3.2 Stock dispersions and materials characterisation  
Four different types of TiO2 were used (manufacturer’s information): (i) bulk TiO2 
powder (ACROS, Titanium (IV) oxide, New Jersey, USA), composed of 75% anatase 
and 25% rutile crystal forms (Al-Jubory and Handy 2012), at a purity of 98.0-100.5% 
TiO2. (ii) Ultrafine TiO2 NP type “Aeroxide” P25 (DeGussa AG, supplied by Lawrence 
Industries, Tamworth, UK) with a crystal structure of 25% rutile and 75% anatase 
TiO2 (purity was at least 99 % TiO2 maximum impurity stated was 1% Si), the 
average particle size was 21 nm. (iii) Anatase TiO2 NP form (US Research 
Nanomaterials, Inc, Houston, Texas, USA) with purity of 99% and 10-25 nm average 
particle size. (iv) rutile TiO2 NP form (US Research Nanomaterials, Inc, Houston, 
Texas, USA) with high purity, 99.9% and 30 nm average particle size. A stock 
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dispersion of 500 mg L−1 for each type of TiO2 was made  by dispersing the particles 
in 200 mL of ultrapure water (Millipore, deionised water) in a 500 mL pyrex glass 
container by vigorous manual shaking for 1 - 2 min. Preliminary studies identified the 
materials as a source of bacterial contamination of cell cultures and subsequently all 
stock dispersions and the dry powder were gamma irradiated to sterilise them (Red 
Perspex, Turntable Irradiation Geometry, Becton Dickinson, Plymouth, England). 
The radiation dose used was 36.42 - 40.72 kGy for 10 h to ensure sterility before 
starting cell culture experiments.  
The particle characterisation followed a similar protocol to our previous studies with 
TiO2 NPs in the intestine (Al-Jubory and Handy 2012). Briefly, sub samples of the 
500 mg L−1 stock dispersions made in ultrapure water were examined for primary 
particle size using transmission electron microscopy (TEM, JEOL-1200EX II) (Fig. 2-
2). The primary particle size was 103.2 ± 16 nm (mean ± S.E.M., particle numbers 
measured = 7), 22.8 ± 0.6 nm (mean ± S.E.M., particle numbers measured n = 169), 
16.4 ± 2.4 nm (mean ± S.E.M., particle numbers measured = 6) and 30.8 ± 2.5 
(mean ± S.E.M., particle numbers measured = 7) for bulk, P25, anatase and rutile, 
respectively. 
The particle size distribution was also determined using nanoparticle tracking 
analysis (NTA, Nanosight LM10, Nanosight, Salisbury, UK, laser output set at 30 
mW at 640 nm). In order to achieve reliable tracks of individual particles, a 10 mg L-1 
dilution in ultrapure water of the concentrated 500 mg L-1 stocks were used. The 
dispersions gave a mean hydrodynamic diameter of 179.3 ± 13.7, 7.1 ± 4.1, 142.3 ± 
14.4 and 88.3 ± 34.1 nm (mean ± S.E.M., n = 3) for bulk, P25, anatase and rutile, 
respectively (Fig. 2-2). Attempts were made to determine particle size distribution of 
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the materials in DMEM culture media. However, the medium alone contained a high 
background of apparent particulates (most likely NaCl crystals) and the DMEM 
medium with supplements gave particle size distributions with a smallest bin size of 
approximately 30 nm and average hydrodynamic diameters for the whole sample 
around 156 nm. Furthermore, the NTA of the DMEM with supplements gave  high 
particle number concentrations (90 x 106 particles) due to the presence of proteins, 
and  completely masked the particle counts due to TiO2 (4-10 times lower than that 
of the culture medium). Thus attempts to detect TiO2 particle distributions in the 
culture medium gave poor reproducibility by NTA due to this high background 
(SeeFig. 2-3). 
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Fig.  2-2:Transmission Electron microscope (TEM) images showing primary particles, and particle size distributions by 
nanoparticle tracking analysis (hydrodynamic diameter, Nanosight LM10) of; (A) bulk TiO2 particles, scale bar = 100 
nm, (B) P25, scale bar = 50 nm, (C) anatase, scale bar = 50 nm and (D) rutile, scale bar = 50 nm at a concentration of 
10 mg L
-1
 (dilutions of the 500 mg L
-1
 stocks) in Milliq water. Particle size distribution plots are individual examples 
from triplicate measurements. 
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Fig.  2-3 : Nanosight particle size distributions  of culture ready media. The histogram is an individual 
example from a triplicate of the culture medium without nanoparticles added. 
 
2.3.3 Experiment 1: Time course of Ti accumulation from different forms of 
TiO2 
This experiment determined the time course of Ti accumulation for the different 
forms of TiO2 in Caco-2 cells over 24 h. Confluent cells (72 h after seeding) were 
exposed to the cell culture medium (as described in section 2.3.1 minus antibiotics) 
containing 1 mg L-1 of  no added TiO2 (control), bulk, P25, anatase or rutile forms of 
TiO2. The six-well plate was the unit of replication in the experiment, with each plate 
containing cells with no TiO2 additions (2 control wells), and a well for each of the 
test materials. At least three plates were prepared for each time point in the 
experiments (n = 3 replicates/time point) and in order to avoid pseudo replication 
experiments were temporally separated and performed on different passages of 
cells. Dosing of the wells was performed by diluting the initial 500 mg L-1 stock to 10 
mg L-1 TiO2 in ultrapure water, and this secondary stock was mixed with fresh culture 
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medium (1 mL of the appropriate 10 mg L-1 TiO2 stock: 9 mL DMEM) to obtain a final 
concentration of 1 mg L-1 TiO2 for the exposures. Two mL of the appropriate media 
was pipetted into each well. Media and cells were then collected at 0, 2, 4, 6, 8 and 
24 h of exposure for total Ti determination, electrolyte concentrations and LDH 
activity (see section 2.3.6 and 2.3.7). 
 
2.3.4 Experiment 2: The effects of nystatin and sodium orthovanadate 
(vanadate) incubation on Ti accumulation 
Having established the time course of Ti accumulation in Caco-2 cells from exposure 
to the different forms of TiO2 the next stage was to assess the effect of mucosal 
(apical) additions of nystatin (a putative endocytosis inhibitor, Lewis et al. 1977) and 
sodium orthovanadate (a P-type ATPase inhibitor which blocks active ion transport, 
Cantley et al. 1978) on Ti accumulation. Cells were grown and exposed to 1 mg L-1 
of the forms of TiO2 as above, but, 1 h before to dosing with the appropriate particles, 
cells were pre-incubated with either 120 IU mL-1 of nystatin (dose to produce 100% 
inhibition, Lewis et al. 1977), or 100 µmol L-1 sodium orthovanadate (enough to block 
metal transport in the intestine, Handy et al. 2000), compared to drug-free controls 
with and without added TiO2 (n = 6 plates/treatment, with separate drug free controls). 
Inhibitors were dissolved in 500 mL of DMEM. This pre-incubation enabled the drugs 
to have direct contact with the cells without the risk of interference from the test 
materials (e.g. loss of bioavailable drug due to adsorption onto particles). The 
inhibitors remained in the medium throughout the experiment, and the appropriate 
TiO2 dose was simply added to the medium after the initial 1 h pre-incubation. After 
24 h cells and media were analysed as described in section 2.3.3..  
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2.3.5 Experiment 3: The effects of chlorpromazine, genistein and amiloride on 
Ti accumulation 
The second experiment above identified a nystatin-sensitive component to Ti 
accumulation, and the final series of experiments were carried out in order to identify 
which endocytosis-related mechanisms might be involved. Three different drugs 
were tested, and drug concentrations were selected after some range determination 
experiments. The drugs consisted of: 27 µmol L-1 chlorpromazine (a specific inhibitor 
of clathrin-mediated endocytosis, Wang et al. 1993), 90 µmol L-1 genistein (a tyrosine 
kinase inhibitor, which prevents caveolae scission and disrupts the actin 
cytoskeleton, Le and Nabi 2003) and 1.25 mmol L-1 amiloride hydrochloride hydrate. 
The latter is a well-characterised blocker of epithelial Na+ channels (Handy et al. 
2002), but may also prevent non-specific macropinocytosis (Iversen et al. 2011). 
Amiloride and chlorpromazine were dissolved in warm deionised water (to ensure all 
solids were in solution) at concentrations of 50 mmol L-1 and 3.7 mmol L-1 
respectively. Genistein was dissolved in  DMSO at a concentration of 9.25 mmol L-1. 
The stock solutions of each drug were filter sterilised (0.22 µm, Millipore) to prevent 
bacterial contamination of the cell cultures, before being diluted to the appropriate 
working concentrations (above) in the culture medium. The experiments were 
conducted exactly as above (n = 6 plates/treatment, with separate drug free controls), 
except that cells were pre-incubated for 1 h with the appropriate drug prior to the 24 
h TiO2 exposure. Samples for Ti, electrolytes and LDH were collected at the end of 
the experiment. 
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2.3.6 Titanium and electrolyte determination in cells  
Following careful removal of the culture media, the cells attached to the dish were 
washed twice with 2 mL of an isosmotic sucrose buffer (300 mmol L-1 sucrose, 0.1 
mmol L-1 ethylenediaminetetraacetic acid (EDTA), 20 mmol L-1 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), buffered to pH 7.4 with  2 mol L-1 Trizma 
base) to remove any residual culture medium and the external electrolytes therein. 
Cells were then carefully scraped off the bottom of the well (Fisher scientific cell 
scraper, 250 mm handle, 18 mm blade) and re-suspended in the well with 1 mL of a 
sucrose lysis buffer (the recipe above, but hypo-osmotic with only 30 mmol L-1 
sucrose). The resulting homogenate was pipetted into 13 mL test tubes (Fisher 
Scientific) and sonicated (power 100 Watt, setting 8 on the speed dialat a frequency 
of 22.5 kHz, Misonix incorporated, XL2000-010, New York) for 30 seconds to ensure 
the lysed sample was thoroughly lysed and mixed. Each sample was then gently 
centrifuged for 1 min to remove debris (~160 g, Heraeus instruments, Biofuge pico, 
Germany) and 200 µL aliquot of the supernatant taken fresh for measurement of 
LDH activity and protein (see below). The remaining 800 µL of the cell homogenate 
was digested in 1 mL of concentrated nitric acid (7 %) at 70 oC for 4 h, and total Ti, 
Na+, K+, Ca2+ and Mg2+ determined by ICP-OES. Samples were vortexed for 20 s 
prior to being drawn into the instrument to ensure mixing, and calibrations were 
performed with matrix-matched multi-elemental standards containing Ti, Na+, K+, 
Ca2+ and Mg2+ in 38% nitric acid. In the absence of certified reference tissues for 
TiO2 particle analysis, spike recovery tests were performed. Samples of cell 
homogenates were spiked with 200 µL of 10 mg L-1 of the different forms of TiO2 and 
showed procedural recoveries of 80.4 ± 4.2, 82.2 ± 1.5, 76.3 ± 4.7 and 75.7 ± 1.8 % 
for bulk TiO2, P25, anastase and rutile forms, respectively (mean ± S.E.M, n = 6 for 
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each material type). Checks on analytical precision showed low coefficients of 
variation within and between samples (< 5%).  
Electrolyte concentrations in the cell homogenates were normalised to cell protein 
content. The latter was measured in triplicate using the bicinchoninic acid (BCA) 
method (MC155208, Pierce, Rockford, USA). Briefly, 15 µL of sample was added to 
300 µL of the BCA reagents and the absorbance read at 570 nm (VERSA max, 
Molecular Devices, Berkshire, UK) in 96-well plates against bovine serum albumin 
standards. Calibrations spiked with and without 1 mg L-1 TiO2 showed no 
interference with the assay or colour reagent ( Fig. 2-4). 
 
 
Fig.  2-4 : The effect of 1 mg L
-1
 bulk TiO2 on BSA protein standards relative to control BSA protein 
standards (no TiO2). The plots are means ± SEM (n = 3) from the replicate data. Statistical analysis 
showed that there were no differences between standards in the presence or absence of 1 mg L
-1
 
bulk TiO2 (Student’s t-test P > 0.05 (*))  
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2.3.7 Lactate dehydrogenase activity 
Lactate dehydrogenase activity was measured in the cell culture media overlying the 
cells (medium LDH) and in the cell homogenates (cell LDH). For the former, 200 µL 
of cell culture media from each well was gently centrifuged for 1 min to reduce any 
cell debris/turbidity (~160 g, Heraeus instruments, Biofuge pico, Germany) and 100 
µL of the resulting supernatant was used in the LDH assay. For the latter, 200 µL of 
cell homogenate was sonicated and centrifuged (section 2.3.6) and then 100 µL of 
the cell supernatant was used in the LDH assay (Plummer, 1971). Briefly, 100 µL of 
sample (medium or cell supernatant) was added to a reaction mixture (2800 µL of 
0.6 mmol L-1 pyruvate in 50 mmol L-1 phosphate buffer at pH 7.4, plus 100 µL of 0.6 
mmol L-1 NADH solution), mixed directly in a 3 mL cuvette and the change in 
absorbance measured over 2 min at 340 nm (Helios ß spectrophotometer). The 
specific activity of the LDH was then calculated using an extinction coefficient of 6.22 
x 10-3 L mol−1 cm−1 . LDH activity is expressed as U mL-1 (µmol min-1 mL-1) of media. 
The percentage of LDH leak from the cells within each well was also estimated from 
the absolute total LDH activity of each well (cells + medium) divided by the LDH 
activity of the medium alone. 
 
2.3.8 Cell morphology and scanning electron microscopy 
Cell morphology was examined directly by phase contrast microscopy 
(Olympus/CK30-F200, Japan) during experiments, whilst separate runs of plates 
were carried out for detailed morphological investigations on fixed samples using 
bright field light microscopy and electron microscopy. Briefly for bright field light 
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microscopy, cells were washed in situ on the cell culture dish with Dulbecco’s 
phosphate buffered saline (DPBS, Lonza, Verviers, Belgium), then fixed with 5 mL of 
fresh methanol for 5 minutes, prior to staining with Giemsa (Giemsa’s stain solution, 
IVD, England). Plates were examined wet using light microscopy (Nikon, 803923-
Japan) and photographs taken using a digital camera (Pentax, K-X) (Fig. 2-5).  
For scanning electron microscopy (SEM), the cells were fixed in situ on the culture 
plates and a disk cut out of the plate wells for mounting on SEM grids. Briefly, cells 
were washed in sucrose wash buffer (section 2.3.6) and fixed for 1 h in 2 mL of 2.5% 
glutaldehyde in cacodylate buffer (0.1 M sodium cacodylate in water followed by the 
drop wise addition of 0.2 M HCl to a pH of 7.4). The cells were washed twice in 
cacodylate buffer prior to being dehydrated in a graded series of ethanol. Cells were 
critically point dried and carbon coated (EMITECH-K850, K450X). Samples were 
imaged and elementally analysed (SEM, JEOL/JSM-7001F, Oxford Instruments 
INCA X-ray analysis system) using a 15 KV accelerating voltage, at a working 
distance of 10 mm. 
A separate series of culture plates was prepared for transmission electron 
microscope (TEM) investigations (3 plates/treatment). It was not possible to 
produceTEM sections from cells adhered to the  plastic cell culture plates. Instead, 
cells were grown on well inserts (Millipore Millicell hanging cell culture insert, 0.4 µm 
pore size designed for 12 well plates) for up to 21 days. Then, in order to increase 
the chances of observing particles in the individual cells by TEM, the microplates 
were exposed to 10 mg L-1 of each form of TiO2 for 24 h (1 mg L
-1 used above). 
Inserts were fixed in 2.5% glutaraldehyde buffered in 0.1 M sodium cacodylate, pH 
7.2, and post-fixed in 2% OsO4. The specimens were then dehydrated in a graded 
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series of ethanol, infiltrated with Spur's resin (Agar Scientific, Essex UK), and 
embedded into coffin moulds using pure resin. Thin sections were cut (> 90 nm) and 
stained with 2% uranyl-acetate and lead citrate, and then examined by transmission 
electron microscope (TEM, JEOL-1200EX II). For block face analysis of the samples, 
specimens were viewed in backscatter imaging mode at an accelerating voltage of 
10 KV and elementally analysed (SEM, JEOL/JSM-7001F, Oxford Instruments INCA 
X-ray analysis system). 
 
2.3.9 Statistics 
Data was analysed using StatGraphics Plus Version 5.1 and shown as means ± 
standard errors (S.E.M) unless otherwise stated. After checking data for kurtosis, 
skewedness, and unequal variance (Bartlett’s test), one-way ANOVA followed by 
Fisher’s least squares difference multiple range test was applied to analyse 
treatment effects, or time effects where appropriate. In the time course experiment, 
two-way ANOVA was used to determine treatment x time effects. Where data were 
non-parametric, the Kruskal–Wallis test (analysis by ranks) was used and 
differences were located using notched box and whisker plots. In some cases the 
Student’s t-test was used to investigate the differences between pairs of data, or the 
Mann-Whitney U test where appropriate for non-parametric data. All statistical 
analysis used the default 95 % confidence limit. Curve fitting for time effects was 
performed using Sigma Plot Version 12.0. Curves were fitted to the raw data, 
although the figures show the mean values for convenience. 
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2.4 Results 
2.4.1 Cell health and viability 
The control cells (not exposed to TiO2 or treated with drugs) showed normal 
morphology (day 4 - 5) during the experiments with the cells remaining confluent and 
attached (Fig. 2-5) to the dishes with intact apical membranes, orientated in the 
correct way with the presence of uniform microvilli. This was also supported by LDH 
activity which remained below 0.2 U mL-1 of cumulative LDH release over the 24 h 
duration of the experiments. The control cells also showed normal electrolyte levels 
with negligible variation in cell electrolyte concentrations. For example, in the time 
course experiment the electrolyte levels in control cells were (mean ± SEM, n = 3 
plates / treatment): Na+, 6359 ± 581; K+, 867 ± 26 ; Ca2+, 16 ± 4 ; and Mg2+, 48 ± 1 
nmol mg-1 protein. The controls across experiments and batches of cells, all had low 
membrane leak, and although electrolyte concentrations showed some variability 
when expressed per mg of cell protein, the values remained in the normal range for 
this cell line. For example, the control cells in the second experiment also showed 
cumulative LDH values (measured over 24 h) in the medium of ≤ 0.15 U mL-1 or 
less, and the ranges of electrolyte concentrations in these controls (from n = 6 plates) 
were: Na+, 4518 ± 533; K+, 718 ± 14; Ca2+, 11 ± 1; and Mg2+, 43 ± 1 nmol mg-1 
protein.  
Similarly for the experiments with inhibitors, the control cells incubated with drugs in 
the absence of TiO2 showed normal morphology and remained adhered to the 
dishes. Cumulative LDH was low (mean ± SEM, n = 6 plates, 0.15 ± 0.5 U mL-1) 
except for cells incubated with 1.25 mmol L-1 amiloride which exhibited a cumulative 
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leak of 0.354 ± 0.026 U mL-1 (Table 2-1). Metabolic and ion transporter inhibitors are 
expected to cause variations in electrolyte levels and some statistically significant 
changes occurred in the electrolyte concentrations relative to the appropriate no 
added drug controls without TiO2 (Table 2-2). For example, additions of vanadate 
caused elevations of cell Ca2+ concentrations and depletion of K+ consistent with ion 
diffusion down their respective electrochemical gradients. Additions of nystatin 
resulted in increases of all the major electrolytes in the cells compared to drug-free 
controls without TiO2 present (Table 2-2). Conversely, additions of chlorpromazine 
depleted cell K+, Na+ and Ca2+ (Table 2-2). Genistein notably caused a 2.7 fold 
increase in cell Ca2+ concentration, and also lowered cell Na+. Amiloride caused the 
expected Na+-depletion consistent with block of the epithelial Na+ channel, but also 
caused K+ and Ca2+ to rise compared to the drug free control without TiO2 (Table 2-
2).  
Cells incubated with the different forms of TiO2 also demonstrated low cumulative 
LDH leak (0.15 ± 0.05 U mL-1), normal morphology (confluent monolayer, orientated 
correctly) (Fig. 2-5 A) and reasonably consistent electrolyte concentrations within the 
physiological range, although there were some TiO2-dependent changes in ion 
concentrations (Table 2-2). 
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Fig.  2-5: Cell morphology after 96 h post seeding following a 24 hour exposure to 1 mg L
-1
 TiO2 crystal 
forms. A) control SEM demonstrating appropriate orientation , confluence and brush border 
development ; B) control Light microscopy (LM); C) bulk exposure LM; D) P25 exposure LM; E) 
anatase exposure LM; F) rutile exposure LM. (n = 3 plates per treatment) Scale bar = 100 µm, stained 
with Giemsa’s stain. 
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Table ‎2-1: Cumulative LDH leak from Caco-2 cells at 24 h following exposure to 1mg L-1 of different TiO2 forms in the presence or 
absence of inhibitors 
 
Treatment     No drug 
Chlorpromazine 
(27 µmol L-1) 
Genistein 
(90 µmol L-1) 
Amiloride HCL 
(1.25 mmol L-1) 
Control U ml-1 External medium 0.129 ± 0.009a  0.158 ± 0.015a 0.184 ± 0.019a 0.354 ± 0.026b 
 Uml-l Cell homogenate  1.565 ± 0.034a 1.558 ± 0.033a 1.584 ± 0.023a 1.277 ± 0.051b 
 % LDH leak  7.723 ± 0.522a 9.346 ± 0.918a 10.56 ± 1.08a 21.99 ± 1.54b 
Bulk U ml-1 External medium  0.153 ± 0.014a 0.143 ± 0.023a 0.176 ± 0.014a 0.407 ± 0.040b 
 U ml-1 Cell homogenate  1.577 ± 0.039a 1.620 ± 0.017a 1.622 ± 0.036a 1.420 ± 0.054a 
 % LDH leak  8.950 ± 0.717a 8.216 ± 1.270a 9.872 ± 0.56a 22.48 ± 1.39b 
P25 U ml-1 External medium  0.199 ± 0.014a 0.177 ± 0.024a 0.212 ± 0.027a 0.404 ± 0.031b 
 U ml-1 Cell homogenate 1.635 ± 0.094a 1.658 ± 0.109a 1.593 ± 0.011a 1.263 ± 0.109b 
 % LDH leak  10.95 ± 0.136a 9.668 ± 0.686a 11.88 ± 1.39a 24.81 ± 3.15b 
Anatase U ml-1 External medium 0.159 ± 0.017a 0.164 ± 0.012a 0.196 ± 0.054a 0.288 ± 0.054b 
 U ml-1 Cell homogenate 1.578 ± 0.031a 1.551 ± 0.022a 1.609 ± 0.018a 1.072 ± 0.052b 
 % LDH leak  9.271 ± 0.947a 9.691 ± 0.766a 10.88 ± 2.703a 21.13 ± 2.92b 
Rutile U ml-1 External medium  0.152 ± 0.011a 0.138 ± 0.007a 0.185 ± 0.030a 0.413 ± 0.064b 
 U ml-1 Cell homogenate 1.550 ± 0.013a 1.539 ± 0.044a 1.604 ± 0.047a 1.404 ± 0.054b 
 % LDH leak  9.086 ± 0.623a 8.374 ± 0.578a 10.46 ± 1.63a 22.81 ± 2.11b 
 
Data are expressed as means ± S.E.M. (n = 6). Values are expressed as µmol min
-1
 mL
-1
 (U mL
-1
). Different letters indicate statistically significant differences within rows 
(ANOVA P > 0.05). The % leak was calculated from the absolute LDH activity of each well (cells + medium) divided by the LDH activity of the medium alone.  
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Table ‎2-2: (Experiments 2 and 3): The total intracellular K+, Na+, Ca2+, and Mg2+ nmol Metal mg-1 protein following exposure to 1mg L-1 
TiO2 forms in the presence and absence of drugs (Series 2: nystatin and vanadate; Series 3, chlorpromazine, genistein, amiloride HCL) 
for 24 h  
 
Electrolytes (nmol mg-1 protein) 
Experiment  2                Control                 Bulk                   P25 Anatase        Rutile 
K+ No Drug 718.8 ± 14.2a 663.9 ± 28.3b 643.8 ± 19.6b 637.9 ± 27.6b 611.1 ± 11.4b 
 Nystatin 927.9 ± 50.8#a 828.8 ± 62.3#b 815.7 ± 30.0#b 822.7 ± 57.9#b  807.1 ± 41.2#b 
 Vanadate 466.8 ± 43.8#a 479.6 ± 36.9#a 469.3 ± 26.9#a 513.3 ± 16.9#a 490.7 ± 37.1#a 
Na+ No Drug 4518 ± 160a 4666 ± 576a 4793 ± 231a 5109 ± 624a 4319 ± 350a 
 Nystatin 6303 ± 468#a 5253 ± 445a 5144 ± 308a 5748 ± 455a 5202 ± 417a 
 Vanadate 3632 ± 427#a 4246 ± 406a 3982 ± 311#a 4457 ± 216#a 4534 ± 568a 
Ca2+ No Drug 10.6 ± 1.2a 14.3 ± 7.0a 28.0 ± 12.4b 20.8 ± 5.4b 19.1 ± 8.2a 
 Nystatin 25.7 ± 9.4#a 19.8 ± 2.2b 27.8 ± 5.7a 14.4 ± 4.6b 17.7 ± 3.1b 
 Vanadate 20.9 ± 3.6#a 25.2 ± 4.6#a 18.0 ± 7.2a 18.7 ± 4.1a 29.1 ± 2.4#b 
Mg2+ No drug 42.6 ± 1.1a 47.8 ± 2.2b 53.4 ± 2.7b 49.8 ± 1.4b 50.7 ± 1.5b 
 Nystatin 56.2 ± 2.9#a 55.3 ± 2.8#a 55.0 ± 1.8a 56.2 ± 4.4#a 55.0 ± 3.1a 
 Vanadate 30.9 ± 3.4#a 38.9 ± 3.1#b 39.4 ± 2.7#b 43.8 ± 2.3b 40.9 ± 2.8#b 
Experiment 3      
K+ No Drug 684.2 ± 16.8a 650.2 ± 31.8b 655.4 ± 19.7b 638.5 ± 25.0b 600.8 ± 34.4b 
 Chlorpromazine 565.2 ± 16.2#a 553.3 ± 40.3#a 534.4 ± 22.2#a 561.3 ± 33.2#a 550.9 ± 18.5#a 
 Genistein 642.5 ± 31.3a 634.6 ± 35.8a 686.5 ± 36.5a 653.7 ± 33.6a 663.4 ± 19.3a 
 Amiloride  1039.8 ± 273#a 977.1 ± 154#a 771.7 ± 120#b 795.0 ± 199#b 827.1 ± 121#a 
Na+ No Drug 6007 ± 359a 5671 ± 474a 5654 ± 365a 5528 ± 477a 4251 ± 337a 
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 Chlorpromazine 1364 ± 160#a 1266 ± 136#a 1100 ± 73#a 1070 ± 50#a 1041 ± 45#a 
 Genistein 3858 ± 396#a 4038 ± 257#a 4080 ± 342#a 4176 ± 208#a 4874 ± 843#a 
 Amiloride 4118 ± 457#a 3708 ± 902#a 3318 ± 802#a 3358 ± 1175#a 3067 ± 521#a 
Ca2+ No Drug 15.5 ± 1.6a 28.5 ± 5.1b 32.1 ± 7.3b 26.9 ± 4.9b 17.9 ± 1.4c 
 Chlorpromazine 12.5 ± 1.3#a 12.8 ± 1.6#a 11.7 ± 1.5#a 12.2 ± 0.8#a 10.1 ± 1.2#a 
 Genistein 48.3 ± 8.1#a 37.0 ± 2.9#a 38.2 ± 7.7#a 40.5 ± 2.4#a 36.1 ± 7.1#a 
 Amiloride 104.1 ± 17.1#a 173.9 ± 69.8#a 86.4 ± 41.1#a 70.1 ± 16.2#a 68.6 ± 11.1#a 
Mg2+ No Drug 40.2 ± 1.1a 40.7 ± 0.6a 41.5 ± 2.0a 39.5 ± 0.9a 37.7 ± 2.1b 
 Chlorpromazine 37.3 ± 1.0#a 38.8 ± 2.9a 36.2 ± 1.7#a 38.6 ± 2.4a 38.3 ± 1.3a 
 Genistein 38.4 ± 1.6a 40.6 ± 1.7b 43.7 ± 2.7b 42.4 ± 0.8b 43.9 ± 0.2#b 
 Amiloride  84.0 ± 5.0#a 70.4 ± 7.5#a 68.4 ± 3.7#a 71.4 ± 12.2#a 79.9 ± 8.3#a 
Values are means ± S.E.M (n = 6 for each group) and are expressed as nmol mg
-1
 cell protein. Different letters indicate statistically significant differences within rows. 
(ANOVA P < 0.05). 
#
 Statistically significant difference of drug controls and treatments relative to ‘no drug’ controls and treatments within column (ANOVA P < 0.05). Series 2 
is the data associated with experiment 2, series 3 is the data associated with experiment 3. 
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2.4.2 Experiment 1 - Time course of Ti accumulation from different forms of 
TiO2  
The time courses of Ti accumulation for exposures to the different forms of TiO2 are 
shown in Fig. 2-6. The unexposed control cells remained at a background metal 
concentration of around 2 nmol Ti mg-1 cell protein throughout. All the TiO2 
treatments showed a non-linear exponential rise of the total Ti concentration in the 
cells, which achieved steady-state concentrations by 24 h. This rise in net Ti 
accumulation by the cells occurred independently of similar elevations of cell Na+ or 
K+ concentrations which remained between 6500 and 9000 and 800 and 1000 nmol 
mg-1 protein, respectively; indicating that the Ti response was Ti-specific and not an 
artefact of general electrolyte changes in the cells. There were some differences in 
the time courses of Ti accumulation for the different forms of TiO2 (Fig. 2-6), and 
these were not explained by osmotic disturbances in the cells or by differences in 
membrane permeability across the treatments. For the latter, the cumulative LDH 
activity in the medium by 24 h remained low, at 0.15 ± 0.5 U mL-1 (not statistically 
different from the control, and no material-type effect was observed, ANOVA, P < 
0.05, Table 2-1). The net Ti accumulation by 24 h was in the following order by 
material-type: bulk and nano P25 > anatase > rutile > unexposed controls. The bulk 
material and P25 nano TiO2 showed the largest net Ti accumulation in 24 h, 
saturating at 14.1 and 13.64 nmol mg-1 protein, respectively, but were not statistically 
different from each other by 24 h (ANOVA P < 0.05). The anatase form showed 
approximately 40% less Ti accumulation than either the P25 or bulk material 
(statistically different by 24 h, Fig. 2-6). There were also some differences in Ti 
accumulation from the pure anatase and rutile forms, with the latter showing 
saturation at a slightly lower Ti concentration (Fig. 2-6). However, the mean values at 
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24 h were not statistically different (ANOVA, P < 0.05). The initial Ti accumulation 
rates calculated from the curves (Fig. 2-6) followed a similar pattern with Ti 
accumulation from the bulk and rutile being faster than those from anatase or P25. 
The initial accumulation rates were 3.01, 2.75, 2.11 and 3.26 nmol mg-1 protein h-1 
for bulk, P25, anatase and rutile, respectively. The times to 50% saturation were 2 h 
39, 3 h 09, 2 h 17 and 1 h 01 min for bulk, P25, anatase and rutile, respectively. 
Initial rates were determined from the equations of each line for each treatment by 
multiplying a * b (Schmid and Sapunov, 1982). The time to 50 % accumulation or t ½ 
was calculated as follows; t ½ = ln(2) / (rate constant), for each treatment.  
 
 
Fig.  2-6 (Experiment 1): Titanium accumulation in Caco-2 cells from exposures to 1 mg L
-1
 of different 
forms of TiO2 for 24 h. Data points are means ± SEM (n = 3 replicates/treatment). Curves were fitted 
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using Sigma plot version 12.0 to the raw data (n = 3 observations/treatment) using the rectangular 
exponential rise to the maximum function (f = y0+a*(1-exp (-b*x)). Equations for the curve fits were as 
follows: For bulk f = 2.64+11.54*(1-exp (-0.261*x)), r
2 
= 0.901; For P25, f = 1.16+12.54*(1-exp (-
0.22*x), r
2
= 0.875; For anatase f = 1.71+7.01*(1-exp (-0.3017*x), r
2
= 0.952; For rutile f = 
2.07+4.86*(1-exp (-0.67*x)), r
2
= 0.731. The unexposed control showed no time-dependent changes 
and therefore a curve was not fitted. Accumulation of all titanium forms is significantly different to the 
controls (ANOVA P < 0.05 (*)) at 24 h. Accumulation of Bulk and P25 titanium forms at 24 h is 
significantly greater than the anatase and rutile forms (ANOVA P < 0.05 (~)).  
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2.4.3 Experiment 2 - The effect of nystatin and vanadate on Ti accumulation at 
24 h  
Nystatin and vanadate incubation increased the level of Ti accumulation for 
exposures to all the forms of TiO2 (ANOVA P < 0.05), except for rutile TiO2 when 
incubated with vanadate (Fig. 2-7). This net Ti accumulation occurred without 
changes in cell membrane integrity (e.g. no membrane blebs were observed) and 
cells remained adhered to the culture dishes throughout. Apical incubations of 100 
µmol-1 vanadate caused the largest increases in Ti accumulation relative to the no 
drug equivalent control (all statistically significant, except for the rutile treatment, P < 
0.05), resulting in increases above the control value of 10, 12, 12 and 0.9 nmol Ti 
mg-1 cell protein for bulk, P25, anatase and rutile, respectively. Similarly, cells 
incubated with 120 IU mL-1 nystatin showed a statistically significant increase in Ti 
accumulation for all forms of TiO2 (ANOVA P < 0.05) with subsequent increases 
being 3, 4, 2 and 4 nmol mg-1 cell protein for bulk, P25, anatase and rutile 
respectively, above the equivalent no drug control with TiO2 (Fig. 2-7). 
 
2.4.4 Effect of titanium dioxide, nystatin and vanadate exposure on cell 
electrolytes concentrations at 24 h 
There were some TiO2-dependent changes in electrolyte concentrations in the cells. 
For example, all forms of TiO2 (no drugs present) caused some depletion of K
+ and 
elevation of cell Mg2+ concentrations compared to the no added TiO2 controls (Table 
2-2). There were also some crystal structure effects without drugs, notably a 
statistically significant elevation of Ca2+ following P25 or the anatase treatments, but 
not with the other materials (Table 2-2). These TiO2-dependent changes in 
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electrolyte concentrations in the cells were all with the electrochemical gradient, but 
were not associated with non-specific membrane leak (LDH leak remained low).  
Incubations of nystatin or vanadate in the absence of TiO2 caused some changes in 
cell electrolyte concentrations relative to the drug-free control (Table 2-2), but there 
were also some effects observed with drugs plus TiO2. For example, in the presence 
of nystatin, all TiO2 treatments showed an increase in cell K
+ concentrations. There 
was a material-type effect with nystatin causing some decrease in cell Ca2+ 
concentrations in the anatase and rutile treatments compared to the nystatin control 
(Table 2-2). Cells incubated with vanadate plus TiO2 exposure showed increases in 
cell Mg2+ for all types of TiO2.  
 
Fig.  2-7 (Experiment 2): Effect of nystatin and vanadate on Ti accumulation in Caco-2 cells incubated 
with 1 mg L
-1
 titanium forms at 24 h. The plots are means ± SEM (n = 6) from the replicate data and 
are expressed as ‘nmol [Ti] mg
-1
 protein’. Statistical analysis at 24 h time point showed that the levels 
of accumulation relative to the no drug controls were different (ANOVA P < 0.05 (*)). # indicates 
statistical differences between vanadate and nystatin (ANOVA P < 0.05). Letters represent 
differences between materials within drug treatment (material-type effect) (ANOVA P <0.05)).  
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2.4.5 Experiment 3: The effect of chlorpromazine, genistein or amiloride on Ti 
accumulation at 24 h 
Following the primary pharmacological experiments with nystatin and vanadate to 
broadly determine any involvement of endocytosis or active transport, respectively, 
in Ti accumulation, more detailed studies were performed with selective inhibitors 
(Fig. 2-8). Incubating the cells with genistein in the presence of TiO2 caused a 
statistically significant reduction (ANOVA P < 0.05) in Ti accumulation relative to the 
TiO2 exposure without the drug regardless of material-type (Fig. 2-8); indicating that 
genistein may block Ti uptake from all forms of TiO2. In contrast, incubations with 27 
µmol L-1 chlorpromazine only caused a reduction of Ti accumulation relative to TiO2 
exposure without the drug (ANOVA P < 0.05) for the bulk and anatase forms of TiO2 
(Fig. 2-8). Cell viability with TiO2 and chlorpromazine or genistein was as expected, 
with cumulative LDH activity remaining low (0.15 ± 0.5 U mL-1 for both drug trials) 
and not statistically different from the no drug controls, or the drug controls without 
TiO2 (Table 2-1). Cells showed no membrane blebs and did not detach from the 
dishes, suggesting the chlorpromazine and genistein effects on Ti / TiO2 
accumulation were physiological.  
Amiloride had no effect on Ti accumulation from TiO2 exposures, except for the bulk 
material which caused a relative increase in the total Ti metal concentration in the 
cells (Fig. 2-8). However, the apparent absence of an effect of amiloride on the cells 
during exposure to the nano forms of TiO2 may be due to some membrane leak. 
Amiloride-treated cells exhibited some of the highest cumulative LDH activity values 
with or without TiO2 present (between 0.35 and 0.45 U mL
-1 in the external medium 
(Table 2-1), being significantly higher than the leak in cells without amiloride 
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(ANOVA P < 0.05). Furthermore, visual inspection confirmed the presence of 
membrane blebbing on the cells. Protein content of the amiloride treated cells was 
lower than expected (< 150 mg cell protein well -1 compared to values of 400-500 mg 
cell protein well-1 for other treatments) which is likely responsible for the impression 
of increased or normal Ti accumulation in the cells. 
 
Fig.  2-8 (Experiment 3): Effects of chlorpromazine, genistein and amiloride on Ti accumulation in 
Caco-2 cells incubated with 1 mg L
-1
 titanium forms at 24 h. The plots are means ± SEM (n = 6) from 
the replicate data and are expressed as ‘nmol [Ti] mg
-1
 cell protein’. Statistical analysis at 24 h 
showed that the levels of accumulation relative to the no drug controls were different (ANOVA P < 
0.05 (*)). Letters represent differences between materials within drug treatment (material-type effect) 
(ANOVA P <0.05). 
 
2.4.6 Effect of chlorpromazine, genistein or amiloride on cell electrolytes at 24 
h 
Although incubations of the cells with drugs in the absence of TiO2 caused some 
changes in electrolytes (Table 2-2, experiment 3), the addition of the different forms 
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of TiO2 generally had no extra effect on the electrolyte concentrations. However, one 
notable exception was the effect of genistein on cell Mg2+ concentrations which 
increased in the presence of all forms of TiO2 compared to TiO2 exposure without the 
drug (ANOVA P > 0.05, Table 2-2, experiment 3). The relative increases in Ti 
accumulation above the control value were 2.2, 5.3, 4.0 and 5.5 nmol Ti mg-1 protein 
for bulk, P25, anatase and rutile, respectively, but there was no material-type effect 
on total Mg2+ concentrations in the cells. 
 
2.4.7 Electron microscopy studies to determine TiO2 particles inside the cells 
Electron micrograph images show particles within cells beneath the apical 
membrane in vesicles or in process of being endocytosed following a 24 h exposure 
to anatase or P25 TiO2 forms in the absence of drugs (Fig. 2-9 A, C, D and Fig. 2.9 
B, C, D). The particles were of the same crystalline morphology as the equivalent 
electron micrographs from the stock dispersions (Fig. 2-2), and the presence of Ti 
being confirmed by EDS (Fig. 2-9 and 2-10). Neither particles nor Ti were present in 
control cells (Fig. 2-10 A) and there did not appear to be any observable intracellular 
pathological differences in cells exposed to all forms of 1 mg L-1 TiO2 relative to 
control cells. Fig. 2-9 A, C and D show electron dense material in the scanning 
electron micrographs, and EDS confirms that these are Ti-rich electron dense areas 
underneath the apical membrane (i.e., inside the cells) and not between or 
basolaterally located underneath the cells. 
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Fig.  2-9: (A- D) SEM images of Caco-2 cells 96 h after seeding having been exposed to 1 mg L
-1
 TiO2 
forms. A) Backscatter image (BSI) of Caco-2 cells exposed to 1 mg L
-1
 ‘anatase’ TiO2‘A’ showing sub-
surface Ti with EDS spectra below ; B) Secondary electron image (SEI) of surface bound anatase 
TiO2 (scale bar represents 2 µm); C) BSI of ‘D’ showing subsurface Ti ; D) SEI image of cell surface 
exposed to P25 TiO2. The cell membrane appears to have covered the TiO2 (projections are microvilli, 
scale bar represents 100 nm); Spectra are labelled according to which image they belong to. The 
spectrum labelled Image D is the spectra associated with an EDS map of the entire image D. 
 
Surface Ti 
MV 
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Fig.  2-10: (A-D) TEM images of cells grown for 21 days in culture inserts; A) TEM of control cells ; B) 
TEM image of cells following exposure to 10 mg L
-1
 P25 TiO2 NPs (Note the invagination in progress 
(measuring 271 nm across)) (scale bar represents 1 µm; C) TEM image of intracellular matrix 
comprising of two vesicles containing NPs (Vesicles are of differing sizes 300 nm and 800 nm 
diameter, Scale bar represents 1 µm); D) SEM block face image in backscatter mode with EDS 
showing intracellular Ti underneath the apical membrane (scale bar represents 10 µm) The thickness 
of the monolayer is between 30 and 40 µm. 
 
2.5 Discussion 
The present study demonstrates that confluent and electrically tight Caco-2 cells are 
capable of Ti metal accumulation within a few days of the epithelial forming. The 
cells will accumulate Ti from TiO2 particle exposures, and the occurrence of deposits 
rich in elemental Ti and oxygen underneath the apical (mucosal) membrane 
suggests at least some of the TiO2 entered the cells in the particulate form. Caco-2 
cells show  drug-sensitive Ti accumulation which is indicative of an active uptake 
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mechanism(s). Critically, the Ti accumulation rate is dependent on the crystal 
structure of the material, with the nano rutile form being taken up the least. The 
differential drug sensitivity of the Ti accumulation suggests more than one pathway is 
involved in Ti accumulation from TiO2 exposures, and given the ability of Caco-2 
cells to exclude the rutile form, the possibility of crystal-structure specific pathways 
cannot be excluded.  
 
2.5.1 Accumulation of titanium from TiO2 exposures 
The present study showed time-dependent accumulation of total Ti metal in Caco-2 
cells which reached steady state from exposures to TiO2 particles (Fig. 2-6). This is 
indicative of an active accumulation mechanism(s) and cannot be easily explained 
by passive uptake of dissolved Ti metal down the electrochemical gradient, or by 
incidental uptake of intact particles through damaged cell membranes. The absence 
of an appreciable diffusive leak through the apical membrane is confirmed by the 
consistently low LDH activity in the external medium (0.1-0.2 U mL-1) in the presence 
of the different forms of TiO2. The incidental passive uptake of dissolved Ti metal by 
solvent drag with the major electrolytes is also extremely unlikely, as the cell Na+ 
concentrations did not change, and the K+ gradient is outward, in the opposite 
direction to that of the net Ti accumulation. In any event, TiO2 particles are poorly 
soluble at neutral pH in NaCl-rich gut lumen salines (Al-Jubory and Handy, 2012) or 
defined NaCl solutions (Schmidt and Vogelsberger 2009), releasing only picomolar 
concentrations of Ti metal that would be insufficient to support the accumulation 
rates observed here from the external medium (Fig. 2-6).  
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An active accumulation mechanism is also supported by the effects of addition of 
inhibitors such as vanadate or nystatin which both increased the net Ti accumulation 
in the cells (Fig. 2-7). The rate limiting step in metal uptake by epithelial cells is 
usually at the basolateral (serosal) membrane where efflux into the blood 
compartment must occur against the electrochemical gradient; and this is also true 
for metals like copper (Cu) that have a vesicular trafficking system which exudes Cu-
containing vesicles at the basolateral membrane by exocytosis (Arrendondo et al,, 
2000; Handy et al. 2000; Dameron and Harrison 1998; Kaplan and Lutsenko, 2009; 
Bury and Handy 2010). Blockage of the primary ion transporting ATPases on the 
basolateral membrane, or the ATPases involved in vesicular trafficking to the serosal 
compartment, will result in the observed net increase in Ti accumulation by the cells 
(Fig. 2-7). Similarly, nystatin which sequesters cholesterol to prevent the initiation of 
the non-specific lipid raft formation needed for membrane invagination during 
calveolae-based endocytosis (Ros-Baro et al. 2001; Le and Nabi. 2003; Silva et al. 
2006) should at least slow vesicular trafficking through the cell leading to the 
observed increase of total Ti in the cells (Fig. 2-7). Al-Jubory and Handy (2012) also 
showed that nystatin prevented transepithelial uptake of Ti from exposures of TiO2 
particles, and although the form of the Ti was not verified in the cells, this occurred 
with a concomitant increase of total Ti content of the gut epithelium. Nystatin does 
not block all modes of endocytosis (clathrin-based processes may continue, Chen et 
al. 2011). Regardless, the observed nystatin-sensitive Ti accumulation (Fig. 2-7) is 
indicative of active mechanism(s) for handling either Ti metal or TiO2 particles by 
Caco-2 cells.  
The total Ti accumulation was between 6 and 14 nmol Ti mg-1 cell protein in 24 h for 
Caco-2 cells for an exposure to 1 mg L-1 TiO2, depending on the form of the material 
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(Fig. 2-6). This is broadly similar to previous reports on this cell line in DMEM 
exposed to 1 mg L-1 TiO2 particles (e.g., Koeneman et al. 2010, 160 ng over 24 h). 
Initial uptake rates, which represent the maximum accumulation rate when the 
experimental system is not at steady-state, appear not to have been previously 
reported for Caco-2 cells. The initial rate of uptake for Ti accumulation was 3-5 nmol 
mg-1 protein h-1, depending on the form of TiO2 (Fig. 2-6). This maximum rate of 
accumulation is broadly similar to that for other metals; notably for copper (trout 
intestinal cells, 1.8 nmol mg-1 protein h-1, Burke and Handy 2005; Caco-2 cells, 0.1 
nmol mg-1 protein h-1 (the maximum rate of influx using radio labelled copper, 
Arrendondo et al. 2000)). The initial accumulation rates in the present study are also 
broadly consistent with the notion of nanomole rates of uptake in the perfused trout 
intestine (initial rates of around 1 nmol Ti g-1 tissue h-1 (Al-Jubory and Handy 2012). 
This similarity in Ti metal uptake rates with intact intestinal tissue may be fortuitous.  
While the Caco-2 cell line is a useful model for exploring relative differences between 
metal treatments, and the mechanisms involved, they are not intended to represent 
in vivo uptake rates in the human gut. Indeed, it is important to note that Caco-2 cells 
were originally immortalized from colon cancer cells. Subsequently, carcinoma cells 
have been shown to have high trace metal uptake rates due to increased cell 
proliferation, membrane turnover and higher concentrations of apical membrane 
metal transporters, which are characteristic of carcinoma cells rather than gut cells 
(Brookes et al. 2006). 
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2.5.2 Membrane maturity and the absorption of intact TiO2 particles 
It is well established that Caco-2 cells of only a few days old can be used for metal 
transport studies, provided the cells are confluent as a polarised monolayer with a 
steady measurable transepithelial resistance of around 250 Ω cm2 and/or have 
demonstrable unidirectional ion fluxes. Indeed, all of these parameters have been 
shown to occur within four days (Peterson et al. 1993; Yamashita et al. 2002; 
Zerounian and Linder 2002; Arrendondo et al. 2000; Moriya and Linder 2006; Linder 
et al. 2006; Sonnier et al. 2011). It is perhaps no surprise that electrolyte and trace 
element transport mechanisms are the first features of intestinal cells to mature 
(Dharmsathaphorn and Madara, 1990); for without these mechanisms in place, 
fundamental process to cell survival such as cell volume control would not occur. 
However, this is the first time that 4 - 5 day old confluent monolayers of Caco-2 cells 
have been used to study the accumulation of nano metals. For ‘intact’ nano particle 
uptake there may be some concern that the proteins necessary for vacuole 
formation and vesicular uptake are not yet localised to the apical membrane. This is 
not the case. Particles can be clearly seen directly under the apical membrane on 
the inside of the cell (Fig. 2-9 - 2-10), with the presence of TiO2 confirmed by EDS. 
Moreover, several of the electron micrographs captured the process of vesicular 
formation and membrane invaginations with particles being captured by the folding 
membrane (Fig. 2-10; B-D). This strongly suggests active processes, with large 
folds being reminiscent of macropinocytosis (Fig. 2.-10; B-D) and the smaller 
vesicles likely a form of endocytosis (Fig. 2-10; C). Peterson et al. (1993) also 
showed F-actin and villin are localised to the apical membrane by day 2-3 in Caco-2 
cells. Moreover, Peterson et al. (1993) also showed no statistical differences in the 
concentration of fodrin and myosin between day 3 and 21 in Caco-2 cells. In short, 
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all the molecular machinery for endocytosis are present in Caco-2 cells early on 
after the monolayer is formed and visual evidence of membrane invaginations are 
present in the current study. Thus Caco-2 cells of 4 days old (post seeding) can be 
used for both dissolved metal and NP metal studies. It was not possible to perform a 
quantitative analysis of the number of crystals or type within each vesicle from the 
electron micrographs (Fig. 2-10 B, C), but there appeared to be more aggregates 
composed of rounded particles rather than striated particles (rutile) in the 
invaginations and vesicles, tentatively suggesting that the anatase crystal form may 
be preferentially accumulated by cells. In contrast to research on metals, nutrient 
absorption studies (e.g., Au and Reddy 2000) tend to use cells around 21 days old 
since these express enzymes involved in digestive processes (e.g., alkaline 
phosphatase activity continues to rise; sucrose-isomaltase localises to the apical 
membrane (Peterson and Mooseker 1993). However, the advantage here is that 
metal transport can be studied without the confounding factors of nutritional 
processes, and for example the non-specific digestive vacuoles associated with 
feeding fully matured cells.  
 
2.5.3 Effect of particle - size and crystal structure on Ti accumulation 
Notably, the type of the TiO2 influenced the total Ti accumulation over 24 h with the 
bulk material showing the greatest uptake, and nano rutile TiO2 the least (Fig. 2-6). 
The bulk material effect may simply be explained on a mass basis. For every particle 
taken up by the cells, the larger bulk TiO2 would inevitably contain more Ti metal. 
However, the bulk material stock dispersions did have one of the higher particle 
number concentrations and mean aggregate sizes (Fig. 2-2), and it is possible that 
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the bulk material was more bioavailable in the experiments. Al-Jubory and Handy 
(2012) also noted this behaviour for the same bulk material in gut salines. Another 
explanation may be associated with the increased settling rate demonstrated by 
larger particles which would increase the contact time of bulk particles with the 
epithelial surface in this particular experimental set up (Teeguarden et al., 2007). 
There is also some evidence of a true-particle size effect on total Ti accumulation by 
the cells. In the present study, both the bulk and P25 materials were 25% rutile: 75% 
anatase (Al-Jubory and Handy 2012). In the time course study, there was generally a 
lag in uptake of P25 compared to the bulk material (Fig. 2-6), and the third series of 
experiments (Fig. 2-8) showed a clear statistical difference with less Ti accumulation 
from the P25 compared to the bulk material. There was also a trend of less Ti 
accumulation from  P25 compared to bulk material in the second experiment 
although it was not a statistically significant difference (Fig. 2-7). Particle-size effects 
on TiO2 uptake by Caco-2 cells have been controversial. Unlike, the present study, 
some reports have used high doses of TiO2 that caused toxicity (Liu et al. 2006; 
Trouiller et al. 2009; Koeneman et al. 2010; Ryabchikova et al. 2010), and are 
therefore unlikely to be measuring true physiological uptake. Whilst others have used 
a bulk material of unspecified crystal structure, perhaps not the same as the nano 
form, making it problematic to separate a true size-effect from any crystal-structure 
effect in the experimental design (Liu et al. 2006; Wang et al. 2007; Kobayashi et al. 
2009; Koeneman et al. 2010). 
There was a crystal-structure effect within the nano forms of TiO2, with the rutile 
being accumulated less than the anatase or P25 (Fig. 2-6). This is not readily 
explained by poor availability of rutile particles in the stock dispersions. Indeed, the 
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rutile form gave the highest particle number concentrations (Fig. 2-2). Unfortunately, 
it was not possible to reliably determine the total Ti metal concentrations in the 
medium over the cells for each crystal structure, as particle settling was observed 
during the experiments especially for the rutile form. Any settling would increase the 
contact of each test material with the cells. Nonetheless, there may be a biological 
reason for less Ti accumulation from the rutile TiO2 NP exposure. One possible 
explanation is that the Caco-2 cells are using different pathways to take up TiO2, 
depending on the form of the material (see below on pharmacology). Alternatively, 
there may be some aspect of cell surface recognition that excludes one crystal form 
over another. Interestingly, Ryabchikova et al. (2010) found that brookite and rutile 
forms of TiO2 NPs produced different morphologies of membrane invaginations in 
MDCK cells by electron microscopy. The authors tentatively interpreted these 
observations as a possible crystal-structure effect on plasma membrane fluidity. 
However, Ryabchikova et al. (2010) also noted a substantial loss of cell viability that 
was crystal structure-dependent (up to 60% of the cells staining with trypan blue at 
100 µg ml-1 of brookite TiO2), which could confound their data interpretation as non-
physiological.  
 
2.5.4 Pharmacological investigation and the accumulation of Ti from 
exposures to different crystal structures 
Having demonstrated that Ti accumulation was sensitive to vanadate or nystatin, 
more detailed experiments were performed with specific inhibitors (Fig. 2-8) to 
determine the pathways involved. These pharmacological investigations were 
intended to be physiological without causing damage to the cells. This was 
confirmed by the low LDH activity in the medium in the presence of drugs with/ 
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without TiO2 present (Table 2-1), and the normal morphology of the (adherent) cells 
in the presence of the drugs. The only exception was a small (0.3 U mL-1, Table 2-1), 
but statistically significant increase in medium LDH activity following exposure to 
1.25 mmol L-1 amiloride. However, this occurred without loss of cell K+ (Table 2-2) 
suggesting the effect was modest.  
Chlorpromazine is arguably a selective inhibitor of clathrin-mediated endocytosis and 
the drug prevents the formation of clathrin lattices at the plasma membrane which 
are essential to initiating the membrane invagination (Wang et al. 1993). In the 
present study, chlorpromazine caused a statistically significant decrease in Ti 
accumulation in Caco-2 cells for exposure to the bulk (contains anatase) and the 
nano anatase form, but not the P25 and rutile materials (Fig. 2-8). This could 
suggest that the anatase form is somehow better detected for uptake by the clathrin-
mediated endocytosis pathway. Such a hypothesis would require a specific receptor-
mediated detection of anatase TiO2 crystals by clathrin-coated pits, but how this 
might occur is unclear. 
Genistein is a tyrosine kinase inhibitor that can be used to manipulate cell volume 
control via its effects on the actin-cytoskeleton (Akiyama et al. 1987; Wodnicka and 
Burridge 1994), and for similar reasons also blocks caveolae-mediated endocytosis 
pathways (Razani.et al. 2002; Van der Ma et al. 2007). In contrast to chlorpromazine, 
genistein decreased the accumulation of Ti from all forms of TiO2, but had the largest 
effects on the rutile and P25 materials (Fig. 2-8). This might suggest that the rutile 
form especially is preferentially taken up through caveolae-mediated endocytosis, 
but the mechanism for this selection is unknown. There is also some cross-talk 
between the endocytosis pathways in mammalian cells, so secondary effects cannot 
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be excluded. For example, genistein may also inhibit F-actin recruitment to clathrin-
coated pits and therefore causes a secondary inhibition or delayed uptake via the 
clathrin-mediated pathway (Zhang and Monteiro-Riviere 2009). This might explain 
why genistein also has some effects on the anatase form of TiO2. A component of 
clathrin-dependent endocytosis also seems to occur without the involvement of 
specific receptors (Kirchhausen 2009). 
An alternative hypothesis to crystal structure-specific pathways of endocytosis is 
incidental size selection into each pathway by particle type. However, this idea is not 
easily explained by the data. For example, on a size basis, the bulk material might 
be expected to have its own pathway, but the drug-sensitivity profile (Fig. 2-8) does 
not support this. Nonetheless, it is curious that within the nano scale materials, the 
nano anatase TiO2 with the smallest primary particle size (16 nm) is the most 
sensitive to chlorpromazine, and the largest nano material (rutile, 30 nm) is affected 
the most by genistein. 
Alternative methodologies for investigating mechanisms of uptake such as SiRNA to 
specifically reduce concentrations of proteins associated with particular endocytic 
pathways (e.g. caveolin, dynamin) could be used to corroborate data produced from 
pharmacological inhibitor trials in light of recent evidence that suggests commonly 
used pharmacological inhibitors (chlorpromazine, genistein, amelirode) show poor 
specificity for inhibiting distinct endocytic pathways (Vercauteren et al., 2010).  
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2.5.5 Ionic regulation in Caco-2 cells during TiO2 exposure 
One of the functions of the gut epithelium in vivo is the absorption of nutritionally 
required electrolytes. Dissolved forms of toxic metals are known to interfere with ion 
uptake across the gut, and for example, Cu interference with Na+ homeostasis 
(Handy et al. 2002). This interference in physiologically functional cells is usually 
explained by competition for ion uptake down the electrochemical gradient through 
ion channels, and/or selective inhibition of specific ion transporters. In the present 
study, direct competition from dissolved Ti2+ is unlikely. Although, the Ti2+ ion has a 
crystalline ionic radius smaller than all the electrolytes reported here, except possibly 
for the Mg2+ ion (in order of size: Mg2+, 86 pm; Ti2+, 100 pm; Ca2+, 114 pm, Na+, 116, 
K+, 152 pm, (Shannon 1976), the appearance of appreciable dissolved Ti2+ in the cell 
culture medium by dissolution is extremely unlikely (solubility reasons above at 
neutral pH). In any event, the likely picomolar concentrations released would be 
easily out competed by the millimolar concentrations of the other ions in the media. 
Nonetheless, TiO2 exposure resulted in increases of the total Ca
2+ concentrations in 
the cells (Table 2-2). The reasons for this are unclear, but TiO2 is reported to 
interfere with Ca homeostasis in keratinocytes (Simon et al. 2010). There were also 
some increases in the Mg2+ content of the cells during the TiO2 exposures, and with 
most of the intracellular Mg2+ being normally bound to membranes inside the cell 
(Romani and Scarpa 1992; Juttner and Ebel. 1997) this may be incidental Mg2+ 
accumulation with endocytosis of TiO2 particles. The depolarising effect of the small 
decrease of the cellular K+ during TiO2 exposure (Table 2-2) would also slow active 
Mg2+ efflux on the Na+/Mg2+  exchanger (see Handy et al. 1996 for the latter). 
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The combined effects of ion transport inhibitors in the presence of TiO2 particles on 
cell electrolyte contents appear not to have been previously reported. In the present 
study, the combined effect of TiO2 plus nystatin caused a decrease of cell K
+ 
concentration compared to the drug alone. The combination of nystatin plus TiO2 
also caused less disturbance to cell Ca2+, with the presence of TiO2 counteracting 
the effect of the drug (Table 2-2). The combined effect of genistein plus TiO2 also 
ameliorated the effect of genistein alone to raise Ca2+. The reasons for these 
interactions require further investigation, and remain unknown.  
 
2.5.6 Conclusion 
This study shows that Caco-2 cells accumulate Ti from TiO2 exposures with 
characteristics that are most easily explained by active uptake of Ti-containing 
particles in physiologically competent cells. Critically, there is a crystal structure-
effect with the anatase form of TiO2 being absorbed faster than the rutile in time-
matched cultures of the Caco-2 cells, indicating this was not a cell maturation effect. 
From a regulatory perspective, it is therefore not safe to simply extrapolate from one 
form of TiO2 to another, and at least some correction factor for the accumulation 
rates of the different crystal structures should be included in dietary exposure hazard 
assessments for human health. Moreover, TiO2 also appears to disturb some 
aspects of electrolyte status in Caco-2 cells, and like other metals, health effects 
assessments should consider interference with the nutritionally required minerals. 
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Chapter 3: Uptake, accumulation and 
transport of different crystal forms of 
Titanium dioxide in differentiated 21 day 
old Caco-2 cells 
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3.1 Abstract 
The gastrointestinal uptake of different crystals of TiO2 was investigated using mature 
Caco-2 intestinal cells cultured on hanging inserts or in flat-bottomed plates. Monolayers 
exhibited time dependent uptake of Ti or TiO2 from TiO2 exposures of 1 mg L
-1 over 24 h, 
influenced by crystal type, irrespective of the cell growth substrate (plates or inserts). The 
initial and overall accumulation rates were (initial) 1.39, 1.24, 1.39, 1.10 nmol mg-1 cell 
protein h-1 and (overall) 0.28, 0.25, 0.19, and 0.09 nmol mg-1 cell protein h-1 for Bulk, P25, 
anatase and rutile respectively, for cells cultured in flat plates. Similarly initial and overall 
accumulation rates were (initial) 1.54, 1.08, 1.02 and 0.40 nmol mg-1 cell protein h-1and 
(overall) 0.40, 0.34, 0.30 and 0.20 nmol mg-1 cell protein h-1 for Bulk, P25, anatase and 
rutile respectively in cells cultured on hanging inserts. The overall rates of Ti or TiO2 
transport (Apical to Basolateral) from 1 mg L-1 TiO2 were 0.11, 0.09, 0.08 and 0.02 nmol 
mg-1 cell protein h-1 for Bulk, P25, anatase and rutile respectively. The appearance of 
detectable Ti in the basolateral media occurred at 6 and 8 h for nano P25 (75% anatase, 
25 % rutile) and nano anatase whilst Ti from bulk particle exposures (75% anatase, 25 % 
rutile) was first detected at 24 h. TiO2 exposures had a negligible effect on apical 
membrane morphology, transepithelial electrical resistance and media LDH activity 
suggesting that TiO2 was well tolerated and did not acutely damage the cells. There were 
some changes in the electrolyte composition of exposed cells relative to controls. A rise in 
the total Ca2+ concentration in the cells was observed for all TiO2 crystal exposures 
irrespective of cell growth substrate. Overall the data demonstrates that accumulation and 
basolateral transport of Ti or TiO2 from TiO2 apical exposures is unlikely to be due to 
passive diffusion through leaky damaged cells or paracellular pathways. Rather the data 
advocates an active process through intact epithelial cells. 
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3.2 Introduction 
Titanium dioxide (TiO2) particles are widely used in a variety of food based consumer 
products such as chewing gum, sweets and bulking agents in over the counter 
medicines labelled as the ingredient, E171 (Weir et al. 2012). Moreover, it is 
estimated that approximately 36% of the particles in these food grade powders are 
less than 100 nm in diameter (Weir et al. 2012). Chen et al. (2013) showed that the 
(NP) fraction of TiO2 in chewing gum reached 93% and that the majority of this is 
swallowed upon chewing. Surprisingly, literature on the effects and translocation of 
TiO2 NPs through the gut is scarce (Bergin and Witzemabb 2013). 
Caco-2 monolayers cultured on permeable inserts are widely used as an in vitro 
model to predict oral absorption and transport of organic compounds and metals 
(Artursson et al. 2001; Zerounian and Linder 2002; Linder and Moriya. 2006) 
because this cell line has been demonstrated to express the structural 
characteristics of human enterocytes (Peterson and Mooseker 1992). Recently, this 
model has been used as a test system for investigating TiO2 NP accumulation 
(Chapter 2, this work) and transport across gut epithelium (Koeneman et al. 2010; 
Janer et al. 2014). The studies on Caco-2 cells so far have demonstrated the effect 
of NPs on the Caco-2 gut cell system using, either fully differentiated (Koeneman et 
al. 2010; Brun et al. 2014; Janer et al. 2014) or partially differentiated cells (Gerloff et 
al. 2012; Gitrowski et al. 2014). For transport studies on nutrients, it is generally 
accepted that fully differentiated cells are required, to ensure maximal tight junction 
integrity and brush border development. However, for metal accumulation studies 
there is some debate regarding the appropriate time point at which partially 
differentiated cells can be used for measurements of net ion influx. For particle 
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uptake studies there is concern that partially differentiated cells will accumulate 
atypical amounts of particles because apical remodelling during enterocyte 
differentiation is more amenable to larger scale endocytic events (Hansen 2009). 
According to Hansen (2009), mature enterocytes are unable to undergo the 
invagination process leading up to endocytosis because microvilli morphology 
sterically hinders the process. In spite of this suggestion, a handful of studies have 
demonstrated TiO2 NP accumulation in vesicles within cells (Brun et al. 2014 - 
Exposures of 50 µg mL-1; Janer et al. 2014 – Exposures of 100 µg mL-1; Gitrowski et 
al. 2014- Chapter 2 – Exposures of 1 µg mL-1). Koeneman et al. (2010) 
demonstrated apical to basolateral transport of Ti following apical administration of 1 
µg mL-1 TiO2 NPs (mixture of anatase and rutile) to differentiated Caco-2 cells. In 
contrast, Fisichella et al. (2012) demonstrated no internalisation or transport of TiO2 
NPs following 24 h exposure to 100 µg mL-1 in differentiated Caco-2 cells. This 
disparity in results for what is considered to be the same cell type may be due to cell 
heterogeneity, which has been demonstrated to occur in Caco-2 cells (Herold et al. 
1994), or to arise from differences in the crystal phases of TiO2 NPs used in 
exposures. NP surface chemistry is well known to alter particle-membrane 
interactions (Rivera Gil et al. 2010). It is also unclear whether morphologically 
different Caco-2 cells differ with regards to functional and biochemical parameters. 
Due to the conflicting reports in the literature regarding NP uptake and translocation 
in Caco -2 cells, there is a need to characterise the morphology of such cell lines and 
the form of TiO2 used in exposures to ensure comparability with the wider literature. 
The aim of the present study was to assess the effect of TiO2 crystal structure on 
uptake, accumulation, apical to basolateral transport, and epithelial integrity on fully 
differentiated Caco-2 cells and gauge whether this is comparable to partially 
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differentiated Caco-2 cells (Chapter 2 – Gitrowski et al. 2014). Secondary objectives 
were to assess whether cell growth substrate affected brush border differentiation 
and subsequent TiO2 accumulation rates. Moreover biochemical endpointsand cell 
electrolyte concentrationswere measured to assess whether exposure to different 
forms of TiO2 have subtle effects on mature cell physiology.  
 
3.3 Materials and methods 
Several experiments were performed using fully differentiated confluent monolayers 
of Caco-2 cells. The first experiment determined the total Ti metal accumulation in 21 
day old Caco-2 cells exposed to 1 mg L-1 of different forms of TiO2 over 24 hours 
cultured in flat bottomed 6 well plates. The second experiment involved growing 
Caco-2 cells for 21 days on polyethylene terephthalate (PET) inserts and 
determining the total Ti metal accumulation and transport (apical to basal) of different 
crystal forms of TiO2 (identical to those used in Chapter 2). Maturation of cells was 
evaluated using SEM and TEM micrographs in conjunction with monitoring tight 
junction integrity by measuring transepithelial electrical resistance (TEER). Cell 
health was assessed using inverted light microscopy observations and measuring 
LDH activity (leak) in culture media. Cellular electrolyte concentrations were 
examined using ICP-OES in order to determine whether subtle biochemical changes 
occured following TiO2 exposures.  
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3.3.1 Cell culture 
The human intestinal cell line, Caco-2 (brush border expressing, European collection 
of cell cultures; catalogue no: 86010202 HTB-37) was cultured as previously 
described (Chapter 2) with the following modifications. Cells cultured in flat bottomed 
6 well plates were incubated for 21 days post seeding to ensure complete cell 
maturation and brush border development. For the second series of experiments, 
cells were cultured for 21 days on BD Falcon cell culture inserts (PET, 1.0 µM pores, 
0.9 cm2 effective growth area) in 12 well plates (only 5 wells were used per plate). 
Cells were seeded at 5 x 10- 4 cells cm-2 and experiments were conducted on cells 
between passage 60 and 75. The basolateral side (serosal) and apical side (mucosal) 
compartments contained 1.5 and 0.5 mL of culture medium, respectively. The culture 
medium was replaced every two days until the 21st day. 
 
3.3.2 TiO2 Stock dispersions and materials characterisation 
Stocks and materials were the same as those used in Chapter 2, section 2.3.2. 
 
3.3.3 Time course of Ti accumulation and apical to basolateral transport from 
different forms of TiO2 
The first experiment determined the time course of Ti accumulation for the different 
forms of TiO2 in mature Caco-2 cells over 24 h in flat bottomed six well plates. This 
experiment followed the same method as previously described (Chapter 2 section 
2.3.3) with the following modifications. Cells were cultured as described in section 
3.3.1. Fully mature confluent monolayers (21 days post seeding) were exposed to 
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the cell culture media containing 1 mg L-1 of either no added TiO2 (control), bulk, 
nano P25, nano anatase or rutile forms of TiO2. The six-well plate was the unit of 
replication in the experiment with each plate containing cells without TiO2 additions, 
and a well for each of the test materials (5 wells were used per plate). Dosing of the 
well was the same as previously described (Chapter 2, section 2.3.3) with three 
plates per timepoint being used. Media and cells were then collected at 0, 2, 4, 6, 8 
and 24 h for total Ti determination, electrolyte concentrations and LDH activity (see 
below). 
The second series of experiments demonstrated the time course of Ti accumulation 
and transport from the mucosal solution (apical) to the serosal solution (basolateral) 
for the different forms of TiO2 in Caco-2 cells cultured on inserts. Similar to the 
previous experiment, the 12-well plate was the unit of replication (only 5 wells were 
used in each plate). As in the previous experiment at least three plates were 
prepared for each time point (n = 3 replicates/time point) temporally separated to 
avoid pseudo replication and take into account passage effects. Insert experiments 
did not start until the cells were 21 days old allowing the TEER resistance to be > 
250 Ω cm2 (See below). Dosing of the wells was performed by diluting the initial 500 
mg L-1 stock to 10 mg L-1 TiO2 in ultrapure water, and this secondary stock was 
mixed with fresh culture media (1 mL of the appropriate 10 mg L-1 TiO2 stock: 9 mL 
DMEM) to obtain a final concentration of 1 mg L-1 TiO2 for the exposures. Exactly 0.5 
mL of the appropriate medium was pipetted into the apical compartment of each 
insert. Media and cells were then collected at 0, 2, 4, 6, 8 and 24 h of exposure for 
total Ti determination, electrolyte concentrations and LDH activity (see below). 
 
117 
 
3.3.4 Transepithelial electrical resistance (TEER) 
TEER is widely used as an indicator of tight junction integrity (Pohl et al. 2009), 
although under short circuit conditions the electrical resistance of the entire 
epithelium is measured and is assumed to be a surrogate of the net resistance of all 
the paracellular pathways (not just tight junctions). TEER was measured using an 
EVONTM voltohmmeter (World Precision Instruments, Sarasota, FL) and the voltage 
resistance through monolayer cells was recorded as Ω.cm2. Measurements were 
obtained by pipetting 1500 µL PBS (NaCl - 137 mmol L-1, KCl - 2.7 mmol L-1, 
Na2HPO4 - 10 mmol L
-1, KH2PO4 - 1.8 mmol L
-1) into the basolateral chamber of the 
EVONTM voltohmmeter, inserting a culture insert and pipetting 500 µL PBS into the 
apical chamber. An insert containing PBS and no cultured cells was used as a blank 
and the resistance reading was subtracted from the sample readings. The readings 
were multiplied by the insert surface area (0.9 cm2). Monolayers of cells were 
incubated with PBS for 5 mins at room temperature to equilibrate samples before 
each reading. Readings for each insert were performed twice to ensure voltages 
were stable and three inserts were analysed per timepoint (day 3, 7, 10, 14 and 21 
post seeding) 
 
3.3.5 Titanium and electrolyte determination in cells 
For the flat bottomed 6 well plate experiment, exactly the same protocol was 
followed as previously described in Chapter 2 (Section 2.3.6). 
A similar protocol was used with the following modifications for the insert 
experiments. At each time point mucosal (apical) and serosal (basolateral) medium 
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was carefully collected and stored in 13 mL tubes for elemental analysis. Inserts 
were carefully washed twice with 1.5 mL PBS prior to measuring TEER. Following 
TEER measurements inserts were carefully washed twice more with isotonic sucrose 
buffer (as described in Chapter 2 section 2.3.6) in order to remove residual 
electrolytes left over following the PBS wash. Filters were carefully removed from the 
insert and placed in 1 mL of sucrose lysis buffer (similar to the sucrose wash buffer, 
but hyp osmotic with only 30 mmol L-1 sucrose) to detach and lyse the cells attached 
to the insert. After 10 min lysed cells were carefully scraped of the filters and the 
resulting 1 mL of homogenate pipetted into 13 mL test tubes and sonicated (power 
100 Watt, setting 8/ frequency 22.5 kHz, Misonix incorporated, XL2000-010, New 
York) for 30 sec to ensure lysed samples were well mixed. A 50 µL aliquot was taken 
for protein determination (BCA assay as described in Chapter 2 section 2.3.6) and 
the remaining 950 µL of the lysed sample containing the cells was digested in 1 mL 
of nitric acid (70%) at 70 oC for 4 h. Then, total Ti, Na+, K+, Ca2+ and Mg2+ was 
determined using inductively coupled plasma - optical emission mass spectroscopy 
(ICP – OES, see below). The remaining cell free filter insert was gently washed once 
more in order to remove any residual cells using 1 mL sucrose lysis buffer prior to 
being placed in a test tube and digested in 1 mL of concentrated nitric acid (70%) at 
70 oC for 4 h, and total Ti determined by ICP-OES.  
 
3.3.6 Trace metal analysis 
All samples were sonicated for 1 h (Branson 2800, Frequency 40 kHz, Danbury, 
USA) and vortexed for 20 s prior to being drawn into the instrument to ensure mixing, 
and calibrations were performed with matrix matched multi elemental standards 
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containing Ti, Na+, K+ Ca2+ and Mg2+ in 38% nitric acid. Instrument detection limits (3 
x standard deviation of the blank + the mean of the blank) (Thomsen et al. 2003) 
were 0.0014, 0.6448, 0.0653, 0.0050 and 0.0086 mg L-1 for Ti, Na+, K+, Ca2+ and 
Mg2+ respectively. 
In the absence of certified reference tissues for TiO2 particle analysis, spike recovery 
tests were performed both in the cell homogenate following the above protocol and 
in culture media. Exactly 1 mL samples of medium and cell homogenates (in sucrose 
lysis buffer) were spiked with 200 µL of 10 mg L-1 of the different forms of TiO2 and 
then the acid digestion protocol was followed (addition of 1 mL of concentrated nitric 
acid (70%) then heated 70 oC for 4 h prior to total Ti determination, total volume 2.2 
mL) and showed procedural recoveries for the cell homogenate of 94 ± 3.2, 82 ± 2.8, 
82 ± 1.2, 72 ± 3.6 and 71 ± 1.6% (Fig. 3-1 panel A ) and for the medium 93.7 ± 2.4, 
75 ± 1.8, 71 ± 2.2, 69 ± 2.4, and 72 ± 3.7% for dissolved Ti, bulk, P25, anatase and 
rutile, respectively (Data presented as  mean ± SEM, n = 6  for each material type) 
(Fig. 3-1 panel B). Electrolyte concentrations in the cell homogenates were 
normalised to cell protein content as described previously (Chapter 2, section 2.3.6).  
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Fig.  3-1: Procedural recovery of Ti in (A) cell homogenate and (B) culture ready medium spiked with 
200 µL of 10 mg L
-1
 TiO2 or 6 mg L
-1
 Ti metal before digestion by nitric acid. Data are mean ± SEM, % 
recovery of Ti metal or TiO2 particles spike, n = 6; Different letters indicate statistically different 
recoveries for the spiked material (ANOVA P > 0.05). 
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3.3.7 Lactate dehydrogenase activity 
Lactate dehydrogenase (LDH) activity is widely used to determine levels of cell 
damage, by assessing the activity of LDH released into the medium following cell 
leakage or rupture. In this study, the culture medium and samples of cell 
homogenate were collected and immediately frozen at -80 0C until later biochemical 
analysis. LDH was measured as described by Bergmeyer and Bernt (1974). The 
reaction mixture contained 250 µL of 0.169 mmol L-1 NADH and 4.45 mmol L-1 
pyruvate in 50 mmol L-1 of potassium phosphate buffer at pH 7.4 and was added to 
50 µL of samples. The LDH activity was determined by the measuring the decrease 
in absorbance at 340 nm (VersaMaxTM, Molecular Devices, Sunnyvale, CA) due to 
the oxidation of NADH, and was allowed to proceed for 15 min with readings taken 
every 11 s. Measurements were carried out in triplicate and enzyme activity was 
calculated using an extinction coefficient of 6.22 x 10-3 L mol-1 cm-1. LDH activity is 
expressed as U mL-1 (µmol min-1 mL-1, where one unit causes the oxidation of one 
µmol of NADH per minute). The percentage of LDH leak from the cells within each 
well was estimated from the absolute total LDH activity of each well (cells + media) 
divided by the LDH activity of the medium alone. 
 
3.3.8 Cell morphology and electron microscopy 
Cell morphology and brush border differentiation was examined using both 
transmission and scanning electron microscopy. Three culture inserts per time point 
were processed. Cells were fixed in situ on the filter inserts. Briefly, cells on the cell 
culture inserts were washed in isotonic sucrose buffer (Described in Chapter 2, 
section 2.3.6) and fixed for 1 h in 2 mL of 2.5% glutaraldehyde in cacodylate buffer 
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(0.1 M sodium cacodylate in water at pH 7.4). The cells were then washed twice in 
cacodylate buffer prior to the insert being carefully cut away from the insert base. 
The insert was cut in half and one half was embedded for ultrathin sectioning and 
subsequent TEM analysis, while the other half was prepared for SEM. For SEM the 
filter was dehydrated in a graded series of ethanol and then critically point dried and 
carbon coated (EMITECH-K850, K450X). Samples were imaged using a 15 kV 
accelerating voltage, at a working distance of 10 mm (SEM, JEOL/JSM-7001F). 
For TEM the insert was post fixed in 2% OsO4 prior to being dehydrated in a graded 
series of ethanol, infiltrated with Spur’s resin (Agar Scientific, Essex UK) and 
embedded into coffin moulds using pure resin. Ultrathin sections were cut (> 90 nm) 
and stained with 2% uranyl-acetate and lead citrate and then examined by 
transmission electron microscopy (TEM, JEOL- 1200 EXII). 
3.3.9 Image analysis  
For quantitative estimation of microvilli (MV) coverage in developing Caco-2 cells 
SEM images were collected and digitally analysed using Image J software (W. 
Rasband, National Institutes of Health, Bethesda, MD, USA, http://rsb.info.nih.gov/ij) 
as follows.  
1. - SEM images of 8000 x magnification were imported into image J and the 
cropping tool was used to remove microscope generated text. The cropped image 
was then autocorrected for brightness and contrast (Fig. 3-2).  
2. - The images were then auto thresholded (creating a binary image) (Fig. 3-3). 
Image binarization or thresholding is a widely used method (González and Woods 
2001) that determines a grey threshold and assigns each pixel of a digital image to 
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one class (image objects). An automated binarization (black and white) was applied 
to each SEM image (Fig. 3-3). The automated thresholding function used by the 
Image J command Image/Adjust/Threshold applies Otsu's method (Otsu 1979) which 
is based on analysis of the shape of the image histogram. The Otsu method turns an 
image with different grey levels (e.g. SEM micrograph) into a black and white one, 
separating the objects from the background. By using binarization it is possible to 
separate the pixels which represent microvilli (brighter pixels) from those that 
represent the rest of the cell membrane (darker zones in an original image), allowing 
quantification cell surface microvilli coverage by calculating the percentage area 
fraction that is black and white (Julio et al., 2008) . Measurement settings were 
altered to measure the percentage area fraction that is black (which corresponds to 
areas with no microvilli) (Fig.3-4). The remaining fraction (white) is microvilli 
coverage. Occasionally the auto threshold function failed to appropriately distinguish 
microvilli from the background of the cell. In these cases the threshold settings were 
manually configured to give a true representation of the villi density. This was 
achieved by having the original image next to the binary image and making the 
background spaces match up. Three cell inserts were imaged per time point with two 
distinct areas imaged per insert (n = 6 images per timepoint). 
Cell height was also calculated from TEM micrographs; a minimum of 12 cells per 
time point where measured. Only cells whose full length (including microvilli) was in 
the plane of the section and approximately 90o to the filter were included. 
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Fig.  3-2: Screenshot of SEM image of 3 day old Caco-2 cell using image J to auto correct brightness 
and contrast. 
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Fig.  3-3: Screenshot of SEM image of 3 day old Caco-2 cell using image J to auto threshold (black 
areas correspond to no micro villi areas whilst white areas represent microvilli). 
 
  
 
 
 
 
 
 
 
 
Fig.  3-4: Screenshot of selected measurement options for analysing binary image. To the right of the 
image the percentage area of the image which is black is shown (in the above example the % area of 
microvilli coverage is (100 – 72.1 = 27.9%). 
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3.3.10 Statistics 
The statistics applied were the same as those used in Chapter 2, section 2.3.9. 
 
3.4 Results 
 
3.4.1 Cell health and viability 
The control cells (not exposed to TiO2) grown on 6 well plates showed normal 
morphology during the experiments with the cells remaining confluent and attached 
to the dishes with intact apical membranes orientated correctly with the presence of 
dense MV. This was supported by LDH activity which remained below 0.1 U ml-1 of 
cumulative LDH activity over the 24 h duration of the experiments and was 
equivalent to a mean LDH leakage of 1.4% ± 0.27% (Fig. 3-7) The control cells 
showed normal electrolyte concentrations. For example, in the time course 
experiment performed on 6 well plates the electrolyte levels in control cells at 24 h 
were (mean ± SEM., n = 3 plates per treatment): Na+, 7690 ±1543; K+, 838 ± 95; 
Ca2+, 34 ± 4; and Mg2+, 60 ± 10 nmol mg-1 protein.  
In the second experiment (cells grown on inserts) control cells exhibited normal 
morphology and the expected TEER (between 250 – 350 Ω cm2 (Moriya and Linder 
2006)) readings for fully differentiated cells which was (mean ± SEM., n = 3 plates 
per treatment) 313 ± 4 Ω cm2 (Fig. 3-9). Moreover electrolyte concentrations were 
similar to cells grown on plates (no significance ANOVA P > 0.05 for all electrolytes), 
with the values for control cells being (mean ± SEM., n = 3 plates per treatment): Na+, 
7429 ±118; K+, 886 ± 65; Ca2+, 32 ± 7; and Mg2+, 52 ± 2 nmol mg-1 protein at 24 h.  
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Cells incubated with different forms of TiO2 in experiments performed in flat culture 
plates (experiment 1) demonstrated low cumulative medium LDH activity (Fig. 3-7) 
and normal apical morphology (Fig. 3-5). Cells cultured on inserts demonstrated 
negligible changes in TEER. Cells grown on both substrates (plates and inserts) had 
reasonably consistent electrolyte concentrations within the physiological range, 
although there were some TiO2  dependent changes in ion concentrations (Table 3-1, 
Series 1 and 2).  
 
Table ‎3-1: (Series 1 and 2): The total intracellular K+, Na+ Ca2+ and Mg2+ 
Metalnmol mg-1 protein of 21 day old Caco-2 cells cultured in plates (Series 1) 
or inserts (Series 2) following exposure to 1 mg L-1 TiO2 forms for 24 h. 
 
Electrolytes (nmol mg-1 protein) 
Series 1 
Time 
(h) Control Bulk  P25 Anatase Rutile 
Electrolyte 
      K+ 0 1020.6±58.4 988.2±95.9 1034.6±18.53 976.7±86.8 1009.9±63.8 
 
2 1072.3±100.9 955.5±152.9 829.2±37.8
* 
843.3±90.8 942.4±171.4 
 
4 1069.3±101.5 966.5±113.0 961.8±107.5
* 
965.9±9.4 755.7±123.5 
 
6 934.4±108.5 853.3±40.8 790.5±54.3
* 750.2±24.6* 765.9±40.9 
 
8 920.9±70.5
a 816.7±2.1b 771.5±72.6a* 748.2±46.8a* 668.9±51.7b* 
 
24 985.4±95.8 689.8±77.8 781.8±41.8
* 700.9±37.8* 569.4±63.1* 
       Na+  0 8545±764 8421±859 7872±412 8016±925 8045±757 
 
2 9611±1567 7289±1381 6651±430 6391±1292 7616±1981 
 
4 7720±113
a 6543±1065a 8783±2795a 6742±136b 5459±865b 
 
6 6396±325 5932±642 6363±1215 5155±405
* 
5065±262 
 
8 5906±1163 9355±3536 6619±1435 5000±398
* 
6012±1434 
 
24 7690±1543 4850±719 5272±431 4321±478
* 
4175±545 
       Ca2+ 0 20.0±5.9 23.7±3.1 39.6±4.7 22.5±7.9 22.3±9.7 
 
2 25.2±6.9 47.3±3.0 39.5±2.8 38.6±7.9 41.4±16.3 
 
4 21.2±7.8
a 25.3±7.3a 45.6±2.1b 42.1±3.9b 30.1±5.6a 
 
6 28.4±4.2 30.5±9.2 30.3±3.8 24.4±1.0 53.1±28.0 
 
8 25.0±6.4 43.8±10.2 30.6±2.2 52.6±9.2 31.3±12.1 
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24 31.8±4.2
a 
41.9±10.1
a 
68.8±5.4
b* 
43.8±12.2
a 
57.7±2.1
b* 
 
      Mg2+ 0 66.0±7.4 62.1±5.9 64.7±2.7 61.4±3.9 62.9±4.9 
 
2 49.4±8.5 44.5±6.8 45.7±5.7 45.8±15.2 49.4±16.6
* 
 
4 40.5±4.7 45.1±6.1 43.7±5.8 50.6±5.3 37.6±1.8
* 
 
6 43.7±7.2 41.1±8.5 37.0±10.3 33.5±6.8 34.9±7.4
* 
 
8 47.9±4.9 57.0±8.8 46.2±6.9 41.0±5.8 43.6±6.1
* 
 
24 60.4±10.0 54.8±4.6 48.2±7.2 38.5±5.9 42.8±0.7
* 
 
Series 2       
  
Control Bulk  P25 Anatase Rutile 
Electrolyte 
      K+ 0 1049.6±104.6 1110.5±120.1 1038.5±139.6 1216.5±51.4 1125.4±71.1 
 
2 865.5±69.3 890.1±95.4 863.3±112.0 820.5±56.9 835.8±63.6 
 
4 1110.4±36.5 1085.7±48.5 1044.7±24.7 1175.2±79.8 1200.5±58.5 
 
6 883.9±34.8 816.3±25.2 960.6±54.4 945.9±68.5 854.3±79.1 
 
8 979.5±51.3 895.3±17.8 959.642.0 907.9±61.9 942.3±37.2 
 
24 886.9±65.2 965.8±39.4 979.2±18.8 835.1±10.9* 907.2±32.1 
       Na+ 0 9352±1363 9521±1280 7893±1115 9981±892 8964±844 
 
2 6745±411 7992±881 8204±883 6679±311 7006±612 
 
4 8660±372 8777±643 8404±237 8469±123 9863±473 
 
6 9041±611 8125±671 8939±872 8257±638 7340±587 
 
8 9245±785 8679±671 8595±309 8430±761 7451±380 
 
24 7429±118 7325±335 7006±157 6339±287 7107±521 
       Ca2+ 0 19.8±5.5 20.5±5.1 29.7±7.2 26.8±6.9 24.8±10.8 
 
2 22.4±4.9 47.2±14.0 27.9±6.3 42.7±7.4 32.3±5.8 
 
4 33.1±3.0 45.5±6.0
* 34.7±14.9 33.8±2.2 50.9±17.5 
 
6 23.9±5.8 33.3±5.3 31.6±4.5 41.1±8.0 30.9±5.3 
 
8 30.1±4.4 35.3±2.9 40.8±2.5 33.6±5.0 32.9±8.7 
 
24 31.8±2.8 51.4±2.9
* 
49.1±3.0* 42.9±3.3 51.3±11.6* 
       Mg2+ 0 74.7±14.2 70.0±8.5 64.9±9.2 76.9±3.6 70.2±5.4 
 
2 59.1±3.9 65.9±9.1 66.1±6.8 52.5±2.3* 57.2±4.0 
 
4 63.8±1.8
a 73.6±3.9b 67.6±4.0a 73.2±2.2b 78.3±1.6b 
 
6 61.9±4.7 62.8±3.3 68.5±7.2 73.7±8.5 64.0±5.7 
 
8 63.1±4.5 71.6±5.1 78.4±4.9 66.4±3.4 69.1±2.9 
 
24 52.3±2.0 60.7±2.1 62.6±2.1 49.8±0.6* 58.0±2.2 
 
Values are means ± S.E.M. (n = 3 for each group) and are expressed as nmol Metal mg
-1
 cell protein. 
Different letters indicate statistical significance within rows. Symbols represent statistical significance 
within columns and electrolytes (ANOVA or Kruskal-Wallis test, P < 0.05). 
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Fig.  3-5: Brush border morphology of cells cultured in 6 well plates (experiment 1) following 24 h 
exposure to 1 mg L
-1
 different forms of TiO2. A) control, B) bulk, C) P25, D) anatase, E) rutile. Scale 
bar = 5 µm 
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3.4.2 Time course of Ti accumulation from different forms of TiO2 in 21 day 
old cells cultured in conventional 6 well plates 
The time course of Ti accumulation for exposures to different forms of TiO2 is shown 
in Fig. 3-6. Unexposed control cells remained at a background metal concentration 
of between 0.5 and 1 nmol Ti mg-1 cell protein throughout. All the TiO2 treatments 
showed a non-linear exponential rise of the total Ti concentration in the cells, which 
achieved steady state concentrations by 8 h. This rise in net Ti accumulation 
occurred without elevations in Na+ (Table. 3-1), indicating that the accumulation was 
not an artefact of solvent drag. There were some differences in the time courses of 
Ti accumulation for the different forms of TiO2 which were not explained by changes 
in membrane permeability. Cumulative LDH leak at 24 h in the media remained low 
and did not exceed 5% (not statistically different from the control, and no material–
type effect was observed (Fig. 3-7). The net Ti accumulation by 24 h was as follows 
by material-type: Bulk > nano anatase> P25> nano rutile > unexposed controls. The 
bulk material and nano anatase showed the largest net Ti accumulation in 24 h 
saturating at 7.3 and 6.0 nmol mg-1 protein respectively, but were not statistically 
different from each other at 24 h (Kruskal Wallis P < 0.05). The P25 nano form 
showed approximately 20% less accumulation than either bulk or nano anatase at 24 
h saturating at 4.9 nmol mg-1 cell protein (statistically different to rutile form, Fig. 3-6). 
The nano rutile form demonstrated much lower accumulation at 24 h saturating at 
2.6 nmol mg-1 protein (significantly different to all the other treatments, Kruskal Wallis 
P < 0.05). Initial Ti accumulation rates calculated from the curves (Fig. 3-6) followed 
a similar pattern, with Ti accumulation from the bulk and anatase being faster than 
those from P25 and rutile. The initial and overall accumulation rates were (initial) 
1.54, 1.08, 1.02 and 0.40 for nmol mg-1 cell protein h-1 and (overall) 0.28, 0.25, 0.19, 
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and 0.09 nmol mg-1 cell protein h-1. The times to 50% saturation were 2 h 28, 2 h 42, 
2 h 06 and 1 h 3 min for bulk, anatase, P25 and rutile, respectively. 
Fig.  3-6: Titanium accumulation in 21 day old Caco-2 cells cultured in conventional 6 well plates from 
exposures to 1 mg L
-1
 of different forms of TiO2 for 24 h. Data points are mean ± SEM (n = 3 
replicates/ treatment). Curves were fitted using Sigma plot version 12.0 to the raw data (n = 3 
observations / treatments) using the exponential rise to the maximum function f = y0+a*(1-exp(-b*x)). 
Equations for the curve fit were as follows: For Bulk f = 1.18+5.53*(1-exp(-0.28*x)), r
2
 = 0.905; For 
Anatase f = 1.73+4.32*(1-exp(-0.25*x)), r
2
 = 0.941; For P25 f = 1.78+3.09*(1-exp(-0.33*x)), r
2
 = 0.917; 
For Rutile f = 2.08+0.48*(1-exp(-0.84*x)), r
2
 = 0.362. The unexposed control demonstrated no time 
dependent changes and therefore a curve was not fitted. Accumulation of all titanium forms is 
significantly different to the controls (Kruskal Wallis P < 0.05) at 24 h (*). Different symbols indicate 
statistically significant differences between treatments (Different TiO2 form exposures).  
* 
* 
* 
* 
~ 
~ 
~ 
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Fig.  3-7: Time course of % LDH leak from 21 day old confluent Caco-2 cells cultured in 6- well plates 
incubated with 1 mg L
-1
 different forms of TiO2. At the indicated times post TiO2 incubation media and 
cell homogenate were analysed for LDH activity. The percentage of LDH leak from the cells within 
each well was calculated from the absolute LDH activity of each well (cells + medium) divided by the 
LDH activity of the medium alone. Data are means ± SEM n = 3. Absence of annotation indicates no 
statistically significant differences between treatments. 
 
3.4.3 Time course of Ti accumulation and transport across cells from 
exposures to different forms of TiO2 in 21 day old cells cultured in 
inserts 
The time course of Ti accumulation for exposures to different forms of TiO2 in cells 
cultured in hanging inserts is shown in Fig. 3-8. Culturing cells on inserts appeared 
to have a negligible effect on the pattern of Ti accumulation in comparison to cells 
cultured in flat bottom plates. All the TiO2 treatments showed a non-linear 
exponential rise of the total Ti concentration in the cells, which achieved steady state 
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concentrations by 8 h (similar to the previous experiment). TEER showed negligible 
changes following exposure to different forms of TiO2 (not statistically different from 
the control, and no material–type effect was observed (Fig. 3-9). The net Ti 
accumulation at 24 h was as follows by material type: Bulk > P25> nano anatase > 
nano rutile> unexposed controls (Table 3-3) which was different to the previous 
experiment, but this order was similar to previous experiments carried out using 4 
day old cells cultured in flat bottomed plates (Chapter 2, Fig. 2-6). Mean Ti saturation 
occurred at 9.6, 8.5, 7.3 and 4.7 nmol mg-1 following exposure to bulk , P25, anatase 
and rutile, respectively for 24 h with the latter being significantly less than the other 
material exposure (ANOVA, P > 0.05). P25, anatase and rutile accumulation at 24 h 
in inserts was significantly more than cells cultured in normal plates (ANOVA P > 
0.05). Initial and overall accumulation rates calculated from the curves were (initial) 
1.39, 1.24, 1.39, 1.10 nmol mg-1 cell protein h-1 and (overall) 0.40, 0.34, 0.30 and 
0.20 nmol mg-1 cell protein h-1 for Bulk, P25, anatase and rutile, respectively. The 
times to 50% saturation were 3 h 51, 3 h 38, 3 h 18, and 1 h 13 for Bulk, P25, 
anatase and rutile, respectively.   
TiO2 particles could freely move through the insert membrane in the absence of cells 
(Table 3-2) and a small proportion was able to cross the insert when cultured cells 
were present. There was a gradual appearance of Ti in the basolateral compartment 
(Fig. 3-10) with Ti being detectable above background media concentrations at 6 h 
for P25, 8 h for anatase and at 24 h for bulk and rutile. Overall transport rates (apical 
to basolateral) and the absolute amount (µg) of apically administered Ti that was in 
or on the cells that managed to cross the cell monolayer and culture inserts by 24 h 
is presented in Table 3-3 for the different TiO2 crystal types. As a percentage of total 
administered dose, cells exposed to bulk had the highest Ti concentrations and the 
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highest overall Ti transport into the basolateral medium (Table 3-3). Rutile TiO2 
exposure demonstrated the lowest uptake and overall transport rates at 24 h and 
was statistically different from all the other TiO2 forms assessed (Fig.3-8, Table 3-3).  
 
Fig.  3-8: Titanium accumulation in 21 day old Caco-2 cells grown in culture inserts following 
exposures to 1 mg L
-1
 of different forms of TiO2 for 24 h. Data points are means ± SEM (n = 3 
replicates/ treatment). Curves were fitted using Sigma plot version 12.0 to the raw data (n = 3 
observations / treatments) using the exponential rise to the maximum function f = y0+a*(1-exp(-b*x)). 
Equations for the curve fit were as follows: For Bulk f = 1.18+7.822 *(1-exp(-0.18x)), r
2
 = 0.905; For 
Anatase f = 1.73+5.86*(1-exp(-0.21*x)), r
2
 = 0.941; For P25 f = 1.78+7.30*(1-exp(-0.1.9*x)), r
2
 = 0.917; 
For Rutile f = 2.08+1.96*(1-exp(-0.56*x)), r
2
 = 0.362. The unexposed control showed no time 
dependent changes and therefore a curve was not fitted. Accumulation of all titanium forms is 
significantly different to the controls (Kruskal Wallis P < 0.05 differences located using a notched box 
plot) at 24 h (*). Different symbols indicate statistically significant differences between treatments at 
24 h (Different TiO2 form exposures). 
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Fig.  3-9: TEER following the administration of 1 mg L
-1
 TiO2 forms over 24 h. Data are mean ± S.E.M (n = 3 replicates 
per treatment per time point). 
 
 
 
Table ‎3-2: Levels of Ti present in the basolateral compartment at 24 h after apical 
administration of 1 µg mL-1 in the absence of cells 
Material Total Ti in mucosal 
compartment at 0 h (µg) 
Total Ti in basolateral 
compartment at 24 h 
(µg) 
% Ti in basolateral 
compartment at 24 h 
Bulk 0.3 0.161 ± 0.005 53.9 ± 1.4 
P25 0.3 0.178 ± 0.006 59.6 ± 1.9 
Anatase 0.3 0.181 ± 0.007 60.5 ± 2.2 
Rutile 0.3 0.184 ± 0.010 61.6 ± 3.2 
Values are means means ± S.E.M.. (n = 2 for each material). Absence of annotation indicates no statistically 
significant difference between treatments. There were no material type differences. 
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Table ‎3-3: Absolute Ti in the cells and basolateral compartment at 24 h following exposure to 1 µg mL-1 TiO2 
Material Mean absolute Ti in the 
cells at 24h 
(Ti in cells-background in 
control cells) (µg). 
Mean % of exposure 
in/on cells 
Mean absolute Ti in basolateral 
compartment (Ti in basolateral 
compartment – background in 
controls) (µg) 
Mean % of exposure in 
basolateral 
compartment 
Mean overall transport 
(apical to basolateral) 
rates of Ti (nmol mg
-1
 h
-1
) 
Bulk 0.0179a 5.9712 0.0057a 1.8889 0.1118a 
P25 0.0155a 5.1687 0.0048a 1.5901 0.0961a 
Anatase 0.0148a 4.9381 0.0047a 1.5560 0.0833a 
Rutile 0.0079b 2.6245 0.0014b 0.4627 0.0269b 
 
Values are means of the triplicate data. Mean % of exposure in/on the cells was calculated from the mean absolute Ti in the cells / by total Ti metal dose in the apical 
compartment (0.3 µg Ti metal). Likewise, mean % of exposure in basolateral compartment was calculated from the mean absolute Ti in the basolateral compartment / by total 
Ti metal dose in the apical compartment (0.3 µg Ti metal). Mean overall transport of Ti (apical to basolateral) were calculated from Ti in basolateral media at 24 h following 
exposures(converted to nmols) / cell protein content and expressed as nmol mg
-1
 h
-1
. Letters indicate statistical differences within columns (ANOVA P > 0.05). 
 
 
Fig.  3-10: Absolute total Ti metal appearance in the basolateral media in µg (Mean ± SEM n = 3). * indicates statistically different to the control value at 24 h (ANOVA P > 
0.05). Letters represent statistically significant differences due to materials at 24 h.  
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3.4.4 Effect of Titanium dioxide on cell electrolyte concentrations 
There were some TiO2 dependent changes in electrolyte concentration in the cells. 
For example all the nano forms of TiO2 caused some depletion in K
+ (Table 3-1 
series 1). This trend was apparent in the second experiment although it was only 
regarded as significant in the cells treated with anatase TiO2. Exposure to all forms 
of TiO2 appeared to increase mean total cellular Ca
2+ over time and this was 
regarded as significant for P25 and rutile in the first experiment and for bulk, P25 and 
rutile in the second experiment (Table 1, Series 1 and 2). Low LDH leak, negligible 
changes in TEER and a general trend of cell Na+ depletion (against the 
concentration gradient) suggests that the changes are material specific, rather than 
attributed to non-specific membrane leak. 
 
3.4.5 Morphological characterisation of differentiating Caco-2 HTB 37 cells 
grown on culture inserts – SEM analysis 
Morphological changes in differentiating Caco-2 cells were investigated using SEM 
and TEM. Complete monolayers had already formed by day 3 and previous work 
(Chapter 2, Fig. 2-1) confirmed cell confluence occurs by 35 h following a seeding 
density of 5 x 104 cells cm-2. MV density appeared to steadily increase over time (Fig. 
3-11, Panel C). At day 3 MV density was heterogeneous with some regions 
exhibiting dense packing whilst other regions were more sparsely populated with MV. 
By day 7 MV density continued to increase although the development was 
heterogeneous in terms of organisation, density and length. By day 10, MV density 
was still increasing and the development of dome regions in the monolayer had 
become apparent (Fig. 3-12, E). By day 14 MV density was approaching maximal 
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packing with MV appearing to be getting longer, but the occasional cell still appeared 
sparsely covered. At day 21 MV had reached maximum packing density and apical 
membranes displayed many dome like regions (Fig. 3-11 H). Similarly, cells grown 
on plastic flat bottomed plates exhibited the same apical morphological 
characteristics to cells grown in inserts at day 21 (Fig. 3-11 I).  
 
3.4.6 TEM analysis 
TEM analysis revealed considerable differences in internal cell morphology and 
development. Cell differentiation was not homogeneous. Even by day 21 cell 
morphology displayed heterogeneous characteristics. Cell height increased in a step 
like manner over time (Fig. 3-11 Panel B). Approximately 70% of the TEM images 
demonstrated cells growing as monolayers, although even at day 21 there were 
patches of cells that were not a monolayer, rather cells were clearly growing on top 
of each other (Fig. 3-13 I). In these situations the most apical cells had sparsely 
populated areas of MV. 
By day 3 cells had formed a flat monolayer (mostly) and cell apical junctional 
complexes were visible between neighbouring cells (Fig. 3-13 A, B, C). Cells were 
dominated by a large nucleus which was positioned in the middle of the cell, with 
organelles occupying the entire space around the nucleus. Microvilli demonstrated 
the heterogenous patchiness noted in the SEM micrographs. Cells that were seven 
days old were indistinguishable from 3 day old cells. At day 10 cells also appeared 
similar to days 3 and 7 except microvilli density had increased and the mitochondria 
were predominantly located above the nucleus. Monolayer height remained the 
same. SEM images of 10 day old cells indicated the development of dome like 
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regions suggestive of more cuboidal like epithelial cells; this was not visualised in the 
TEM micrographs. At day 14 junctional complexes were clearly visible on most 
adjacent cells. Microvilli density had increased and organelles appeared to be 
orientated above the nucleus. There were also clear pseudopodia anchoring the 
cells to the growth substrate within the pores of the insert. Cells were taller than 
previous days (Fig. 3-13). 
By day 18 the cells were starting to take on a cuboidal appearance and were 
generally taller than less mature cells (measured from insert to MV, Fig.3-11 and 3-
13 EF). MV appeared to be maximally packed on most cells although there was still 
the occasional sparsely populated cell. Moreover, there appeared to be an increase 
in non-specific vacuoles occupying the space in between the apical membrane and 
the nucleus. By day 21 cells appeared to be more columnar (Fig.3-13). MV were 
longer, straighter and more organised. Organelles appeared to be congregated 
above the nucleus and junctional proteins extended further into the cells. There were 
still areas where the cells were growing on top of each other with heterogeneous 
microvilli development (Fig. 3-13).   
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Fig.  3-11;Panel A: Trans-epithelial electric resistance (TEER) was measured during Caco- 2 cell 
differentiation. Data represents mean ± SEM (n = 3). Panel B: Quantitation of cell height increase over time. 
A minimum of 12 cells per time point was measured in TEM micrographs. Data shown represents the mean 
± SEM. Panel C: Quantitation of the increase in microvilli density over time. Microvilli were quantified using 
SEM micrographs. Data represents mean ± SEM of 6 images taken from 3 separate inserts (n = 6). 
Different letter indicate significant differences between time points within graph panels (ANOVA P > 0.05)  
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Fig.  3-12: SEM sequence of apical brush border development in unexposed cells. Villi density increases over time as do the amount of dome like regions. Multiple images of 
the same day aim to show the extent of the MV coverage. Image I: 21 day old cells cultured in flat bottomed plates. Apical morphology is indistinguishable from 21 day old 
cells cultured in inserts. Scale bar represents 1 µm.  
Day 3 Day 7 Day 7 
Day 10 Day 10 Day 18 
Day 21 Day 21 Day 21 
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Fig.  3-13: TEM sequence of cell maturation in unexposed cells cultured on inserts (I). 3 day old cells showing, A) heterogeneous MV development, B) junctional complex (TJ), 
C) and monolayer formation, D) 14 –day old cells are still flat, however mv density is increasing, E) cells beginning to appear cuboidal, F) appearance of nonspecific vacuoles 
(V) and clear junctional complexes, G) cells are more columner with central nucleus (N) and dense MV, H) mitochondria situated below the apical membrane, uniform MV, I) 
Day 21 showing areas of under-developed cells growing on top of each other.   
Day 3 Day 3 Day 3 
Day 14 Day 18 Day 18 
Day 21 Day 21 Day 21 
I 
I 
TJ 
V 
V 
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3.5 Discussion 
The present study demonstrates that mature, confluent Caco-2 cells with fully 
differentiated brush borders are capable of accumulating and transporting Ti from 
TiO2 particle exposures. However, the precise form of the Ti taken up by the cells 
and/or translocated to the serosal compartment was not determined. Similar to 
immature Caco-2 cells (4 day old, Chapter 2), the mature cells show Ti accumulation 
which is influenced by the crystal structure of TiO2 with the rutile form being taken up 
the least irrespective of cell growth substrate. These novel experiments were used to 
determine the rate of apical to serosal appearance of total Ti metal from exposures 
to different forms of TiO2 in addition to assessing cellular electrolyte concentrations 
of fully differentiated Caco-2 cells following 24 h exposures to TiO2. The main 
findings were that accumulation occurs irrespective of cell maturation and culture 
substrate and that TiO2 crystal structure influences uptake and transport.  
 
3.5.1 Brush border morphogenesis 
Batch related morphological heterogeneity of Caco-2 cell differentiation has been 
well illustrated (Herold et al. 1994). Moreover, it is uncertain whether morphologically 
distinct Caco-2 cells also differ with respect to functional and biochemical 
parameters. In order to reliably compare studies using differentiated cells, it is 
important to characterise the development of the cell line in addition to defining 
culture conditions. This study has demonstrated (for this batch) that monolayer 
formation occurs in less than 3 days and that microvilli density and TEER increase 
steadily over time. Development of cuboidal epithelial cells appears to happen 
relatively late (day 18) and is not homogenous across the cell population. Moreover, 
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by day 21 the cells did not have homogenous morphology and there were still 
patches of cells that appear to be growing on top of each other. Growing cells on 
culture inserts provides a more natural environment than normal culture plates, with 
better basolateral accessibility, ideally allowing for better enterocyte differentiation. 
Nevertheless, this batch of cells had the same apical morphology and similar 
intracellular electrolyte concentrations irrespective of the culture matrix conditions 
which conforms to previous research (Herold et al. 1994). 
Interestingly TEER values reported for Caco-2 cells range from 200 > 3500 Ω cm2 
(for the latter see Johannessen et al. 2013). There appear to be contradictions in the 
unitary expression of TEER in the literature (Ω cm2 Koeneman et al. 2010 or Ω/ cm2 
Janer et al. 2014). Firstly, values of 3500 Ω cm2 are considerably high for epithelial 
resistance readings in gut epithelial cells, considering the tightest epithelial cells 
(freshwater fish gill) in culture conditions have resistance readings of 1000–5000 Ω 
cm2 (Wood et al. 1998); secondly, resistance is inversely proportional to the cross 
sectional area of the insert, i.e. the larger the insert the less resistance, so the 
resistance reading is multiplied by the area of the insert (usually in cm) to normalise 
the reading to Ω cm2. If units are plotted as Ω / cm2 when expressing TEER values 
they are implying a proportional relationship of resistance to insert size which is 
incorrect. 
 
3.5.2 Accumulation and basolateral appearance of Ti from TiO2 exposures in 
21 day old Caco-2 cells 
Similar to the previous study (Chapter 2) this study demonstrated a time dependent 
accumulation of total Ti metal in mature Caco-2 cells from exposures to TiO2 
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particles (Fig. 3-6; 3-8) regardless of culture conditions (flat plates or use of cell 
culture inserts). Gradual reduction in cell Na+ (against the concentration gradients) 
and the gradual depletion of K+ in the opposite direction to the net Ti accumulation in 
conjunction with low medium LDH activity and healthy cell appearance suggest Ti 
accumulation is not due to passive diffusion through leaky cells or via solvent drag, 
rather, it is an active process. 
The presence of Ti in the basolateral medium suggests transport of Ti or TiO2 from 
TiO2 particle exposures across the epithelial layer. The potential mechanisms of 
transport are 1) through the paracelluller route in between tight junctions; 2) by 
damaging cells thus creating a hole in the monolayer; 3) or through an epithelial cell 
(Koeneman et al. 2010). For paracellular transport through intact tight junctions 
individual particles would need a diameter smaller than 5 nm to diffuse in between 
the monolayer, furthermore, a high divalent ion concentration in the tight junction 
would likely result in increased particle aggregation and diffusion would be hindered 
by junctional proteins. TEER was unaffected by TiO2 exposures suggesting tight 
junctions maintained their integrity. Characterisation of the materials (Chapter 2, Fig. 
2-2) demonstrated < 0.5% of the particles were in the 5 nm size range. The results of 
this present study demonstrate more than 0.5% of the administered concentration 
was detected in the basolateral compartment. Penetration through a hole in the 
monolayer is also unlikely considering the cells were healthy and there were 
negligible changes in TEER (ion leak) and media LDH leak relative to control cells. 
Overall the data suggest paracellular transport and/or transport of particles through 
holes in the epithelial layer are unlikely thereby implying transport through intact 
epithelial cells as the most probable transport route. This conclusion is in line with 
previous conclusions of Koeneman et al. (2010).  
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The main purpose of this study was to assess the effect of TiO2 crystal structure on 
uptake, accumulation, apical to basolateral transport, and epithelial integrity on fully 
differentiated Caco-2 cells and gauge whether this is comparable to partially 
differentiated Caco-2 cells. The form in which TiO2 crosses the epithelial layer was 
not assessed. However, given the similarity of the results with the previous work on 4 
- 5 day old Caco-2 cells (Chapter 2) one could tentatively assume the majority of Ti 
which accumulated (in the cells) and crossed the epithelium was in the form of intact 
particles. A number of researchers (Koeneman et al. 2010; Brun et al. 2014; 
Gitrowski et al. 2014, Chapter 2) have demonstrated intact particle accumulation in 
Caco-2 cells. Moreover, Brun et al. (2014) revealed, using X-ray absorbtion 
spectroscopy (XAS), Ti rich intracellular regions of the cell contained Ti still in the 
TiO2 NP state and the crystalline phase and speciation remained identical to stocks, 
indicating no partial dissolution had occurred (Brun et al. 2014). In contrast, Schmidt 
and Vogelsberger (2009) demonstrated TiO2 can undergo picomolar rates of 
dissolution at neutral pH in 100 mM NaCl solution. This level of Ti dissolution would 
be insufficient to support the accumulation and transport observed here, suggesting 
a large percentage of the detected Ti is in particulate form (TiO2).  
The overall apical to basal transport rates of Ti from exposures to different forms of 
TiO2 appear not to have been previously reported for the individual forms of TiO2 
exposed to fully differentiated Caco-2 cells. These rates, between 0.02 (Rutile) and 
0.11 (Bulk) nmol mg-1 protein h-1 are broadly similar to previous reports using 
mixtures of TiO2 forms (Koeneman et al. (2010) reported 0.141 nmol insert
-1 h-1 
mixture of anatase and rutile). Moreover, this is broadly similar to other metals 
known to have active transport mechanisms (Iron 0.036 nmol mg-1 protein h-1 Linder 
et al. (2006) ; Copper 0.003 nmol insert-1 h-1 Arrendondo et al. 2000). It is important 
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to note values reported in this study are likely to be lower than actual transport rates. 
Spike recoveries demonstrated between 20% and 30% reduction in detectable Ti 
from different forms of TiO2 spiked into culture medium (Fig .3-1). 
 
3.5.3 Effect of particle size and crytal structure on accumulation and transport 
The form of TiO2 influenced the total Ti accumulation over 24 h with the bulk material 
showing the greatest accumulation and the nano rutile the least (Fig. 3-6; 3-8). This 
pattern has been demonstrated in 4 day old cells grown in plates (Chapter 2) and 21 
day old cells grown in plates and inserts (Fig. 3-6; 3-8). Bulk uptake may be 
explained on a mass basis. For every particle of bulk taken up would inevitably 
contain more Ti metal then the NP. The reason for the greatly reduced uptake of 
rutile is unclear. This is not explained by poor availability of the particles in the stock 
dispersions (Chapter 2) or by the ability to detect the particles using ICP- OES in the 
cell homogenate or media (Fig. 3-1). It remains possible that the surface properties 
of rutile TiO2 are the cause for reduced uptake; however, more research would be 
required to confirm this (See Chapter 2, section 2.5).  
The appearance of Ti in the basolateral medium appeared to be influenced by 
particle size and form. Ti from P25 TiO2 exposures was the first to be detected in the 
basolateral medium, followed by anatase and finally bulk. Ti from the rutile form was 
detected by 24 h but the amount was negligible in comparison to controls (Fig. 3-10). 
Interestingly the crystal composition of the bulk TiO2 used in this trial contained the 
same percentages of anatase and rutile crystal types as the nano P25 (75% anatase, 
25% rutile) (Al-Jubory and Handy 2012), suggesting a size effect on apical to basal 
transport. A simple reason for the disparity in Ti appearance between bulk and nano 
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P25 TiO2 could be due to the porosity of the cell insert. The filter membrane itself 
represents a barrier for TiO2 diffusion. Steric constraints due to narrow pores and 
available area for diffusion will affect different sized particles to a different extent. In 
this present study between 53 and 61% of the apically administered material was 
detected in the basolateral media at 24 h in the absence of cells (Table 3-2) Similarly 
Janer et al. (2014) demonstrated that only 44.5 ± 16% of a 100 mg L -1 NP (anatase 
NPs mean diameter of 18 nm) solution administered to the apical chamber of an 
insert perforated with 1 µm pores could migrate into the basolateral compartment in 
the absence of cells. It would be reasonable to assume that larger particles would 
migrate through the insert at a reduced rate and the data herein shows bulk particle 
apical administrations have the lowest recovery from the basolateral medium relative 
to the NPs (not statistically significant). Fortuitously, filter inserts taken from the bulk 
trial appeared to have the highest Ti concentration from 6 h (just below the detection 
limit) compared to the other TiO2 forms. Moreover, Ti from bulk TiO2 exposures was 
only detectable in the basolateral media by 24 h suggesting a slower rate of 
migration through the inserts.  
 
3.5.4 Cell maturity and the effect of culture matrix on accumulation 
Previous work on 4 day Caco-2 cells demonstrated higher rates of accumulation in 
comparison to the present study (Chapter 2, Fig. 2-6). A possible reason for reduced 
uptake may be due to apical membranes with dense microvilli having a reduced 
ability to undergo the invagination process preceding large endocytic events 
(Hansen et al. 2009). The actin core bundles innervating the MV are anchored 
bellow the apical membrane and hinder the invagination process. Nevertheless, 
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endocytic processes can continue unabated in areas between neighbouring microvilli 
and in areas where limited brush border differentiation has taken place.  
Interestingly, there appears to be an effect of culture matrix on total Ti accumulation 
(Fig. 3-6; 3-8). Cells cultured in plates demonstrated lower accumulation of Ti from 
TiO2 exposures in comparison to cells cultured in inserts. The reasons for this are 
unclear and would merit further investigation. Interestingly the effect of crystal 
structure on the pattern accumulation remained the same (rutile was taken up the 
least) independent of cell maturation status and culture matrix.  
 
3.5.5 Ionic regulation 
Similar to the previous study (Chapter 2) TiO2 exposure caused increases in total 
cellular Ca2+ and decreases in K+ over the 24 h exposure period. This occurred 
irrespective of growth substrate and material. The reasons for this are unclear 
although potential mechanisms are reviewed in Chapter 1, section 1.3.8. The 
similarity of electrolyte changes over time when comparing mature cells (21 day old) 
with 4 day old cells (Chapter 2) suggests cell ion regulatory functions are set early in 
the maturation of cells, supporting the notion that immature cells are a useful proxy 
for metal accumulation studies without the need to wait for cells to mature fully. 
 
3.5.6 Conclusion 
This study shows that fully differentiated Caco-2 cells accumulate Ti from TiO2 
exposures in a manner indicative of active uptake which is similar to 4 day old cells. 
Cells cultured on inserts demonstrated accumulation and transport of Ti and/or TiO2 
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from TiO2 exposures. Critically, there is a crystal structure effect with the anatase 
form being absorbed and transported faster than the rutile form in mature cells 
cultured on inserts. Similarly, this pattern of accumulation was observed in mature 
and immature cells cultured on flat bottom plates. Short term exposure of TiO2 
appears to disturb some aspects of electrolyte status in Caco-2 cells, without 
affecting membrane integrity (LDH and TEER) and apical morphology, similar to 4 
day old cells (Chapter 2). 
Calculated human daily exposures to TiO2 NPs have been shown to be in the region 
of 1.8 – 4.5 ng cm2 of intestine (Brun et al. 2014). This study exposed 1 cm2 of Caco-
2 cells to 0.55 µg TiO2 particles which is 125 fold higher than calculated expected 
exposure scenarios. This exposure could be considered as a worst case acute 
exposure scenario. Modelling chronic exposure scenarios to different forms of TiO2 
NPs which reflect dietary concentrations needs to be completed in order to inform 
dietary exposure assessments for human health. Moreover, standardization of the 
filter materials, experimental procedures and analytical techniques in combination 
with documenting cell line development (age and differentiation) in NP accumulation 
and transport studies would improve the comparability of results between 
laboratories and allow for a better understanding of NP cell interactions.  
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Chapter 4: Uptake of titanium 
from TiO2 nanoparticle exposure 
in the isolated perfused intestine 
of female Wistar rats (Rattus 
norvegicus) 
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4.1 Abstract 
In vivo studies have raised concerns that titanium dioxide nanoparticles (TiO2 NPs) may be 
taken up across the gut of mammals, but there is limited information on the uptake 
mechanism(s) and kinetics of NPs across the gastrointestinal tract. Whole gut sacs and the 
isolated perfused intestine of rat (Rattus Norvegicus) were used to determine the parts of 
the gut involved in absorption, and the intestinal uptake rates of Ti from both bulk and nano 
TiO2 exposures across rat gut. Pharmacological inhibitors were used to explore 
mechanisms of Ti uptake from TiO2 exposures. Luminal exposure of whole gut sacs to 1 mg 
L-1 TiO2 NP for 4 h caused accumulation of Ti in the small and large intestine, with 70% or 
more of the Ti in the mucosa, rather than underlying muscularis. Perfused intestines 
exposed to 1 mg L-1 nano TiO2 or the equivalent bulk powder in the mucosal solution for 4 h 
showed a time-dependent accumulation of Ti in the serosal perfusate with a mean initial flux 
rates into the serosa (mean ± S.E.M n = 5 ) of 4.402 ± 0.461, 25.08 ± 2.545, and 2.814 ± 
0.929 nmol g-1 h-1 for TiO2 bulk, nano, and controls (no-added TiO2), respectively. This 
demonstrates that Ti from TiO2 exposures can cross the gut and enter the serosal solution 
with the nano form being faster than bulk. The addition of 100 μmol L-1 sodium 
orthovanadate, (P-type ATPase inhibitor) or 120 U mL-1 nystatin (putative endocytosis 
inhibitor) to the serosal solution increased mean Ti tissue concentrations for both bulk and 
nano TiO2 exposures compared to the no drug exposures (e.g., from 0.265 ± 0.044 to 0.673 
± 0.133 and 0.447 ± 0.081 µmol g-1 dry weight for bulk TiO2 exposures in the no drug, 
nystatin and vanadate treatments, respectively. Similarly for nano TiO2 exposures tissue Ti 
concentrations were 0.293 ± 0.048 to 0.403 ± 0.062 and 0.388 ± 0.064 µmol g-1 dry weight 
for no drug, nystatin and vanadate treatments, respectively) and reduced Ti serosal flux for 
the nano exposures. Overall, the data suggests an active absorption mechanism is 
responsible for Ti uptake from both bulk and nano TiO2 exposures across the perfused rat 
intestine that is drug sensitive.  
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4.2 Introduction  
The mechanism(s) of NP uptake across the intestinal epithelium of mammals 
remains poorly understood (Handy et al. 2008; Shaw and Handy 2011). Handy (2008) 
argued that apical uptake of intact NPs in fish is unlikely to occur through ion 
transport pathways or paracellular diffusion (tight junctions) because NPs are too 
large. Transport through vesicular mediated processes seems more likely, with 
analogous arguments having been made for mammalian gut exposed to carbon NPs 
(Panessa-Warren et al. 2006), which is unsurprising considering the functional and 
structural similarities of intestinal epithelium within vertebrates. NPs have been 
shown to cross cell membranes in Caco-2 cells following apical exposures of 1 mg L-
1 (Koeneman et al 2010) and traverse entire cells (apical to basal) without disrupting 
junctional complexes (Koeneman et al. 2010; Chapter 3). Furthermore work by 
Gitrowski et al. (2014) (Chapter 2) and Brun et al. (2014) have shown intact TiO2 
particles occupying vesicles within Caco-2 intestinal cells, suggesting that, at least at 
the apical membrane, the majority of TiO2 NPs are taken up in particulate form.  
The translocation of Ti or TiO2 from TiO2 NP exposures to systemic body sites has 
been demonstrated in a number of species. (e.g. mice – Wang et al. 2007; rats - 
Tassinari et al. 2014; trout - Ramsden et al. 2009). For example, Wang et al. (2007) 
demonstrated an increase in organ Ti concentration (liver, spleen, kidney, lungs and 
brain) 2 weeks after a single oral exposure of 5 g kg-1 bw. Ramsden et al. (2009) 
demonstrated an increase in spleen Ti concentration in trout following 8 week 
exposures of diets containing 10 – 100 mg kg−1 of TiO2. Data on the rates of Ti 
translocation in vivo or ex vivo are sparse, nevertheless, mucosal to serosal 
transport rates of Ti or TiO2 from TiO2 NP exposures of 1 mg L
-1 in perfused trout 
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intestines have been shown to be in the order of 2 nmol g-1 (dry weight) h−1 (Al-
Jubory and Handy 2012) whilst rates for bulk particles were 0.85 nmol g−1 h−1. In 
vitro Caco-2 intestinal cell transport rates (apical to basolateral) have been shown to 
be between 0.11 and 0.02 nmol mg-1 (cell protein) h-1 (Chapter 3), depending on TiO2 
crystal structure or 0.141 nmol insert-1 h-1 (Koeneman et al. 2010) for a mixture of 
TiO2 NP crystal types. The overall translocation rates of Ti or TiO2 from TiO2 
exposures in Caco-2 cells are considerably greater than demonstrated translocation 
rates for the perfused trout intestine (for the same exposure dose), suggesting that 
cell lines may not accurately reflect the situation in vivo. There are a number of 
limitations that need to be considered when extrapolating uptake and transport data 
from immortalized cell lines to in vivo or ex vivo. For instance, Caco-2 cells only 
represent a monolayer of mucous-free enterocyte-like cells and are likely to express 
characteristics of carcinoma cells rather than normal gut enterocytes. Further, the in 
vivo - ex vivo situation is quite different. There are four layers of intestinal tissue 
(mucosa, submucosa, muscularis and serosa) and a thick layer of anionic mucus 
protecting the absorptive surface. Furthermore, luminal pH and digesta matrix varies 
considerably with anatomical location, and at the absorptive interface there are a 
number of different cells types (e.g. goblet cells, enterocytes, paneth cells and M 
cells). With this in mind, it remains uncertain whether the processes mediating 
particle uptake are the same in cell lines as they are in vivo or ex vivo.  
The aim of this study was to determine which part of the mammalian gut is most 
likely involved in uptake and accumulation of TiO2 NPs by using isolated whole gut 
sacs from rats. Having determined which areas are likely associated with particle 
uptake, precise measurements of total Ti uptake rates (mucosa - serosa) using the 
perfused intestine preparation were performed and the results interpreted in the 
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context of particle behaviour in the gut lumen. These ex vivo preparations allow 
manipulations of the mucosal or serosal solutions to measure concentration- 
dependent uptake rates, or can be used to investigate uptake mechanisms through 
the addition of pharmacological inhibitors. Mechanism(s) of uptake were explored 
with pharmacological agents and involved using nystatin (a putative inhibitor of lipid 
raft caveolae endocytosis) and sodium orthovanadate, which is a P-type ATPase 
inhibitor, which non-specifically blocks the ATPase family of ion pumps including the 
Na+- K+ ATPase. In order to accurately interpret whether apparent uptake had any 
surface-bound components of Ti, some rapid solution dipping experiments were 
performed with a view to measuring the instantaneous adsorption of TiO2 to the 
intestine. Ex vivo preparations of trout intestine have been successfully used to 
explore TiO2 NP uptake (Al-Jubory and Handy 2012) at 15°C but, it is uncertain 
whether the preparation would be successful with more delicate rodent gut 
performed at 37°C. 
 
4.3 Materials and methods 
 
4.3.1 Stock animals 
Adult Wistar female rats (Rattus norvegicus albinus) weighing 185 ± 5 g (mean ± 
S.E.M., n = 42) were purchased from Harlan Laboratories and placed in suitable 
cages (no more than 6 animals per cage), maintained at a constant temperature (18-
23°C), appropriate humidity (40 – 50%) and photoperiod (12 h light: 12 h dark). Rats 
were fed a standard formulation (2018 Teklad 18% protein rodent diet, Harlan 
Laboratories) comprised of 18, 5 and 5% of protein, fat and fibre, respectively. 
Animals had access to drinking water ad libitum. ICP-OES analysis for total metal 
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concentrations in the feed revealed a total Ti concentration of 3.28 ± 0.61 mg g−1 dry 
feed (mean ± S.E.M., n = 5). Prior to beginning the experiments, all rats were starved 
for 48 h to let the gut empty of residual food, to facilitate eversion of the gut and to 
minimise incidental binding of titanium from undigested food on the gut epithelium. 
 
4.3.2 Preparation of gut sacs 
Whole gut sacs were used to determine which parts of the gastrointestinal tract are 
mainly involved in Ti absorption from TiO2 exposures and prepared according to 
Hoyle and Handy (2005) derived from the original method of Handy et al. (2000). 
This physiological technique involves removing the whole gut from the animal, filling 
the lumen with the test substance of interest, and then suturing closed the different 
anatomical parts of the gut so that regional uptake into the tissue can be measured 
over a few hours. Rats were humanely sacrificed by cervical dislocation (in 
compliance with ethical approval in the UK). The weight of the rat was measured; 
then the entire gastrointestinal tract was carefully removed, washed and flushed 
through with the physiological saline which contained (in mmol L−1): NaCl, 117.5; KCl, 
5.7; NaHCO3, 25.0; NaH2PO4.2H2O, 1.2; CaCl2.2H2O, 5.0; MgSO4, 1.0; glucose, 5.0; 
mannitol, 23.0; osmolarity 320 mOsm (Osmomat 030, Gonotec) adjusted to pH 7.4 
with a few drops of 10 mol L−1 HCl. The length of the rat gut required a slight 
modification of the Handy and Hoyle (2005) technique due to anatomical differences. 
In brief, the gut was cut where the stomach meets the duodenum and where the 
ileum meets the caecum. Physiological saline was flushed through each gut section 
followed by ligating the posterior end of the tissue sections prior to filling the lumen 
with physiological saline with a concentration of 1 mg L−1 TiO2 (Bulk, NP, or no 
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added TiO2 control as appropriate). The remaining parts of the gut were ligated with 
surgical silk around the upper end of the oesophagus, duodenum and caecum and 
further sutures applied to separate each region of the gut (oesophagus, stomach, 
duodenum, jejunum, ileum, caecum and large intestine). The gut was then placed in 
a bath containing 700 ml of the same physiological saline (no added TiO2). The bath 
(serosal side) was continuously stirred and gassed with 95% O2: 5% CO2 at 37°C for 
4 h. The 4 h duration time for this experiment was chosen following previous metal 
perfusion studies which indicated saturable uptake within 4 h (e.g. Cu in catfish gut, 
Handy et al. 2000; Hg in trout gut, Hoyle and Handy 2005; TiO2 in trout gut, Al-
Jubory and Handy 2012). After each experiment the gut was carefully opened and 
washed with deionised water to remove excess TiO2, then divided into sections of 
intact oesophagus, stomach, duodenum, jejunum, ileum, caecum and large intestine 
for metal analysis and histology (see below). In some experiments, each part of the 
gut was further divided longitudinally into two equal parts; one part was stripped of 
the mucosa, while the other part was left whole, to enable calculation of the relative 
proportion of Ti in the mucosa and underlying muscularis (Hoyle and Handy 2005). 
 
4.3.3 Surface binding experiment 
To aid data interpretation on Ti accumulation in the mucosa, some rapid solution 
dipping experiments were done to quantify surface binding of Ti. The approach 
followed a well-established method for tissue (Handy and Eddy 2004) and is well 
known for metal salts (Shaw and Handy 2011) and has previously been reported for 
TiO2 NPs in trout intestine (Al-Jubory and Handy 2013). The technique involves 
allowing the tissue to instantaneously adsorb metal onto the surface of the 
158 
 
epithelium over a few seconds (i.e., before true uptake can occur) and then 
determine the metal concentration on the tissue. Measurements were made on 
jejunum segments. Briefly, rats were sacrificed and the intestinal tract was quickly 
removed, everted, and then rinsed in clean saline (as above). Pieces of everted 
jejunum were then dipped (mucosa facing the solution) in 500 ml of fresh 
physiological saline for 15 s (control dip to equilibrate the surface of the tissue with 
the saline), then dipped in to 1 mg L−1of TiO2 bulk or NPs in 500 ml physiological 
saline for 30 s. Finally, tissues were rinsed of excess TiO2 by dipping in two 
consecutive 500 ml beakers of clean physiological saline (total of 15 srinsing). 
Tissues were then digested in nitric acid and analysed for total Ti metal content (see 
below). 
 
4.3.4 Preparation of the isolated perfused intestine 
The isolated perfused intestine technique has been used in mammalian physiology 
for many years to study the uptake of ions and water (e.g., Rao 2009; Wapnir 1991), 
and has also been used for measuring the uptake of toxic metals like copper and 
mercury (e.g., Handy et al. 2000) and more recently TiO2 uptake in trout (Al-Jubory 
and Handy 2012). The approach involves removing the intestine from the animal, 
carefully turning it inside out (everted) so that mucosal epithelium is on the “outside” 
and can be directly bathed in the external media (usually in a static, stirred bath of a 
gut saline). This enables the experimenter to change the composition of the bath (i.e., 
the mucosal or luminal-side solution) so that uptake mechanisms can be investigated 
(e.g., by adding different concentrations of the test substance to the bath, or by 
adding inhibitors). Uptake of substances by the preparation is generally recorded in 
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two ways: (i) measurement of the test substance in the gut tissue at the end of the 
experiment, (ii) measurement of the appearance of test substance on the blood side 
of the preparation (i.e., transepithelial uptake to the serosal perfusate). The perfusate 
usually flows constantly in the preparation (via a peristaltic pump) to prevent the 
system from coming into a diffusional steady-state so that true uptake rates can be 
measured. In this study the isolated perfused intestine was prepared according to 
Handy et al. (2000). The rats were sacrificed (as above) and the entire intestinal tract 
(from oesophagus to the rectum) was quickly removed. The length of the small 
intestine (duodenum to ileum) was measured and divided into three equal segments. 
A 10 cm segment was cut from the jejunum portion of the small intestine 
(anatomically it is difficult to distinguish the jejunum section from the rest of the small 
intestine externally, however, its position can be noted prior to excision of the 
gastrointestinal tract). The jejunum segment was then everted, connected to the 
perfusion apparatus, and bathed in 700 mL of the physiological saline (described 
above), at 37°C, gassed with 95% O2: 5% CO2 (a standard gas mixture used for gut 
perfusion work). The intestine was serosally perfused (1 mL min−1 via an Ismatec 
peristaltic pump) using the gut saline described above 4 h. Perfusions were 
conducted in parallel to eliminate time-dependent artefacts with a control (no added 
TiO2 and two treatments (e.g., + TiO2 NPs or bulk powder) performed each day. The 
eluted serosal perfusate was collected manually in 10 min fractions, and the volume 
determined gravimetrically. Five ml of the mucosal solution (bath samples) were 
collected every 30 min for Ti, Na+ and K+ analysis (see below), and to monitor pH. At 
the end of each experiment the guts were carefully washed in deionised water to 
remove excess TiO2 and residual electrolytes from the saline. Samples of each gut 
were also taken for histopathology and electron microscopy. In separate experiments, 
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the effects of adding 100 μmol l−1 sodium orthovanadate (a P-type ATPase inhibitor; 
Kuhlbrandt 2004) to the serosal perfusate was tested in order to discover whether Ti 
uptake had an energy - dependent component or additions of 120 IU ml−1 nystatin (a 
putative endocytosis inhibitor) to the mucosal solution to explore if cholesterol is 
involved in uptake processes. 
 
4.3.5 Lactate dehydrogenase (LDH) assay 
The routine viability criteria for the perfused intestine preparation are the presence of 
steady perfusate flow, net efflux of water across the gut, and negligible LDH leak 
from the tissue (Handy et al. 2000). LDH activity was determined by the same 
method described in Chapter 3, Section 3.3.7. Typically, in perfused organ 
preparations, the maximum LDH activity in the medium from a normal healthy tissue 
would not exceed 1 U ml−1 (1 μmol min−1 ml−1) with the data for all samples below 
this value (see Results). 
 
4.3.6 Trace metal analysis 
The methodology for trace metal analysis in tissues was based on the original nitric 
acid digestion method of Handy et al. (2000) for fish intestine, but with some novel 
modifications that enable detection of Ti from intact TiO2 NPs dispersed in the tissue 
digest without the need for hydrofluoric acid or hot sulphuric acid digestion (see 
Lomer et al. (2000) for the traditional H2SO4 method for foods). The modification 
presented here involved adding Triton X-100 to dilute the nitric acid digest, and with 
mixing/shaking it was possible to get good nebulisation of the sample in the spray 
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chamber of the ICP-OES to detect both the total Ti metal concentration from the NP 
exposure and other dissolved trace metals in the sample (Shaw et al. 2013). Briefly, 
tissues from all experiments were oven dried to a constant weight at 100°C for up 48 
h (Gallenkamp Oven BS Model OV-160), then the samples were transferred into 20 
mL scintillation vials (VWR International Ltd, Poole, UK) and digested in 1 or 4 mL 
(depending on tissue weight) of concentrated nitric acid for 3 h at 70°C in a water 
bath. The digested samples were allowed to cool, and then Triton X-100 was slowly 
added to each digest with Milli-Q water (ultra-pure ion free water) to achieve a final 
concentration of 2% Triton X-100 in each sample. Typically this involved adding 3.2 
or 0.8 mL of 10% Triton X-100 and diluting to a final volume of 16 or 4 mL (for tissue 
weights of 1 g or 0.1 g, respectively). Digests were then analysed for total Ti metal, 
Na+, K+, Ca2+ and Mg2+ concentrations by ICP-OES. Critically, samples were 
sonicated (Bransonic 60 Hz) for 2 h prior to being vortexed (10 s) and immediately 
introduced to the instrument (IKA MS2 Minishaker; set at 2500 r min−1). The 
instrument detection limit (3 x standard deviation of the blank + the mean of the 
blank (n = 6) (Thomsen et al. 2003)) for measuring the gut salines or matrix matched 
standards was calculated as 1.7 μg L−1, equivalent to 35 nmol L−1 of Ti metal, and for 
the entire digestion protocol 1.9 μg L−1, equivalent to 40 nmols L−1 of Ti metal (for a 
typical 0.5 g tissue sample this equates to 0.001 μmol Ti metal g−1 dry weight of 
tissue). The optimised protocol gave good spike recovery for rat tissue (e.g., mean ± 
SEM, n = 6; 97.5 ± 2.9% for spiking with Ti metal, and 90.2 ± 1.4% for spiking with 
TiO2 NPs) and low coefficients of variation within and between tissue samples from 
different rats (around 5% or less for repeats of the entire protocol). Spike recovery of 
mucosal bath (physiological saline) solutions was (mean ± S.E.M, n = 5); 89 ± 4% 78 
± 1.5% for spiking with Ti metal and nano TiO2, respectively. Calibrations with 
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different concentration of Triton-X100 in standards had a negligible effect (no 
problems with instrument calibration with metals standards or TiO2 dispersions 
(Shaw et al. 2013)). Tissue Ti levels are reported as μmol of Ti metal g−1 dry weight. 
The bath solution was measured for Ti to confirm the TiO2 exposure and for 
convenience the data are reported as mg L−1 of TiO2 (for the bath solution only) after 
correcting the Ti metal data using the stoichiometry of the compound (Ti content of 
TiO2 as 60% of the mass). All other data are reported as total Ti metal 
concentrations (in the tissues and eluted perfusates).  
 
4.3.7 TiO2 bulk and NP stock solutions 
A 0.5 g L−1 dispersion of bulk TiO2 was prepared from 0.5 g of TiO2 powder (ACROS, 
Titanium (IV) oxide, New Jersey, USA; manufacturer’s information: purity of 98.0-
100.5% TiO2). The manufacturer’s technical support indicated a crystal structure 
mixture of anatase (75%) and rutile (25%) (Al-Jubory and Handy 2012). The powder 
was dispersed and stirred (Stuart magnetic stirrer, set at half speed) in 1 litre of 
ultrapure (ion free) Millipore water for 20 min. The particle size was determined by 
two independent methods. First, sub samples of the 0.5 g L−1 stock dispersion were 
examined for primary particle size using transmission electron microscopy (TEM, 
JEOL-1200EX II) and examples of the particles are shown in (Fig. 4-1 A) with a 
primary particle size measurement of 115.4 ± 13 nm (mean ± S.E.M., n = 6) for bulk 
TiO2. The second approach was for particle size distribution using NP tracking 
analysis (NTA, Nanosight LM 10, Nanosight, Salisbury, UK, laser output set at 30 
mW at 640 nm). In order to measure particle size distribution by NTA the initial stock 
dispersion (0.5 g L−1) was diluted to 1 mg l−1 in the physiological saline used for gut 
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perfusions (see below) to account for matrix effects on aggregation (1 ml of the initial 
stock made up to 500 ml of saline, stirred as above), and the resulting dispersion 
gave mean values of 213 ± 23 nm for the average particle size with 10% of the 
particles being smaller than 148 ± 7.17 nm (bin size, mean ± S.E.M., n = 3 ) for bulk 
TiO2 (Fig. 4-1 C).  
The TiO2 NPs used here was the same as that used by Federici et al. (2007) and Al-
Jubory and Handy (2012). The powder form of ultrafine titanium dioxide NP type 
“Aeroxide” P25 (DeGussa AG, supplied by Lawrence Industries, Tamworth, UK) with 
(revised manufacturer’s information): a crystal structure of 25% rutile and 75% 
anatase TiO2, purity was at least 99% TiO2 (maximum impurity stated was 1% Si), 
the average particle size was 21 nm with a specific surface area of 50 ± 15 m2 g−1. 
Chemical analysis of stock dispersions revealed no metal impurities (data not 
shown), and the batch purity was high. 
A stock dispersion containing 0.5 g L-1 was made as above. Transmission electron 
microscopy showed the structure and the primary particle size of P25 NPs to be 22.8 
± 6 nm (mean ± S.E.M., n = 6), while the mean aggregate size of the NPs was 148.8 
± 18 nm (mean ± S.E.M., n = 6; Fig. 4-1 B). The dosing of the bath was the same as 
that reported for the bulk material (above), and the distribution of the 1 mg L−1 TiO2 
NPs in the physiological saline prior to the start of experiments was also confirmed 
by NTA. The mean values for particles (primary and aggregates) were 146 ± 15 nm 
with 10% of the particles being smaller than 58 ± 6 nm (mean ± S.E.M., n = 3; Figure 
1 D). Prior to administering TiO2 to the mucosal bath saline (and saline for Nanosight 
analysis) both stocks were dispersed with sonication in a bath-type sonicator (500 ml 
of stock, 35 kHz frequency, Fisher brand FB 11010, Germany) overnight. 
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Fig.  4-1: Electron micrographs showing (A) bulk and (B) nano TiO2 particles in a 0.5 g L
−1
 stock 
dispersion. Particle size distributions measured by nanoparticle tracking analysis (NTA) are shown 
below; (C) bulk TiO2 and (D) TiO2 NPs in a 1 mg L
−1
 stock dispersion in physiological saline (without 
the gut present); (E) bulk TiO2; and (F) and nano in the mucosal solution following a 4 h perfusion 
graphs are individual examples from triplicate measurements of each.  
C D 
E F 
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4.3.8 Histology and transmission electron microscopy 
After each perfusion, a piece of tissue from the middle of each preparation was 
carefully collected for light microscopy. Briefly, tissues were rinsed and fixed in 10% 
buffered formal saline for at least 48 h, dehydrated in graded series of ethanol, and 
cleared in xylene prior to embedding in paraffin blocks. Seven micrometre sections 
were stained with haematoxylin and eosin. Slides were examined using light 
microscopy (Olympus Vanox - TAH2) and photographs were taken using a digital 
camera (Olympus camedia C-2020 Z). For scanning electron microscopy (SEM), 
briefly, tissue was washed in physiological saline (above) and fixed in 2.5% 
glutaldehyde in cacodylate buffer (0.1 M sodium cacodylate, pH of 7.2, for 2 h). 
Tissues were then washed twice in cacodylate buffer prior to being dehydrated in a 
graded series of ethanol. Tissues were critically point dried and carbon coated 
(EMITECH-K850, K450X). Samples were imaged and elementally analysed (SEM, 
JEOL/JSM-7001F, Oxford Instruments INCA X-ray analysis system) using a 15 KV 
accelerating voltage, at a working distance of 10 mm. For the transmission electron 
microscope investigations, small fragments from the centre of the jejunum were fixed 
in glutaraldehyde (2.5%), buffered in 0.1 M sodium cacodylate, pH 7.2, and post-
fixed in osmium tetra oxide 2% (OsO4). The pieces were then dehydrated in a 
graded series of ethanol and infiltrated with a graded series of Spur’s resin. 
Embedding as a small capsule was performed using pure resin. Thin sections were 
cut (70 - 90 nm) and stained with 2% uranylacetate and lead citrate, then examined 
by transmission electron microscope (TEM, JEOL-1200EXII). 
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4.3.9 Calculations and terminology 
All calculations on uptake rates were performed according to Handy et al. (2000). 
Briefly, data were graphically presented as the cumulative appearance of Ti metal in 
the perfusate, plotted against exposure time for example perfusions; and with 
cumulative perfusate flow shown on the same graph. The absolute Ti content of 
each 10 min fraction (μg) was calculated by multiplying the total Ti metal 
concentration in each tube (μg mL−1) by the total volume of perfusate/tube (mL). Ti 
contents of each fraction were summed for the cumulative plots (reported as nmol 
absolute Ti metal). The initial (first 10 min) and overall (240 min) net Ti flux rates 
(Jnet,Ti, in nmol g
−1 dry tissue h−1) to the serosal perfusate were calculated from the 
perfusate Ti content (in nmol) divided by the tissue dry mass and corrected to 1 h, 
while the initial (first 10 min) and overall (240 min) net water flux rates (Jnet, H2O, in 
mL g−1 dry tissue h−1) to the eluted perfusate were calculated from the differences 
between the rates of cumulative perfusate and effluent flow divided by the tissue dry 
mass and corrected to 1 h. The moisture content of tissues was determined by 
taking the weight of the tissue before and after oven drying and calculated as:((wet 
weight - dry weight)/wet weight) x 100. In the present study, we therefore use precise 
terminology for the absolute amounts of Ti metal in the perfusates (nmols, not a 
concentration), the concentration of total Ti metal in the tissue (μmol g−1 dry weight 
of Ti metal, not TiO2 compound), and distinguish this from the mg L
−1 of TiO2 
compound added to the bath when confirming the exposure. The phrase “total Ti 
metal concentrations” is used to mean the total mass concentration of Ti (not TiO2 
compound) in the tissue or relevant salines determined by ICP-OES; it does not 
imply anything about whether the Ti is present as particulate TiO2 or as a dissolved 
Ti species. The term “Ti accumulation" is used to mean a net increase in the total Ti 
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metal concentration in the tissue over time, determined by ICP-OES of the tissue 
digests. The phrase “Ti uptake” is used specifically to mean the net uptake of total Ti 
metal to the serosal compartment in relation to the flux calculations above. 
 
4.3.10  Statistical analysis 
All data were presented as mean ± S.E.M and analysed using Stat Graphics 
Centurion XVI Plus while figures were drawn using Excel (2010). The data 
(treatment or time effects) were tested after checking for kurtosis, skewedness, and 
unequal variance (Bartlett’s test). Parametric data were tested by one-way ANOVA 
or general linear model (for time/treatment interactions) followed by the Tukey’s HSD 
multiple range test. Non-parametric data that could not be transformed were tested 
using the Kruskal-Wallis test (analysis by ranks) and differences were located using 
notched box and whisker plots. The Student’s t-test was used as well to investigate 
the differences between pairs of data, or the Mann-Whitney U test where appropriate 
for non-parametric data. All statistical analysis used a 95% confidence limit, so that p 
values equal to or greater than 0.05 were not considered statistically significant. 
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4.4 Results 
 
4.4.1 Ti accumulation in whole gut sacs 
The whole gut sac preparation was used to determine which regions of the gut were 
accumulating Ti from TiO2 exposures (Fig. 4-2). All regions of the intact gut except 
the oesophagus, stomach and caecum showed statistically significant elevations of 
total Ti metal concentrations in the tissues from exposure to bulk or nano TiO2 
compared to the unexposed controls, with the greatest increases in the small 
intestine (duodenum, jejunum and ileum) and the large intestine. There were no 
statistically significant differences between the regions of the gut that accumulated 
TiO2 (ANOVA, P < 0.05) nor were there any material-type effects (comparison of 
bulk versus nano treatment, Kruskal-Wallis, P > 0.05) on the tissue total Ti 
concentration. Comparisons of the proportions of total Ti metal concentrations in the 
mucosa relative to the intact gut confirmed that most (65% or more) of the 
background Ti in the small intestine of control animals was in the mucosa. Similar 
observations were made for the guts exposed to both bulk and nano TiO2 (Table 4-1). 
The percentage of Ti retained in the mucosa for bulk exposures was 77, 77, 67 and 
59% for the duodenum, jejunum, ileum and large intestine, respectively. For nano 
TiO2 exposure, the percentage of Ti retained in the mucosa was 69, 82, 72, and 79% 
for the duodenum, jejunum, ileum and large intestine, respectively. 
169 
 
Fig.  4-2: Total Ti metal concentrations µmol g
-1
 tissue dry weight following exposure of isolated whole gut sacs to 1 mg L
−1
 TiO2 in the gut lumen for 4 h (Values are means ± 
S.E.M. (n = 5 for each group)). *Statistically significant difference from the control (Kruskal-Wallis or ANOVA P < 0.05). Different letters within treatments indicate a statistically 
significant difference between regions of the gut (Kruskal-Wallis or ANOVA P < 0.05). 
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Table ‎4-1: Absolute Ti metal concentrations in intact gut and corresponding mucosa following exposure of isolated whole gut sacs to1 
mg l−1 TiO2 in the gut lumen for 4 h. 
 
Values are means ± S.E.M. (n = 5 for each group) expressed as absolute Ti content in μg
−1
 except Ti % in mucosa. Whole gut sacs were filled with physiological saline 
(control), 1 mg l
−1
 bulk TiO2 and 1 mg l
−1
 TiO2 NP at 37°C for 4 h.% Ti in mucosa is calculated for each region of the gut, % Ti in mucosa = [Absolute [Ti] in mucosa / Absolute 
[Ti] in corresponding intact gut section] x 100. * Statistically significant difference from the control value within columns (Kruskal-Wallis or ANOVA, P < 0.05).There were no 
gut region effects on [Ti] content. There were no material- type effects (bulk versus nano) within each region of the gut. Data was not normalised to dry weight because the 
moisture content of the mucous skewed the normalisation. 
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4.4.2 Histology of the whole gut sac 
Morphological examination of different gut sections (stomach, jejunum and large intestine) 
following a 4 h incubation with 1 mg L−1 bulk or nano TiO2 in physiological saline demonstrated 
that the preparation was well tolerated. The gut sections exhibited normal morphology (Fig. 4-3) 
with no obvious pathologies in the tissues. The tissues exposed to bulk and nano TiO2 appeared 
to show aggregates of ‘particles’ in contact with the mucosa, the morphology of the aggregates 
and the lack of similar aggregates in the control treatments tentatively suggest that these may be 
TiO2 (Fig.4-3 D-I). 
 
Fig.  4-3: Histology of gut sections following 4 h gut sac experiment. A) Control stomach, B) Control jejunum, C) 
Control large intestine, D) 1 mg L
−1
 Bulk TiO2 stomach, E) 1 mg L
−1
 Bulk TiO2 jejunum, F) 1 mg L
−1
 Bulk TiO2 large 
intestine, G) 1 mg L
−1
 Nano TiO2 stomach, H) 1 mg L
−1
 Nano TiO2 jejunum, I) 1 mg L
−1
 Nano TiO2 large intestine. 
Scale bar represent 100 μm, sections were 7 μm thick and stained with haematoxylin and eosin (n = 5 rats per 
treatment). 
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Table ‎4-2:Total Ti metal, Na+, K+, Ca2+ and Mg2+ concentrations of gut tissue segments from whole gut sacs following luminal exposure 
to 1 mg L−1 of TiO2 for 4 h. 
Values are means ± S.E.M. (n = 5) for each group expressed as μmol g
−1
 dry mass of intestinal tissue, except moisture content (%). Whole gut sacs were filled with 
physiological saline (control), 1 mg l
−1
 bulk TiO2 and 1 mg l
−1
 TiO2 NP at 37°C for 4 h. * Statistically significant difference from the control value within columns and electrolytes 
(Kruskal-Wallis or ANOVA, P < 0.05). ! Statistically significant difference from bulk TiO2 values within columns and electrolytes (Kruskal-Wallis or ANOVA, P < 0.05). Different 
letters (within rows) indicate a statistically significant difference between regions of the gut (Kruskal-Wallis or ANOVA, P <0.05). 
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4.4.3 Electrolyte and moisture composition of whole gut sacs 
The tissue electrolyte concentrations are shown in Table 4-2. There were some 
differences in the electrolyte composition of different gut regions, which is to be 
expected, but, there were no treatment-dependent effects of either bulk or nano TiO2 
on the Na+, K+, Ca2+ or Mg2+ concentrations in the whole gut sacs, with the exception 
of the oesophagus treated with nano TiO2, which caused an increase in all of the 
measured tissue electrolyte concentrations (ANOVA P < 0.05). This is likely 
attributed to the differences in moisture content compared with the bulk and control 
treated oesophagus (71.6 % ± 1.4 (Nano), 51.5 % ± 3.5 (Control) 52.3 % ± 11.2 
(Bulk)). 
 
4.4.4 The effect of TiO2 on the viability of the perfused intestine 
All the perfused intestine preparations were within the normal ranges for the selected 
viability measurements. Individual perfusions all displayed steady cumulative 
perfusate flow (Fig. 4-11), and LDH activity in all experiments remained below 1 
μmol min−1 mL−1 (1 U mL−1). The maximum LDH activities in the serosal perfusate at 
a given time point for the control, bulk TiO2 and nano TiO2 were 0.04, 0.02 and 0.04 
U mL−1, respectively. There were no statistically significant differences between 
treatments in either cumulative perfusate or mucosal salines LDH activities (Fig. 4-4). 
There were no TiO2 treatment dependent effects on [K
+], [Na+], [Mg2+], [Ca2+] and pH 
of the mucosal solution, which is indicative of a normal leak free intestine. The 
measured concentrations of [K+], [Na+], [Mg2+], [Ca2+] and pH in the fresh mucosal 
saline were 6.59 ± 0.22, 162.6 ± 4.00, 0.8 ± 0.016, 3.26 ± 0.035 mmol L−1 and 7.47 ± 
0.01, respectively (means ± S.E.M, n = 5). Following the 4 h treatment there were 
174 
 
only minor increases in the mucosal saline electrolyte concentrations for all 
experiments. For example, the average increase of [K+] and [Na+] in the control runs 
was 0.34 ± 0.074 and 4.5 ± 3.4 mmol L−1 respectively (means ± S.E.M, n = 5). The 
bulk and nano TiO2 treatments exhibited a similar pattern to the control with the 
average increase of [K+] and [Na+] being 0.47 ± 0.076 and 9.4 ± 3.9 for bulk and 0.61 
± 0.22 and 16.9 ± 6.1 for nano TiO2, respectively, over the course of the experiment. 
The grand mean change in pH (grand means of controls and treatments) for all 
experiments was 0.256 ± 0.023 which is representative of the expected base 
secretion of the intestine. The pH changes for each of the treatments was 0.226 ± 
0.033, 0.260 ± 0.039 and 0.282 ± 0.049 for the control, bulk and nano treatments, 
respectively (Table 4-3). 
Ultrastructural examination of the perfused intestine after 4 h indicated that tight 
junction integrity and brush border morphology were maintained throughout the 
experiment. The addition of 1 mg L−1 bulk or nano TiO2 to the mucosal solution 
appeared to cause no appreciable changes in enterocyte ultrastructure (Fig. 4-5 and 
4-6). Taken together, all the perfused intestine viability measurements were met 
which is indicative of a structurally and physiologically normal intestine following a 4 
h perfusion. 
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Fig.  4-4: (A); The effect of 1 mg L
−1
 TiO2 exposure on the cumulative perfusate LDH activity 
(cumulative sum of units of LDH activity per minute) over 4 h in perfused intestine at 37 °C, gassed 
with 95% O2: 5% CO2 gas mixture. Values are means ± S.E.M (n = 5). Statistical analysis for the 4 h 
time point showed no differences between cumulative totals between treatments (ANOVA P = 0.1102). 
(B); Cumulative absolute LDH activity in the mucosal solution over 4 h. Statistical analysis at 4 h 
showed no differences between cumulative totals between treatments (ANOVA P = 0.5504). 
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Table ‎4-3: pH and total Na+ and K+ concentrations in the mucosal solution during exposure of the isolated perfused 
jejunum to 1 mg l-1 of TiO2. 
 
Values are means ± S.E.M. (n = 5) for each group expressed as mmol L
−1
 for both Na
+
 and K
+
 in the mucosal solution. There were no significant difference 
between treatments nor were there any time effects (ANOVA, P > 0.05). 
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Fig.  4-5: TEM of the everted perfused intestine (Jejunum) following a 4 h perfusion. A) Everted control 
showing normal morphology with densely packed uniform microvilli; B) Everted jejunum exposed to 1 
mg L
−1
 Bulk TiO2 showing normal morphology intact mitochondria and intact tight junctions; C) 
Jejunum exposed to 1 mg L
−1
 nano TiO2 showing normal morphology. Images are representative of 
individual animals from replicated experiments (n = 5). Scale bars represent 5 μm). (N) Nucleus, (MV) 
Microvilli, (Mt) Mitochondria, (GC) Goblet cell, (M) Mucous, (TJ) Tight junction, (MA) Macula Adherens.  
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Fig.  4-6: SEM of the everted perfused intestine (Jejunum) following a 4 h perfusion. A) A villus from 
the control group covered in mucous showing normal morphology. Scale bar represents 10 μm; B) 
Control treatment showing densely packed villi which is indicative of a healthy gut. Scale bar 
represents 200 μm; C) Perfused intestine exposed to 1 mg L
−1
 bulk TiO2 exhibiting normal villi 
morphology. Scale bar represent 100 μm; D) Jejunum exposed to 1 mg L
−1
 nano TiO2 showing normal 
morphology. Scale bar represents 100 μm. Images are representative of individual animals from 
replicated experiments (n = 5). 
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4.4.5 The effect of pharmacological agents on the viability of the perfused 
intestine 
Addition of 120 IU mL-1 nystatin to the mucosal solution or 100 μmol L−1 sodium 
orthovanadate to the serosal solution had little effect on the viability criteria. 
Individual perfusions all displayed steady cumulative perfusate flow (Fig. 4-12), and 
LDH activity in all experiments remained below 1 μmol min−1 mL−1 (n = 5) (Fig. 4-7). 
The maximum LDH activity at a given time point in the nystatin trial for the control, 
bulk and nano TiO2 exposures was 0.03, 0.03 and 0.02 U ml
−1 respectively (Fig. 4-7). 
Similarly for the sodium vanadate trials the maximum LDH activity at any given time 
point for the control, bulk and nano exposures where 0.02, 0.02 and 0.01 U ml-1, 
respectively (Fig. 4-7). There were no statistically significant differences between 
treatments in either cumulative perfusate LDH activity or mucosal saline LDH activity; 
nor where there any differences in these measurements between the drug and no 
drug trials (ANOVA, P < 0.05).  
The 4 h perfusions in the presence of drugs had negligible effects on mucosal saline 
electrolyte concentrations. For example, in the nystatin treatment the average 
change of [K+] and [Na+] in the control trials (no added TiO2) over 4 h was -0.001 ± 
0.114 and 2.621 ± 3.149, (S.E.M. n = 5) respectively. Addition of bulk or nano TiO2 
treatments in the presence of nystatin exhibited a similar pattern to the control, with 
the average increase of [K+] and [Na+] (mmol l−1) being 0.025 ± 0.158 and 3.4 ± 3.9 
for bulk and -0.007 ± 0.167 and 3.99 ± 2.52 for nano TiO2, respectively, over the 
course of the experiment. There were no drug treatment-dependent effects on the 
mucosal bath pH. The grand mean change in pH (grand means of controls and 
treatments) for all experiments in the presence of nystatin was 0.11 ± 0.024. The pH 
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change for each of the treatments was 0.182 ± 0.044, 0.064 ± 0.026 and 0.084 ± 
0.043 for the control, bulk and nano treatments, respectively (Table 4-4). 
Addition of 100 μmol L−1 sodium orthovanadate to the serosal perfusate had little 
effect on [K+] and [Na+] leak into the mucosal solution. The increases in mucosal 
solution [Na+] concentrations were 5.66 ± 2.45, 8.81 ± 3.39, and 9.49 ± 1.632 mmol 
L−1 for the control, bulk and nano TiO2 treatments, respectively, over the 4 h 
perfusion. [K+] leak into the mucosal solution at the end of the 4 h perfusion was as 
0.277 ± 0.096, 0.415 ± 0.198 and 0.39 ± 0.07 mmol L−1 for the control, bulk and nano 
treatments respectively. The pH change followed a similar pattern to the other 
experiments. The grand mean change in pH for all the experiments perfused with 
100 μmol L−1 sodium vanadate was 0.186 ± 0.022. Ph change for each of the 
treatments was 0.213 ± 0.053, 0.183 ± 0.003 and 0.163 ± 0.012 for the control, bulk 
and nano exposures, respectively (Table 4-5) none of which was regarded as 
statistically significant. The data indicates that gut integrity and viability was 
maintained throughout the perfusion experiments for all treatments and exposures 
(drugs and TiO2). 
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Fig.  4-7: Panel; A) The effect of 120 IU mL
-1
 nystatin in the mucosal solution on the cumulative perfusate LDH activity over 4 h; C) Cumulative absolute LDH activity in the 
mucosal solution over 4 h in the presence of nystatin; B) The effect of 100 μmol L
−1
 vanadate in the serosal perfusate on the cumulative perfusate LDH activity over 4 h; D) 
Cumulative absolute LDH activity in the mucosal solution over 4 h in the presence of vanadate. Values are means ± S.E.M (n = 5). Addition of 1 mg L
−1
 TiO2 (bulk or nano) to 
the mucosal solution had no effect on the cumulative perfusate LDH activity (cumulative sum of international units of LDH activity per minute) or the cumulative absolute LDH 
activity in the mucosal solution at 4 h within groups or between groups relative to the controls (ANOVA or Kruskal wallis P > 0.05). All baths were maintained at 37°C gassed 
with 95% O2: 5% CO2 for 4 h. 
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Table ‎4-4: pH and total Na+ and K+ concentrations in the mucosal solution during exposure of the isolated perfused jejunum to 1 mg l-1 
of bulk or nano TiO2 in the presence of 120 IU ml
-1 nystatin. 
 
Values are means ± S.E.M. (n = 5) for each group expressed as mmol L
−1
 for both Na
+
 and K
+
 in the mucosal solution. There were no significant differences between 
treatments nor were there any time effects (ANOVA, P > 0.05). 
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Table ‎4-5: pH and total Na+ and K+ concentrations in the mucosal solution during exposure of the isolated perfused jejunum to 1 mg 
L−1 of TiO2 in‎the‎presence‎of‎100‎μmol‎L
−1 sodium orthovanadate. 
 
Values are means ± S.E.M. (n = 5) for each group expressed as mmol L
−1
 for both Na
+
 and K
+
 in the mucosal solution. There were no significant differences between 
treatments nor were there any time effects (ANOVA, P > 0.05). 
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4.4.6 Confirmation of 1 mg L−1 TiO2 exposure in mucosal saline solution 
The exposure to TiO2 was confirmed by a number of procedures;1) measuring the 
mass concentration of TiO2 and particle size distributions in the mucosal solution 
(Fig. 4-8); 2) using nanoparticle tracking analysis (NTA, Fig. 4-1); 3) measuring total 
Ti metal concentration in the intestinal tissue (Table 4-6). NTA measurements were 
made on samples collected a 0 and 240 min during the experiments using triplicate 
measurements for a sample each time. TiO2 concentrations of 1 mg L
-1 in the 
mucosal solution (bulk and nano) produced an unstable colloidal dispersion. The 
mean size distribution of the particles were smaller at the end of the 4 h perfusion 
(Fig. 4-1 - E-F) changing from 213 to 90 nm for the bulk material, and from 146 to 30 
nm for the NPs and is probably a reflection of the faster settling rate of larger 
aggregates (Keller et al. 2010) rather than selective uptake of larger particles by the 
tissue. Analysis of the concentration of Ti from mucosal saline samples taken 
throughout the experiment implied that bulk TiO2 settles out of suspension at a much 
faster rate than the nano form (ANOVA P < 0.05) (Fig. 4-8). Addition of drugs 
(nystatin and sodium orthovanadate) to the mucosal or serosal solutions had little 
effect on the mass concentration of TiO2 in the mucosal solution in comparison to no 
drug treatments. The nano TiO2 dispersion in the mucosal solution maintained a 
relatively consistent concentration, diminishing by (grand means) 0.160 ±0.027 mg 
L−1 for the duration of the experiment (equivalent to a 20% loss of TiO2 from the 
starting concentration at 4 h). In contrast, 1 mg L−1 bulk TiO2 dispersions settled 
much faster resulting in an average loss of 0.494 ± 0.0498 mg L−1 suspended TiO2 
by the end of the experiment (equivalent to a 62% loss of suspended TiO2 from the 
starting concentration at 4 h (Fig. 4-8) (means ± S.E.M, n = 15)). 
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Fig.  4-8: The concentration of TiO2 in the gassed and stirred mucosal solution over 4 h in the presence of the intestine. 
A) No drug; B)120 IU mL
-1
 nystatin added to the mucosal saline; C) 100 μmol L
−1
 sodium orthovanadate added to the 
serosal perfusate. Values are means ± S.E.M., n = 5 * indicates statistical significance at 4 h relative to the control. 
˜indicates a statistical significance between materials at 4 h (ANOVA P < 0.05). 
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4.4.7 Titanium accumulation from TiO2 exposures in the perfused rat jejunum 
in the presence or absence of pharmacological agents 
The accumulation of Ti in the tissue following the perfusions is shown (Table 4-6). 
Total Ti metal concentrations in the tissues were higher in both of the TiO2 
treatments compared to the no added TiO2 controls (ANOVA P < 0.05). These were 
0.265 ± 0.044 and 0.293 ± 0.048 µmol g-1 dry weight for bulk and nano TiO2 
respectively, compared to 0.027 ± 0.08 µmol g-1 dry weight in the control.  
Mucosal applications of 120 IU mL-1 nystatin caused a mean increase in tissue Ti 
concentration for bulk and nano TiO2 exposures relative to the no drug treatments. 
Tissue Ti concentrations following the 4 h exposure to TiO2 in the presence of 
nystatin were 0.673 ± 0.133 and 0.403 ± 0.06 µmol g-1 dry weight for bulk and nano 
TiO2, respectively. The increase in Ti for the bulk exposure was statistically 
significant compared to the no drug bulk TiO2 exposure (t test, P < 0.05) and 
significant at the 90% confidence level compared to the no drug nano exposure (t- 
test, P = 0.061). Similar to the nystatin treatment, addition of 100 μmol L−1 vanadate 
to the serosal perfusate caused a mean increase in tissue Ti concentrations. Ti 
tissue concentrations after 4 h were 0.447±0.08 and 0.388 ± 0.06 µmol g-1 for bulk 
and nano TiO2, respectively. These increases were not statistically different to the no 
drug TiO2 treatments nor where than any material type differences (Table 4-6). 
TEM images of the jejunum epithelium in the no drug trials are shown in Fig. 4-9. For 
the TiO2 treatments electron dense particles of similar morphology to the TEM 
characterised stocks were observed in vesicles (Fig. 4-9). Moreover, cells were 
intact relative to the controls implying accumulation is not due to incidental leak into 
damaged epithelium (Fig. 4-5 and 4-9). 
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Table ‎4-6: Total Ti, K+, Na+, Ca2+ concentrations and % moisture of jejunum tissue following exposure to 1 mg L-1 TiO2 with 
or without drugs for 4 h. 
 
Values are means ± S.E.M. (n = 5) expressed as total Metal μmol g
−1
 dry mass of intestinal tissue, except for moisture content (%).* Statistically significant 
difference from the control value within columns. 
a
 Statistically significant difference of nystatin values relative to the no drug trials within columns, treatments 
and electrolytes. 
b 
Statistically significant difference of vanadate values relative to the no drug trials within columns, treatments and electrolytes. 
†
 Statistically 
significant difference of vanadate values relative to nystatin values within columns, treatments and electrolytes (all data was tested using either ANOVA or 
Kruskal Wallis t-test or mann whitney U where appropriated and significance determined by, P < 0.05 or notched box whisker plots). 
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Fig.  4-9: TEM of the everted perfused intestine (Jejunum) following a 4 h perfusion. A) Control; B-C) 1 mg L
-1
 bulk 
TiO2 exposures showing intact cells with vesicles containing morphologically similar particles to the characterised 
stocks.; D-E) 1 mg L
-1
 nano TiO2 exposures showing intact cells with particle containing vesicles. The composition of 
the particles was not confirmed in the electron micrographs. 
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4.4.8 Instantaneous surface adsorption 
Measurements from the rapid solution dipping protocol to determine surface-bound 
Ti on everted jejunum segments revealed low insignificant amounts of Ti metal 
instantaneously bind to the tissue surface (before true uptake can occur). The Ti 
metal concentration of the dipped everted jejunum segments was (means ± S.E.M, n 
= 6) 39.6 ± 9.0, 55.5 ± 6.9 and 73.0 ± 15.0 nmol g−1 dry weight for the control, bulk 
and nano TiO2 exposures, respectively (Fig. 4-10). The Ti concentrations in jejunum 
segments exposed to the bulk or nano TiO2 were not statistically different from the 
unexposed control (ANOVA P = 0.138). Furthermore ’dipped’ tissue concentrations 
of total Ti metal were also significantly lower than those reported in the whole gut 
sacs (small intestine and large intestine) and perfusions treated with TiO2 (t-tests, P 
values all < 0.05). The instantaneous adsorption of Ti represents 33 and 50 % of the 
total tissue Ti reported for the jejunum segment of the gut sac experiment and 20 
and 24 % of the total tissue Ti reported for the intestinal perfusions for bulk and nano 
treatments respectively. 
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Fig.  4-10: Tissue concentration of Ti (nmol g
−1
 dry weight) following a 20 s dip in 1 mg L
−1
 bulk or 
nano TiO2 in physiological saline (means ± S.E.M. n = 6). There were no statistically significant 
differences between treatments. 
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4.4.9 Tissue electrolytes and moisture content of the perfused intestine in the 
presence or absence of pharmacological agents 
The tissue electrolyte concentrations and moisture content of the perfused jejunum 
are shown in Table 4-6. There were no TiO2 treatment effects on tissue electrolyte 
levels (Na+, K+, Ca2+ and Mg2+). Although not significant, mean tissue Ca2+ 
concentration appeared to be consistently higher for both treatments relative to the 
control whilst tissue K+ was lower (none of these were significant though). Metabolic 
and ion transport inhibitors are expected to cause changes in the electrolyte status of 
tissues and in both the no-added TiO2 controls and the TiO2 NP treatments nystatin 
and vanadate treatment caused elevated Ca2+ tissue concentrations (ANOVA, P < 
0.05). In the nystatin treatments mean Na+ and K+ tissue concentrations increased 
and this was significant within controls and bulk exposures relative to the no drug 
counterparts. Vanadate exposure caused a mean increase in tissue Na+ and 
decrease in K+ concentrations for all the exposures relative to the no drug trials 
(ANOVA, P < 0.05) and a significant reduction in tissue K+ compared to the nystatin 
treatments (ANOVA, P < 0.05). Mg+ levels were largely unaffected. There were no 
significant drug or treatment effects on tissue moisture content (Table 4-6). 
 
4.4.10 Net Ti and water flux across the perfused intestine 
The cumulative appearance in the serosal compartment for representative 
experiments is shown in Fig. 4-11. All treatments maintained a steady perfusate flow 
and both the TiO2 exposures demonstrated a steady increase in the appearance of 
total Ti metal in the serosal perfusate compared to the controls. Calculated net Ti 
uptake rates and water fluxes across the intestine are shown (Table 4-7). Only the 
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nano TiO2 exposure showed a statistically significant elevation of Ti flux to the 
serosal compartment compared to the control treatment (Table 4-7). The mean initial 
and overall flux rates for the nano TiO2 exposures were 10 and 2 times higher, 
respectively, compared to the control values and 5 and 1.5 times higher than the 
bulk initial and overall flux rates. Moreover, initial and overall flux rates were different 
from each other, indicating that there may have been a saturation of the nano Ti 
uptake mechanism with respect to the overall flux rate, but not the initial flux rate. 
Bulk Ti flux was regarded as significant at the 90% confidence interval (t-test P = 
0.059) for initial flux rates compared to the control initial flux and for overall flux rates 
(t-test) P = 0.062).  
All treatments demonstrated a net outward flux of water across the intestine. Addition 
of both bulk and nano TiO2 caused a significant increase in initial and overall rates of 
water flux compared to the control (ANOVA, P < 0.05; Table 4-7). The initial net 
outward water flux was -6.017 ± 10.68, -31.316 ± 14.321 and 33.989 ± 14.731 ml g−1 
h−1  for the control, bulk and nano exposures respectively. Overall water flux rates for 
the bulk and nano treatments remained similar to the initial flux rates and there were 
no statistically significant material-type effects on water flux rates (Table 4-7). The 
control showed a statistically significant difference between initial and overall water 
flux rates (P < 0.05) with values of. -6.017 ± 10.68 to -27.618 ± 3.184 mL g−1 h−1 for 
initial and overall rates, respectively. 
 
4.4.11 Effect of inhibitors on Ti and water flux on the perfused intestine 
Addition of either nystatin or vanadate to the preparation had effects on the 
appearance of Ti in the serosal perfusate. Perfusate flow remained unaffected in the 
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presence of drugs (Fig. 4-12). The initial and overall Ti flux rates for the Bulk TiO2 
treatment in the presence of either inhibitor appeared to be unaffected relative to the 
no drug treatment. In contrast to the bulk treatment, the nano treatments exhibited 
marked reductions in initial and overall Ti flux rates relative to the no drug treatments, 
suggesting a particle size sensitive drug effect (ANOVA, P < 0.05). There was a 5 
fold decrease in initial Ti flux rates for both the nystatin and vanadate nano 
treatments relative to the no drug treatment (ANOVA, P < 0.05). Overall Ti flux rates 
were also reduced relative to the no drug treatment albeit by a lesser amount than 
the initial Ti flux reduction. For example, overall Ti flux rates decreased from 7.846 ± 
0.808 to 3.857 ± 0.284 nmol g−1 h−1 for the no drug nano compared to the vanadate 
nano treatment, respectively (ANOVA, P < 0.05) (Table 4-7). 
The effects of these two drugs on the perfused intestine preparation caused a 
statistically significant increase in outward water flux in the controls (no added TiO2). 
The nano TiO2 treatment with vanadate appeared to cause a decrease in the overall 
net outward water flux relative to the no drug treatment, -48.731 ± 5.034 to -39.015 ± 
3.705 mL g−1 h−1. In contrast, the bulk vanadate treatment caused an increase in net 
outward water flux relative to the no drug treatment (-41.731 ± 5.034 to -52.766 ± 
3.914 mL g−1 h−1 for the no drug bulk TiO2 and vanadate bulk TiO2 treatment, 
respectively) (Table 4-7). 
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Table ‎4-7: Effects of exposure to 1 mg L−1 TiO2 with or without inhibitors on the 
Ti and water fluxes across the isolated perfused jejunum segment of rat 
intestine 
 
Values are means ± S.E.M. (n = 5) expressed per gram dry mass of intestine per hour. Negative 
values indicate a net loss from the serosal solution. Initial and overall rates were calculated from 
cumulative perfusate data at 10 min and 4 h respectively.* Statistically significant difference from the 
control within drug groups and treatments; 
a
Significant difference of nystatin trial compared to no drug 
trial within treatment; 
b
Significant difference of vanadate trial compared to no drug trial within 
treatment; 
c
Significant difference between nystatin and vanadate trials within treatments. 
d 
Significant 
difference between bulk and nano within drug treatments within columns 
†
Significant difference 
between initial and overall flux rates (Kruskal-Wallis, ANOVA, and/or t-test P < 0.05). 
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Fig.  4-11: The cumulative appearance of total Ti metal in the serosal compartment (blue bars, nmol Ti metal) of 
perfused intestine preparations from rat exposed to 1 mg L
−1
 of TiO2 in the mucosal saline. Cumulative perfusate flow 
(red squares, mL) is also shown. Graphs are representative examples of individual perfusions from replicated 
experiments (all groups, n = 5 perfusions). (A) Control with no added TiO2, (B) bulk TiO2, (C) nano TiO2. Rat weights 
(g) in the examples are 200, 190 and 220, respectively. 
Time (min) 
Time (min) 
Time (min) 
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Fig.  4-12: The cumulative appearance of total Ti metal in the serosal compartment (blue bars, nmol Ti metal) of perfused intestine preparations from rat exposed to 1 mg L
−1
 
of TiO2 in the mucosal saline in the presence of either 120 IU mL
-1
 nystatin (mucosal solution) or 100 μmol L
−1
 sodium orthovanadate (serosal perfusate). Cumulative 
perfusate flow (red squares, ml) is also shown. Graphs are representative examples of individual perfusions from replicated experiments (all groups, n = 5 perfusions). (A) 
Control Nystatin treatment with no added TiO2, (B) bulk TiO2 in the presence of nystatin, (C) nano TiO2 in the presence of nystatin, (D) Control vanadate treatment with no 
TiO2, (E) bulk TiO2 in the presence of vanadate, (F) nano TiO2 in the presence of vanadate. Rat weights (g) in the examples are 180, 210 and 170, 190, 220, 190, respectively. 
Time (min) Time (min) 
Time (min) 
Time (min) Time (min) Time (min) 
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4.5 Discussion  
This study is the first to show Ti tissue accumulation and Ti flux across the rat gut 
from bulk and nano TiO2 exposures that are drug sensitive and in the opposite 
direction to water flux, implying that an active uptake mechanism is responsible. The 
presence of particles in the cells implies that at the apical membrane there is some 
particle internalisation. The key findings of this study are that Ti accumulation mainly 
occurs in the small and large intestine of the rat gut following exposure to TiO2 
particles (bulk or nano) with the majority of this Ti (ions or particles) found in the 
mucosa and not in the muscularis (Fig. 4-2, Table 4-1). There were material size 
effects on initial and overall Ti flux rates between nano and bulk TiO2 exposures. The 
former was much greater than the latter (Table 4-7) suggesting that transport rate 
appears to be affected by particle size. 
 
4.5.1 Where is TiO2 absorbed along the gut? 
To our knowledge regional differences in Ti accumulation along the whole rat gut 
have not been previously reported. In this study, treatment with either the bulk or 
nano TiO2 resulted in Ti accumulating in all the regions of the gut, from the 
oesophagus to the hind intestine, but, this was only deemed significant along the 
whole of length of the small intestine (duodenum, jejunum, ileum) and the large 
intestine (Fig. 4-2). Importantly, the majority of the Ti in both nano and bulk TiO2 
treatments was in the mucosa rather than the muscularis (usually 70% or more, 
Table 4-1), indicating that some of the accumulated Ti was associated with the 
epithelial cells (see below). 
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The tissue appeared to be healthy with expected tissue water contents (water %), 
and there did not appear to be any major departures from normality for the major 
electrolytes (Table 4-2), particularly Na+ which plays an essential role in maintaining 
osmoregulatory processes in tissues. The viability criteria for the whole gut sac were 
met suggesting that the tissue was not leaking and that Ti accumulation was not an 
artefact of osmotic solvent drag. Rather, the data suggests that the intestine (small 
and large) is the primary region of the gut involved in the uptake of Ti (particles or 
dissolved Ti) following TiO2 exposures. The idea that the small intestine is involved 
in the uptake of metal (particles or dissolved species) in vertebrates is consistent 
with much of the literature on metal uptake in the vertebrate gut (Hoyle and Handy 
2005, Handy et al. 2000, 2002, Al-Jubory and Handy 2013, Onishchenko et al. 2012). 
Approximately one third of the apparent accumulation of Ti metal in/on the gut sacs 
can be accounted for by surface adsorption, with about 55 nmol g-1 dry weight being 
instantaneously bound (Fig. 4-10), compared to 150 nmol g-1 dry weight in the gut 
sacs exposed to bulk TiO2. Handy and Eddy (2004) found that dissolved ions can be 
detected in the blood after 90 s, and thus the binding experiment has to be shorter 
than this to measure true binding. A longer exposure may have resulted in a slightly 
elevated surface bound Ti component although the instantaneous surface binding of 
metals is not linear over time with the majority of the binding occurring in the first 30 
s (Handy & Eddy 2004). Therefore, it is likely that only a small fraction of the Ti found 
in/on the gut sac (or perfused intestine) over 4 h is due to surface binding and that 
the Ti tissue measurement is reflective of Ti concentration in (accumulation) rather 
than on (adsorption) the tissue. 
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4.5.2 Viability of the perfused intestine 
The viability criteria applied for the perfusion technique in this study were the same 
as previous research (Al-Jubory and Handy 2012, Handy et al. 2000). In brief, the 
histological integrity of the gut; perfusate and mucosal LDH activity; the leak of ions 
([K+], [Na+]) into the mucosal solution and the perfusate flow.  
Histological and ultrastructural examination of the gut following the perfusions for all 
treatments showed normal morphology (Fig. 4-5, 4-6, 4-9) indicating a structurally 
sound intestinal barrier. LDH activity is regarded as a sensitive viability indicator 
(Campbell et al. 1999) and in this this study perfusate and mucosal LDH activity 
were below that found in vivo (< 2.2 U mL−1, Gershbein and Raikoff 1977) in all 
experiments (Fig. 4-4). Electrolyte leak from the tissue into the mucosal solution was 
low with only statistically insignificant micromolar changes in Na+ and K+ 
concentrations (Table 4-3). Moreover, perfusate flow rates remained steady in all 
experiments (Fig. 4-11,). Similarly, addition of 120 IU mL-1 nystatin to the mucosal 
solution or 100 µmol L-1 sodium orthovanadate had little effect on the assessed 
viability parameters (Fig. 4-7 (LDH), 4-12 (Perfusate flow) and Table 4-4, 4-5 
(mucosal solution electrolyte concentration)). 
The pH of the mucosal solution fluctuated slightly with a net increase of 0.256 ± 
0.023 (grand means of controls and treatments) suggesting either the uptake of H+ 
ions by the tissue, or the efflux of bicarbonate (HCO3
-) resulting in a more alkaline 
pH. The intestine is involved in osmoregulation and acid base balance. A net 
secretion of water and bicarbonate is expected without dramatic changes in tissue 
Na+ and K+, which was demonstrated suggesting that the physiological performance 
of the gut remained intact.  
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When viewed together the above criteria indicate thatthe perfused intestines 
remained in a viable condition throughout the experiments. Furthermore, this 
technique can be effectively used to measure Ti uptake (accumulation and uptake) 
from bulk or nano TiO2 exposures in the delicate rat intestine at 37
°C. 
In order to clarify what is meant by ‘expected’ gut secretions it would have been 
useful to perform a positive control perfusion by administering a detergent to the 
mucosal solution. This information would have provided a bench mark for a non-
viable gut prepartion. For example, the lack of histological integrity, reversing of 
water flux and the concomitant decrease of Na+ and K+ from the mucosal solution 
would have provided useful information about a failed preparation. The use of 
detergents to assess LDH leak however would likely give a gross underestimate of 
the bath LDH leak and subsequent tissue damage because of the expected reversal 
of water flux (from the bath into the tissue). Nevertheless a positive control would aid 
in data interpretation and have provided histological evidence of a damaged gut.  
 
4.5.3 TiO2 exposure and distribution of the particles in the mucosal solution 
TiO2 exposures were confirmed during gut perfusions by measuring the mass 
concentration of TiO2 in the mucosal solution (Fig. 4-8) and by the detection of 
elevated total Ti metal concentrations in/on exposed tissues (Table 4-6). The 
concentrations measured by ICP-OES showed a decrease of Ti over time (Fig. 4-8). 
At the end of the 4 h perfusions the grand % loss of suspended TiO2 were 62% and 
20% for the bulk and nano treatment, respectively (Fig. 4-8), indicating a loss of Ti 
from the mucosal solution. This occurrence is well known for dissolved metals and is 
associated with the normal protective role of mucus secreted by the preparation 
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which will chelate and then precipitate metal ions (e.g., for Cu perfusions, 77% of the 
added Cu is lost at exposures of 100 μmol L-1, Handy et al. 2000) or in the case of 
particles bind and promote settling. Moreover, the gravimetric settling of particles 
and the effect of a high ionic strength mucosal solution will enhance aggregation and 
subsequently, particle settling over time. The particle size distribution measures 
support the idea that at the end of the perfusion smaller particles remain suspended 
in the perfusate (Fig. 4-1) which may be why NPs maintain a more stable dispersion. 
Similar losses of Ti from mucosal solutions have been reported by Al-Jubory and 
Handy (2012) for TiO2 particles in mucosal salines. 
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4.5.4 Ti accumulation and efflux in the perfused intestine 
Total tissue Ti concentration increased in all intestines exposed to either bulk or 
nano TiO2 in comparison to the control. There were no material type differences on 
tissue Ti concentration (Table 4-6). Nevertheless, because Ti accumulates in the 
tissue this suggests that the efflux of Ti from mucosa to serosa is slower than apical 
uptake of Ti. Interestingly, the mean values reported herein for tissue Ti 
accumulation are three times higher for the bulk treatment in perfused rat intestine 
(0.265 µmol g-1 dry weight) than in trout intestine (0.094 µmol g-1 dry weight (Al-
Jubory and Handy 2012) and 15 times higher for the nano treatment (0.293 µmol g-1 
dry weight herein compared to 0.019 µmol g-1 dry weight (Al-Jubory and Handy 
2012). Overall Ti flux rates are also considerably higher (for bulk Ti flux in rat 
intestine 5.082 ± 1.257 whilst in trout intestine 0.85 ± 0.32 nmol g-1 h-1 (Al-Jubory and 
Handy 2012); for nano exposed rat intestine 7.846 ± 0.868 for trout intestine 2.38 ± 
0.68 nmol g-1 h-1 (Al-Jubory and Handy 2012). Possible explanations for this 
observation include anatomical differences and differences in the perfusion 
temperature, and the metabolic rate of trout in comparison to rats. Metabolic rates in 
endotherms are typically higher than ectotherms and the temperatures at which the 
perfusions were performed would exacerbate these differences (15°C- trout, 37°C 
rat). It would be interesting to see whether reducing rat intestinal perfusion 
temperature to 15°C would reduce uptake (Ti flux) and tissue accumulation of Ti to 
the levels demonstrated in trout perfusions. 
The form of detected tissue Ti is unknown, although TEM images of enterocytes 
following perfusions showed particles of similar morphology to those characterised in 
the stock solutions beneath the apical membrane in vesicles (Fig. 4-1 and Fig. 4-9). 
Analogous observations have been made in rat and mouse gut associated lymphoid 
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tissue (rat - 12.5 mg kg-1 for 10 days - Jani et al. (1994); mouse – 12.5 mg kg-1 - Brun 
et al (2014)) and trout intestinal enterocytes (Al-Jubory and Handy 2012) suggesting 
(at least at the apical membrane) that the Ti is still in particulate form.  
Perfused intestine exposed to both bulk and nano TiO2 (no pharmacological 
inhibitors) demonstrated a cumulative increase of total Ti in the serosal perfusate 
(Fig. 4-11), suggesting transepithelial uptake of Ti or TiO2 from TiO2 exposures. The 
possibility of some dissolved Ti into the serosal compartments cannot be excluded 
(Al-Jubory and Handy 2012). In a cellular environment at physiological pH (7.4) the 
majority of free Ti would likely complex with chloride ions then water prior to binding 
oxygen and precipitating back into TiO2. Stable ionic Ti
(+) species would only be 
found in miniscule concentrations and in physiological conditions these species 
would be found at the centre of anionic complexes  such as Ti(OH)4 (Schmidt and 
Vogelsberger 2009). Interestingly Al-Jubory and Handy (2012) showed that the 
dissolution rate of particles in a high KCl solution (typical of intracellular 
environments) is between 18-26 nmol Ti metal h−1, which represents around 0.01% 
loss of metal from the particles every hour (Al-Jubory and Handy 2012. Therefore, it 
remains possible that a small percentage of detected serosal Ti is ionic. 
The nano TiO2 exposures resulted in higher amounts of Ti in the serosal perfusate 
than the bulk material, and initial and overall flux rates of Ti for nano TiO2 exposures 
were much greater than both the control and bulk treatment Ti flux rates (Table 4-7). 
A possible explanation for this observation may simply be that the particle size 
influences uptake and efflux rate and that smaller particles are taken up and 
transported faster than larger particles. This has been demonstrated in a number of 
different models, for example, SiO2 transport in HepG2 cells (Hu et al. 2011); and in 
the Desai et al. (1996) rat in situ intestinal loop preparation which demonstrated a 15 
204 
 
– 250 fold increase in uptake for 100 nm polylactic polyglycol particles compared to 
500 nm and 1 µm. Moreover, initial Ti flux rates in the nano treatment were 
considerably larger than the overall flux rates (Table 4-7). A possible explanation 
may be due to saturation of the processes mediating particle translocation (possibly 
ATP availability or vesicle scission proteins) which is indicative of active transport 
systems. 
 
4.5.5 Mechanism(s) of TiO2 transepithelial uptake 
The appearance of Ti in the eluted perfusate in conjunction with the outward net 
water flux (from tissue to mucosal bath (Table 4-7)) and negligible changes in 
mucosal and tissue electrolytes (K+, Na+) imply that a carrier mediated mechanism(s) 
is responsible for Ti translocation rather than a passive mechanism such as solvent 
drag associated with osmotically stressed tissue.  
This is also supported by the effect that addition of inhibitors such as vanadate or 
nystatin had on the perfused intestine. Both drugs caused mean increases in Ti 
tissue concentrations (Table 4-6). There was a significant decrease in the serosal 
efflux of Ti from nano TiO2 exposures relative to the no drug trials (Table 4-7) whilst 
Ti flux rates from bulk particle exposures were unaffected by both drugs even though 
mean Ti tissue concentration was elevated relative to the no drug bulk TiO2 
exposure. This tentatively suggests that there may be different uptake pathways for 
different sized particles.  
Vanadate increases the rate of apical caveolae budding into the cell (Parton et al. 
1994) through tyrosine phosphatase inhibition which results in the unregulated 
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activation of a tyrosine kinase signalling pathway leading to increased rates of 
caveolae budding (Parton and Richards 2003; Nucifora and Fox 1999) and 
subsequent apical uptake. The reduction of Ti efflux into the serosal compartment in 
the presence of vanadate in the nano treatment suggests some differential drug 
sensitivity which may be due to increased dissolution potential of nano TiO2 in 
intracellular fluid (Al-Jubory and Handy 2012) due to an increased material surface 
area. Inhibition of ATPases is known to be involved in loading metal ions into 
vesicles destined for exocytosis at the basolateral membrane (For example, Cu ions 
are loaded into the trans Golgi network through the action of Cu-ATPase (Dameron 
and Harrison 1998)) would reduce efflux of Ti. Ti could potentially cross the cell 
using similar ATP-ase trafficking systems to Cu, which are known to be hijacked by 
other non-essential toxic metals like mercury (Hoyle and Handy 2005). Inhibition of 
metal-transporting ATPases on the basolateral membrane may result in the 
observed net increase in tissue Ti concentrations (Table 4-6). Further work 
elucidating the exact mechanism by which vanadate interferes with uptake and 
transport is required.  
Similarly, Ti efflux was reduced in nano exposures in the presence of nystatin 
suggesting differential drug sensitivity influenced by particle size. Nystatin has been 
shown to sequester cholesterol, which is thought to be involved in the production of 
exocytic vesicles in cells (Chintagari et al. 2006; Salaun et al. 2004). Reduction of 
exocytosis apically or basolaterally would result in a net increase of tissue Ti. Al-
Jubory and Handy (2012) showed that nystatin prevented transepithelial uptake of Ti 
from exposures of TiO2 particles and this occurred with a concomitant increase of 
total Ti in the intestinal tissue. Curiously flux rates from bulk Ti seemed unaffected 
even though there was a significant increase in tissue Ti (bulk nystatin exposure 
206 
 
tissue Ti concentration of 0.673 ± 0.133 compared to 0.265 ± 0.044 µmol g-1 for the 
bulk no drug exposure - Table 4-6). More research is required to assess particle size 
effects on uptake. Regardless, the observed nystatin/vanadate - sensitive Ti 
accumulation (Table 4-6) is indicative of active mechanism(s) for handling either Ti 
metal or TiO2 particles by intestinal tissue. 
 
4.5.6 The effect of TiO2 on water flux and tissue electrolytes in the perfused 
intestine  
Exposure to either bulk or nano TiO2 caused an increase in initial and overall net 
outward water flux (Table 4-7) in comparison to the control without dehydrating the 
tissue or significantly altering tissue Na+. A possible explanation for this includes an 
increase in the oncotic (colloidal osmotic pressure) pressure of the mucosal saline 
through the addition of TiO2 particles. Significant increases in colloidal osmotic 
pressures have been demonstrated in solutions containing 1 g L-1 silicon dioxide NP 
dispersions in comparison to pure water (Quant et al. 2008). Moreover, colloidal 
pressure increased by 30% when temperature of the dispersion was increased from 
26 to 36°C (Quant et al. 2008). 
Tissue electrolyte concentrations were not significantly affected following TiO2 
exposures in the absence of drugs relative to controls, but, there were some trends 
which should be mentioned. The increase in net water efflux was accompanied by 
reduced mean tissue K+ levels relative to the control (probably due to solvent drag 
associated with water efflux), and increased mean tissue calcium levels. Although 
not significant this pattern of electrolyte changes following exposures to TiO2 has 
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been demonstrated in previous studies (Chapter 2, Section 2.4.4, Chapter 3, Section 
3.4.4). 
The mechanisms responsible for these changes are uncertain although passive 
solvent drag of K+ out of the tissue and reduced Na+/K+ ATPase activities may 
provide a tentative explanation for these changes. Reduction of intestinal Na+/K+ 
ATPase activity has been demonstrated in fish exposed to 1 mg L−1 TiO2 (Federici et 
al. 2007). Ramsden et al. 2009 also demonstrated a 50% reduction in brain Na+/K+ 
ATPase activity in trout brain following 8 week dietary exposures in trout to 100 mg 
kg-1 TiO2 NP diets. 
Elevation of intracellular calcium in epithelial cells or whole tissues exposed to TiO2 
particles has also been demonstrated (Gitrowski et al. 2014- Caco-2 cells-Chapter 2 
and Chapter 3, Al-Jubory and Handy 2012- Trout intestine, Simon et al. 2011 Lung 
epithelium cells). The mechanisms underpinning these changes in calcium 
homeostasis are also unclear, although, inhibition of, Ca2+ ATPase, Ca2+/Mg2+ 
ATPase in mouse brain following oral TiO2 exposures has been demonstrated (Hu et 
al. 2010). TiO2 interference with electrolyte homeostatic mechanisms would be 
worthy of further investigation. 
 
4.5.7 Effects of inhibitors on tissue electrolytes 
Metabolic ion transporters are expected to cause changes in the electrolyte 
cocnetrations in cells and tissues. 100 µmol L-1 serosal administration of vanadate 
caused an increase in tissue Na+ and a decrease in K+ concentrations in comparison 
to the no drug treatments. This is to be expected, considering vanadate inhibits 
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Na+/K+ ATPase activity resulting in tissue Na+ increases due to passive influx and 
concomitant decreases in tissue K+ via passive efflux (with the concentration 
gradient). Tissue calcium levels increased in the presence of vanadate compared to 
no drug controls. This is most readily explained through vanadate’s inhibitory effect 
on Ca2+ ATPase (Barrabin et al. 1980) and the subsequent reduction in efficacy of 
the sodium calcium exchanger (Blaustein and Lederer 1999) which hinders the efflux 
of calcium that has entered the cells down the extreme diffusion gradient (10−3 M 
outside, 10−6 M inside) resulting in the increase observed herein. Similar changes in 
electrolytes have been demonstrated in trout intestine in the presence of vanadate 
(Al-Jubory and Handy 2012). Likewise 120 IU ml-1 mucosal administrations of 
nystatin caused increases in Na+ and Ca2+. Nystatin is well known for increasing cell 
membrane permeability to monovalent cations (e.g. Na+) (Eilam and Grossowicz 
1982), which in turn will reduce the efficacy of the sodium calcium exchanger 
(reduces the concentration gradient of Na+) resulting in an increase in cellular 
calcium (Blaustein and Lederer 1999). 
 
4.5.8 Concluding remarks 
This study shows that the primary areas of Ti absorbtion from TiO2 exposures (bulk 
and nano) are the small and large intestine. Moreover, the isolated perfused intestine 
preparation works with NPs in rat jejunum and the expected viability criteria are met 
with these materials. Additionally, this work demonstrates that Ti or TiO2 from TiO2 
exposures can cross the mammalian intestine. There is a material-type effect with 
much higher Ti flux in to the serosal compartment from the nano form. Ti or TiO2 
absorption and transport from both bulk and nano TiO2 exposures are time-
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dependent, saturable and in the opposite direction to water flux, with tissue 
accumulation being affected by pharmacological inhibitors. Taken together this 
suggests an active absorption mechanism is responsible rather than passive 
diffusion. From a regulatory perspective, a dietary exposure hazard to human health 
should be considered in risk assessments. The overall net uptake rates reported 
here for Ti are between 5-7 nmol g-1 h-1 depending on particle size roughly double 
those reported for copper (Handy et al. 2000), but about 10 fold less than Hg uptake 
rates (40-50 nmol g-1 h-1 for 0.2-2 mg L-1 of Hg metal, Hoyle and Handy 2005) in the 
perfused intestine. The fact that Ti or TiO2 from the nano form is transported faster 
than bulk TiO2 also implies that risk assessments based on the bulk material will 
underestimate the nano systemic distribution hazard. The assumption that the 
traditional bulk forms of TiO2 powders are not absorbed via the small intestine should 
also be reconsidered. The risk of dietary exposure to NPs is likely to increase 
through a number of avenues (toothpaste, food) with the major exposure route 
associated with drinking water processed through wastewater treatment plants 
(Westerhoff et al. 2011). Long term chronic exposure scenarios to nano TiO2 need to 
be performed in order to clarify whether an increased uptake risk is associated with 
an increased risk of developing pathological conditions. 
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Chapter 5:  Age and feed status 
effects on tissue Ti concentration 
in female Wistar rats (Rattus 
norvegicus): A pilot study 
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5.1 Abstract 
Titanium dioxide nanoparticles (TiO2 NPs) have potential applications as food 
additives, but concerns persist about their safety, absorption and subsequent 
systemic distribution following oral exposures. Children are identified as having the 
highest exposure and may face the greatest health risks. The toxicological sensitivity 
of TiO2 in different aged mammals following oral exposure is not clear.  
The aim of this pilot study was to determine whether animal age influences Ti tissue 
concentration in secondary target organs (kidney, liver, spleen) following ad libitum 
food consumption of a standard maintenance diet known to contain Ti; and to assess 
whether Ti tissue concentrations in rats changes in the absence of food. Young (23 
day old) female rats demonstrated significant decreases in brain, spleen, lung tissue 
and whole blood Ti concentrations following the removal of feed (Mean Ti 
concentration of feed was 3.28 mg g-1 dry weight) for 48 h. For example, whole blood 
Ti concentrations decreased from 19.1 to 6.2 nmol mL-1 in fed and food deprived 
animals, respectively (Student’s t-test, P < 0.05). Older (3 - 6 months) rats 
demonstrated no differences in tissue Ti concentration associated with feed status. 
Critically, there was an age effect with older rats demonstrating lower tissue Ti 
concentrations in liver, kidney and spleen following long term chronic dietary 
exposures to relatively large concentrations of Ti in comparison to young rats. 
Overall the data demonstrate that young rats show rapid decreases in whole blood 
and tissue Ti concentrations when standard laboratory feed is removed. The 
implications of this study suggest in vivo chronic oral exposure studies with TiO2 
need to assess the Ti concentration of control feed. 
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5.2 Introduction 
The European Union allows TiO2 to be applied in food products at quantum satis 
levels under good manufacturing procedures (European Union 2003). Worldwide 
human consumption of food grade TiO2 in 2012 was estimated to be almost 6 metric 
tonnes (USGS 2013). Moreover, TiO2 is permitted for use in animal food stuffs at 
quantum satis levels, and because it is not a nutritionally required mineral, the 
concentration and form does not need to be explicitly mentioned in animal diet 
formulations (European Union 2003).  
The FAO/WHO Expert committee of food additives tasked with evaluating the toxicity 
of TiO2 historically concluded that there was no need to establish daily intake levels 
due to its insolubility, lack of absorption and lack of accumulation (JECFA 1969). 
Since this original toxicological assessment, numerous in vivo and in vitro studies 
have demonstrated Ti/TiO2 uptake and translocation from TiO2 exposures across 
vertebrate GIT epithelium following oral exposures (Jani et al. 1994; Wang et al. 
2007; Cui et al. 2010; Al-Jubory and Handy 2012; Tassinari et al. 2014). Interestingly, 
Ti/TiO2 from both nano and bulk TiO2 particle exposures has been detected in 
systemic body sites or the serosa following exposures to vertebrate intestinal 
epithelium (Jani et al. 1994; Al-Jubory and Handy 2012, Chapter 4).  
For example Al-Jubory and Handy (2012) confirmed the appearance of Ti from 1 mg 
L-1 nano and bulk TiO2 (aggregate diameter of bulk 1124 ± 331 nm ) in the serosal 
fluid following mucosal administration of TiO2 particles (bulk and nano) to perfused 
trout intestine and this occurred in a saturable time dependent fashion. 
Pharmacological evidence implied this was an active process (Al-Jubory and Handy 
2012), and TEM evidence indicated a proportion of the Ti within enterocytes was in 
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particulate form (TiO2). Jani et al. (1994) demonstrated in vivo gastrointestinal 
absorption and translocation of Ti from (liver, kidney, spleen) TiO2 particle (500 nm 
diameter) exposures following daily oral gavage of 12.5 mg kg-1 TiO2 particles for 10 
days. SEM evidence implied at least some of the Ti was still in particulate form (TiO2). 
More recently, Tassinara et al. (2014) orally exposed rats to TiO2 NPs (< 25 nm 
diameter) for 5 days at a concentration of 2 mg kg-1 b.w day-1, and reported a 
significant mean tissue Ti increase of 0.01 µg g-1 wet weight in the spleen. In 
contrast, Cho et al. (2013) demonstrated no changes in organ or whole blood Ti 
concentrations relative to controls animals following daily TiO2 NP exposures of 
1073.5 mg kg-1 b.w day-1 for 13 weeks. This lack of agreement in the literature may 
be due to a number of factors. For example, the crystal structure of theTiO2 particles 
used was different. Tassinara et al. (2014) used a pure anatase (< 25 nm diameter), 
while Cho et al (2013) used an 80/20 % anatase/rutile mix (26 nm diameter). 
Moreover, the age of the rats used in both studies was different. In the Tassinara et 
al. (2014) study the rats were 8 weeks old, whilst in the Cho et al (2013) study the 
rats were 19 weeks old at the time of sampling. 
The effect of age on metal uptake metabolism and toxicity for non-nutritionally 
required metals is poorly understood. A recent study by Wang et al. (2013) 
assessing the comparative toxicity of TiO2 NPs in 3-week (youth) and 8-week (adult) 
old Sprague-Dawley rats following oral exposure of 10, 50, 200 mg kg-1 bw day-1 
TiO2 NPs for 30 days demonstrated increased intestinal permeability to TiO2 NPs in 
younger rats. Moreover severe liver oedema, heart injuries and non-allergic mast cell 
activation in stomach tissue were reported in 3 week old rats. In contrast 8 week old 
rats exhibited only slight toxic effects (Wang et al. 2013). There is limited information 
on the toxicological sensitivity and accumulation potential of TiO2 in different aged 
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animals which is of concern considering children are thought to preferentially 
consume food products that contain more TiO2 than their adult counterparts (Weir et 
al. 2012). Historically, increased metal accumulation and tissue distribution in 
younger animals relative to older animals has been well demonstrated for some 
metals e.g. lead, iron (Forbes and Reina 1972), cerium (Inaba and Lengemann 1972) 
and copper (Terao and Owen 1977), whilst the opposite has been shown to occur for 
other metals (e.g. mercury- Weiner and Nylander 1993; Cadmium -Wong et al. 1980). 
These age differences in metal uptake are attributed to differences in ADME. For 
instance copper and iron are readily taken up across the placenta leading to an 
increase in metal tissue concentrations in prenatal animals and post natal animals. 
As the animal develops, metal handling mechanisms are able to excrete some 
nutritionally and non nutritionally required metals. In contrast mercury and cadmium 
tissue concentration increases with age because these metals are poorly excreted 
and accumulate over the life time of the animal. Given this, it is unclear where TiO2 
sits in terms of accumulation profiles compared to other non-nutritionally consumed 
metals. 
Chapter 4 Section 4.3.1 demonstrated that standard laboratory rodent feed had a 
mean Ti concentration of 3.28 mg g-1 of feed. Assuming rats consume 5 g of food 
per 100 g of body weight (Bogdanske et al. 2011) rats are exposed to 164 mg kg-1 
bw day-1 Ti through their normal diet. This is considerably higher than concentrations 
used in recent studies aimed at assessing the Ti tissue distribution following TiO2 
oral exposures (e.g. 6.8-8.6 mg kg-1 bw day-1 for 5 days (Geraets et al. 2014); 1-2 
mg kg-1 bw day-1 for 5 days (Tassinari et al. 2014); single oral dose 12.5 mg kg-1 
(Brun et al. 2014)). A number of recent studies assessing absorption and distribution 
of Ti from TiO2 exposures have failed to evaluate, or specify the Ti concentration of 
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the food that animals are fed during experimental procedures (Wang et al. 2007; Cho 
et al. 2013; Geraets et al. 2014; Tassinari et al. 2014). Moreover, the primary method 
for detecting tissue Ti in these studies is though total metal concentration determined 
by ICP-OES or ICP-MS; which makes it difficult to differentiate newly acquired Ti 
from the experimental exposure compared to that derived from the food of the 
animals. This problem of detecting newly acquired metal against an existing tissue 
background is well known for nutrients such as iron and copper (Que et al. 2008; 
Niwa et al. 2014), but has not been previously considered for TiO2. 
The primary objectives of this pilot study were to assess whether Ti could be 
detected in a variety of primary target organs in rats and then determine whether 
animal age influences Ti tissue concentration in these target organs (kidney, liver, 
spleen) following ad libitum food consumption of a standard maintenance diet known 
to contain Ti; and to assess whether Ti tissue concentrations in rats change in the 
absence of food. Further aims included assessing the physiological effects of acute 
food deprivation on tissue electrolytes and proximal carcass composition in young 
rats.  
 
5.3 Materials and methods 
 
5.3.1 Stock animals and diet 
Female Wistar rats of different ages (21, 110 and 172 days, respectively) bred in the 
University of Plymouth animal facilities were used for this study. The standard living 
conditions and feed were the same as those described in Chapter 4 Section 4.3.1. 
Rats were fed a standard formulation (2018 Teklad Global 18% protein rodent diet, 
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Harlan Laboratories) comprised of 18, 5 and 5 % of protein, fat and fibre  
respectively. ICP-OES analysis of total metal concentrations in the feed revealed a 
measured Ti concentration of 3.28 ± 0.61 mg g−1 dry feed (mean ± S.E.M., n = 5). 
Characterisation of the form of Ti in the feed was not possible. SEM with 
concomitant X-ray analysis (SEM, JEOL/JSM-7001F Oxford instruments INCA X-ray 
analysis system) of feed samples revealed no discrete particles of Ti amongst the 
food matrix. 
 
5.3.2 Treatments 
The first pilot experiment determined the effect of age on trace element and 
electrolyte concentrations in a selection of target organs in rats. The concentration of 
Ti, K+, Na+, Ca2+ and Mg2+ in the spleen liver and kidneys of rats of different ages (23, 
110 and 172 days old, respectively) were compared with unfed (48 h without food) 
rats of the same age. The weight (g) of each group of rats (in age order) at the 
beginning of the experiment was 75 ± 1.3, 186 ± 2.5 and 202 ± 2.3 g (Means ± 
S.E.M, n = 12), respectively.  
The second pilot experiment investigated the effect of 48 h without food on carcass, 
tissue and whole blood electrolytes in 23 day old rats. Moreover, proximate carcass 
composition analysis was also performed with a view to assessing changes in 
protein, lipid and energy composition in 23 day old unfed rats in comparison to rats 
fed the standard diet ad libitum. The weight (g) of the rats at the beginning of the 
experiment was 79 ± 2.1 (means ± S.E.M, n = 10).  
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5.3.3 Tissue sampling 
Rats were humanely sacrificed by cervical dislocation (in compliance with ethical 
approval in the UK) following asphyxiation with CO2. Tissues/organs were carefully 
removed for electrolyte analysis in the following order; brain, liver, kidney, spleen, 
intestine and skinned muscle from the bicep femoris and then processed for ion 
analysis. Contents of the gastrointestinal tract were removed by rinsing the lumen 
with physiological saline (as described in Chapter 4, Section 4.3.2). The skinned 
eviscerated carcasses, and excised tissues, were separately weighed (wet weight) 
and then all the separate tissues were dried to a constant weight at 100°C for up 48 
h (Gallenkamp Oven BS Model OV-160). The moisture content of tissues was 
determined by taking the weight of the tissue before and after oven drying and 
calculated as: ((wet weight - dry weight) / wet weight) x 100. 
Dried tissues were subsequently transferred into separate 20 ml scintillation vials 
(VWR International Ltd, Poole, UK) and digested in 1 or 4 ml (depending on tissue 
weight- See Chapter 4, Section 4.3.6) of concentrated nitric acid for 3 h at 70°C in a 
water bath before following the same exact digestion protocol mentioned previously 
(Chapter 4, Section 4.3.6).  
 
5.3.4 Proximate analysis of eviscerated carcasses and diet 
Carcasses and diet were subjected to analysis for determination of moisture, protein, 
lipid, ash and gross energy. Samples were ground into a fine powder and analysed 
on a dry matter basis. Analysis was conducted in duplicate for each sample 
according to AOAC (2007) guidelines and is described in the following sections.  
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5.3.5 Crude protein  
Determination of total crude protein in the diets and feed ingredients was performed 
in duplicate for each animal by the Kjeldhal method, which determines total nitrogen 
content of samples which is assumed to come from protein (McDonald 2009). Total 
nitrogen is multiplied by a factor of 6.25 (a definition assuming that animal protein 
contains 16% nitrogen) to calculate the crude protein content. Briefly, ~100 mg of 
dried sample was weighed directly into a micro Kjeldahl tube along with one catalyst 
tablet (3 g K2SO4, 105 mg CuSO4 and 105 mg TiO2; BDH Ltd. Poole, UK) and 10 ml 
low nitrogen 98% sulphuric acid (H2SO4) (Sp. Gr. 1.84, BDH Ltd. Poole, UK). 
Digestion of samples was performed with a Gerhardt Kjeldatherm digestion block 
(Gerhardt Laboratory Instruments, Bonn, Germany) using the following protocol; 100 
ºC for 30 min, 225 ºC for 45 min (1 h if samples had high lipid content) and 380 ºC 
for 1 h. Once digestion was complete and following a cooling period, the samples 
were distilled using a Vodapest 40 automatic distillation unit (Gerhardt Laboratory 
Instruments, Bonn, Germany), the distillate was neutralised with 0.1 M H2SO4 and 
from the titration value the crude protein value was determined using the following 
formula: (McDonald 2009). 
 % Nitrogen = (ml sample Titrant – ml Blank Titrant) x (Acid Normality) x (MW of 
Nitrogen) / Sample wt.  
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5.3.6 Lipid  
Lipid content was determined in duplicate for each sample using the Soxhlet 
extraction method (Sukhija and Palmquist 1988). Briefly, ground carcasses and diets 
were weighed (~3 g) and placed into a cellulose thimble lightly plugged with cotton 
wool and inserted into the condensers and raised into the ‘rinsing’ position of a 
SoxTec™ extraction system (Tecator Systems, Hӧgnӓs, Sweden; model 1043 and 
service unit 1046). Pre-weighed glass cups containing 40 ml of petroleum ether (to 
dissolve the fat) were clamped into the condensers and extraction levers were 
moved to ‘boiling’ position for 30 min. Following this, the extraction levers were set to 
‘rinsing’ position for 45 min (to evaporate the ether). The glass cups containing the 
extracted lipid were then left to cool for 30 min and weighed. Total lipid was 
determined by the following formula:  
Total lipid (%) = ((final weight of beaker – initial weight of beaker) / initial sample wt.)) 
x 100 
 
5.3.7 Ash  
Ash (total mineral or inorganic content) content was determined in duplicate for each 
sample by adding a known sample weight (~500 mg) to a pre-weighed ceramic 
crucible. The crucibles and samples were then incinerated in a muffle furnace 
(Carbolite, Sheffield, UK) at 550°C for 12 h. After cooling in a dehumidification 
chamber, percentage ash was determined from the sample residue by:  
 Ash (%) = ((Sample residue (g) – crucible wt. (g)) / (initial sample wt. (g))) x 100  
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5.3.8 Gross energy  
Gross energy was determined in duplicate for each sample in MJ kg-1 with a Parr 
Adiabatic Bomb Calorimeter model 1356 (Parr Instrument Company, IL, USA). 
Briefly, ground carcasses were compressed into a 1 ± 0.5 g pellet and weighed. The 
pellet was then placed into a nickel crucible with a 10 cm length fuse wire, which was 
formed into a ‘U’ shape to touch the pellet. The crucible was then carefully placed 
into the chamber and filled with oxygen to complete the loading process. The bomb 
was then placed in a vessel containing 2 kg of water to determine the released heat 
energy. Prior to initiating the reaction the sample weight was keyed into the 
calorimeter for determination of MJ gross energy per kg as calculated by the 
instrument algorithm.  
 
5.3.9 Trace metal analysis 
The same protocol described in Chapter 4, Section 4.3.6 was followed. The 
instrument limit of detection (L.O.D) (calculated using - 3 x standard deviation of the 
blank + the mean of the blank (n = 6)) (Thomsen et al. 2003) using matrix matched 
standards were calculated as 3.3 μg L−1 which is equivalent to 70 nmol L−1 of Ti 
metal, and for the entire digestion protocol (procedural blank) 4.05 μg L−1(equivalent 
to 0.084 µmol L−1 of Ti metal, and for a typical 0.5 g tissue sample equates to 0.003 
μmol Ti metal g−1 dry weight of tissue. L.O.D for matrix matched blanks and 
procedural blanks for Na+, K+, Mg2+, Ca2+, Fe, Cu and Zn are listed in Table 5-1. All 
analysed sample data was above the detection limits calculated from procedural 
blanks.  
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Given that the form of Ti in the food was unknown, spike recoveries were performed 
on rat liver with Ti metal, Bulk TiO2 and P25 TiO2 NPs. Liver tissue was selected as 
the spiking medium because research by Shaw et al. (2013) has demonstrated that 
tissues with a high lipid concentration give reduced Ti recovery rates following 
spiking of TiO2 NPs relative to other organs. The digestion protocol (Chapter 4, 
Section 4.3.6) gave good recoveries for rat liver spiked with 200 µL of 6 mg L-1 Ti 
metal (which for a 16.2 ml sample is equivalent to a spiked Ti concentration of 74 µg 
L-1 Ti metal) and average recoveries for liver spiked with 200 µL of 10 mg L-1 Bulk or 
nano P25 TiO2. Percentage recoveries were (Mean ± S.E.M, n = 6): 67.4 ± 6.9, 65.8 
± 1.8 and 92.5 ± 6.8% for bulk, nano P25 and Ti metal, respectively, for spiking at 
the end of the digestion protocol (analytical spikes) (Fig. 5-1). Tissue Ti is reported 
as nmol Ti metal g-1 dry weight and tissue and blood electrolytes are reported as 
µmol Ti metal g-1 dry weight or µmol mL-1, respectively. 
 
 
Fig.  5-1: Analytical recovery of Ti in liver tissue digests spiked with 200 µL of 10 mg L
-1
 TiO2 or 6 mg 
L
-1
 Ti metal. Data are mean ± S.E.M % recovery of Ti metal or TiO2 particles spike, n = 6; Different 
letters indicate statistically different recoveries for the spiked material (ANOVA P > 0.05) 
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5.3.10 Statistics 
Routine statistics were the same as those described previously (Chapter 4, Section 4.3.10). 
 
Table ‎5-1: ICP –OES matrix matched and procedural blanks limit of detection 
 
Matrix matched  Procedural matrix matched  
L.O.D. for a 0.5 g 
tissue sample  
Element 
µg L-1 µmol L-1 µg L-1 µmol L-1 
Metal µmol g-1 dry 
weight 
Na 69.89 3.042 77.87 3.386 0.108 
K 514.14 13.18 601.33 15.419 0.493 
Mg 5.19 0.225 5.1 0.213 0.007 
Ca 6.54 0.164 8.17 0.204 0.007 
Fe 4.46 0.173 5.11 0.197 0.006 
Cu 5.39 0.085 6.24 0.098 0.003 
Zn 4.17 0.064 5.33 0.081 0.003 
Ti 3.3 0.069 4.05 0.084 0.003 
Values are means n = 6. L.O.D is calculated using the following formula: 3 x Std deviation of the blank + the average of the blank. Estimated detection limits 
for a 0.5 g sample are calculated from procedural matrix matched detection limits in µmol L
-1
. Briefly (0.016 (L) * L.O.D Metal (µmol L
-1
)) / 0.5 g (Dry tissue) = 
µmol Metal g
-1
 dry weight. Procedural blanks have been subjected to the full digestion protocol (Chapter 4, Section 4.3.6). 
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5.4 Results 
5.4.1 Pilot study 1: The effect of feed status and age on tissue Ti and 
electrolyte concentrations 
Removing feed for 48 h had the expected effects on weight loss, with younger 
animals losing relatively more weight as a % of body mass than older animals. The 
mean weight loss as a % of initial body weight post removal of food was 9.7 ± 1.3, 
4.4 ± 1.1 and 2.9 ± 0.6% for 23, 110 and 172 day old rats, respectively. Rats fed until 
sampling had a mean % weight increase of 4.5 ± 0.7, 2.0 ± 0.6 and 0.3 ± 0.3% for 23, 
110 and 172 day old rats, respectively (Fig. 5-2). 
The mean Ti concentrations of rat spleen, liver and kidney for different aged animals 
that had been fed for 48 h or fed ad libitum until sampling is shown in Fig. 5-3; Panel 
A, B, C. Young fed rats demonstrated higher mean Ti tissue concentrations than 
unfed rats. These differences reduced with increasing age.  
The mean concentration of Ti in the spleen of fed 23 day old rats was significantly 
greater than unfed animals (t-test, P < 0.05). The values were (Mean ± S.E.M) 98.2 ± 
17.6 and 40.9 ± 7.8 nmol g-1 dry weight for fed and unfed animals respectively. Mean 
liver and kidney tissue Ti concentrations in fed 23 day old rats were also elevated 
compared to unfed rats, although this was not significant.  
Fed young rats had significantly higher spleen and liver Ti concentration than fed 
older rats (ANOVA, P < 0.05). For example, Ti spleen concentrations were 54 nmol 
g-1 dry weight higher in young animals compared to 110 day old rats. In contrast to 
fed rats, unfed young rats had similar spleen, liver, kidney Ti tissue concentrations 
compared to unfed older rats. Older rats (110 and 172 days) demonstrated no 
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significant changes in spleen, liver or kidney Ti concentration associated with feed 
status. 
The tissue moisture content of the spleen and kidney were also significantly higher in 
23 day old rats in comparison to older rats irrespective of feed status (ANOVA, P < 
0.05) (Table 5-2). Older rats (Day 110 and 169) demonstrated no differences in 
tissue % moisture.  
 
 
Fig.  5-2: Change in body mass following 48 h food deprivation or fed ad libitum (Mean  ± S.E.M n = 6) 
until sampling Black, blue and red bars represent 23, 110, and 172 day old rats respectively. * 
indicates statistically significant changes in % body mass change within treatments between different 
aged rats (ANOVA, P < 0.05). 
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Fig.  5-3: Concentration of Ti nmol g
-1 
dry weight in Spleen (A), kidney (B) and liver (C) of different 
aged rats following food deprivation in comparison to fully fed individuals (n = 6) per treatment per 
time point. * indicate significant differences between treatment within age groups. Different letters 
indicate significance between animals of different ages within treatment (ANOVA, P < 0.05). Absence 
of symbols indicates no significant differences. 
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5.4.2 Feed status effects on tissue electrolytes 
There were some age and feed status effects on tissue electrolyte concentrations in 
rats. For example mean spleen Na+, Ca2+ and Mg2+ concentrations in 23 day old rats 
increased from (Mean ± S.E.M, n = 6) 78.9 ± 2.3, 3.8 ± 0.2 and 20.5 ± 0.3 µmol g-1 
dry weight (fed animals) to 94.2 ± 1.5, 5.8 ± 0.4 and 23.5 ± 0.7 µmol g-1 dry weight 
for Na+, Ca2+ and Mg2+, respectively, for unfed animals (t-test or Mann Whitney U P 
< 0.05). This same pattern was observed in the kidney for 23 day old rats with 
electrolyte concentrations increasing from 149 ± 8.8 and 4.2 ± 0.2 (fed animals) to 
189 ± 6.5.and 5.3 ± 0.2 µmol g-1 dry weight for Na+ and Ca2+, respectively, in unfed 
animals (Table 5-2). There were also some age-related differences in electrolyte 
concentration within treatments. For example older fed and starved rats had higher 
concentrations of Na+ and lower concentrations of Ca2+ in the kidney liver and spleen 
in comparison to 23 day old rats (within treatments ANOVA or Kruskal Wallis, P < 
0.05) (Table 5-2).  
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Table ‎5-2: Concentration of tissue Na+, K+, Ca2+ and Mg2+ (metal µmol g-1 dryweight) and % moisture of spleen liver and 
kidney in different aged rats subjected to 48 h food depravation or fed ad libitum until sampling 
Rat age (Days) -  Organ % Moisture Na+ K+ Ca2+ Mg2+ 
 
23 S Spleen 75.0 ± 0.5a 94.2 ± 1.5 * 280.0 ± 10.4 5.8 ± 0.4 *a 20.5 ± 0.3* 
23 F Spleen 76.4 ± 0.5a 78.9 ± 2.3 a 262.3 ± 5.7 3.8 ± 0.2a 23.5 ± 0.7a 
110 S Spleen 72.5 ± 0.5b 89.3 ± 2.5 261.1 ± 3.9 3.0 ± 0.2b 18.6 ± 0.6 
110 F Spleen 73.5 ±2.9b 94.6 ±0.8b 277.6 ± 6.6 3.1 ± 0.1b 19.7 ± 0.6b 
172 S Spleen 71.3 ± 1.2b 105.2 ± 11.4 240.1 ± 9.7 2.8 ± 0.3b 18.2 ± 1.3 
172 F Spleen 71.9 ± 1.3b 111.4 ±11.6b 254.6 ± 8.9 2.9 ± 0.2b 19.2 ± 1.2b 
       23 S Liver 70.3 ± 0.3 63.3 ± 5.5 133.7 ± 5.4 2.1 ± 0.2*a 18.1 ±0.3*a 
23 F Liver 70.3 ± 0.2 66.6 ±2.7a 140.4 ± 5.0 1.6 ± 0.1 14.3 ± 0.2 
110 S Liver 70.5 ± 0.6 86.5 ± 9.6 123 ± 4.6 1.5 ± 0.1b 13.4 ± 0.4b 
110 F Liver 71.3 ± 0.9 91.7 ± 12.0b 131.2 ±7.4 1.6 ± 0.1 14.3 ± 0.7 
172 S Liver 70. 6 ± 0.7 86.8 ± 7.9 119.0 ± 6.0 1.4 ± 0.1b 14.2 ± 0.7b 
172 F Liver 70.9 ± 0.7 91.8 ± 7.6b 126.4 ± 6.1 1.4 ± 0.1 15.1 ± 1.0 
       23 S Kidney 77.7 ±1.6a 189 ± 6.5* 164.0± 2.9a 5.3 ± 0.2*a 18.8 ± 0.2a 
23 F Kidney 75.7 ± 0.5a 149 ± 8.8a 153 ± 8.8 4.2 ± 0.2a 18.6 ± 0.8a 
110 S Kidney 73.6 ± 0.7b 167.8 ± 7.8 143.2 ± 4.1b 3.4 ± 0.2b 15.4 ± 0.5b 
110 F Kidney 72.6 ± 0.8b 179.5 ± 12.1ab 153.0 ±8.2 3.6 ±0.3b 16.4 ± 0.9ab 
172 S Kidney 71.8 ± 0.5b 147.1 ± 7.7 124.8 ± 5.2c 2.7 ± 0.1c 13.9 ± 0.7b 
172 F Kidney 71.2 ± 0.6b 156.9 ± 9.9b 132.7 ± 6.8 2.8 ± 0.1c 14.9 ± 0.8b 
Values are means ± S.E.M (n = 6 for each group) and are expressed as µmol g
-1
 dryweight. Different letters represent differences between age within 
treatments, organs and electrolytes. The absence of letters indicated no differences.* indicates significant differences between fed (F) and starved (S) 
animals within age, organs and electrolytes. (ANOVA, Kruskal - Wallis, t-test or Mann Whitney U test P < 0.05). 
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5.4.3 Pilot study 2: Tissue and whole blood Ti concentrations in young rats: A 
comparison between fed and unfed animals 
Following the first experiment, the most significant changes in tissue Ti and 
electrolyte concentrations occurred in 23 day old rats. This observation informed the 
next part of the study, which explored the effect of food deprivation (48 h without 
food) on Ti concentrations in tissue and whole blood in 23 day old rats in comparison 
to fed animals of the same age.  
The mean tissue Ti concentrations are shown in Fig. 5-4. Animals fed ad libitum had 
higher mean concentrations of Ti in all tissues, except muscle (Fig. 5-4). Ti 
concentrations were significantly elevated in brain, lung, and jejunum of fed animals 
(t-test or Mann Whitney U, P < 0.05) and these increases were 64.3, 49.1 and 181.7 
[Ti] nmol g-1 dry weight respectively. Spleen Ti concentrations were statistically 
different between treatments at the 90% confidence level (P = 0.053 (unlike the first 
pilot experiment). However, average Ti concentrations followed the same pattern as 
that found in the first experiment. Significant increases in whole blood Ti 
concentrations were demonstrated in fed rats compared to unfed animals (P < 0.05). 
For example mean whole blood Ti concentrations were 6.2 and 19.1 nmol mL-1 in 
unfed and fed animals respectively (Fig. 5-5, Panel H). 
 
5.4.4 Feed status effects on tissue electrolytes 
Similar to the first experiment, tissue electrolytes changed markedly between unfed 
and fed animals. Macro electrolyte concentrations (Na+, K+, Mg2+, Ca2+ and Fe) 
increased in all the organs of starved animals with the majority being statistically 
significant (t-test, P < 0.05) (Table 5-4). This was probably due to changes in tissue 
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moisture content. For example, lung and spleen tissue in unfed animals had 
significantly lower water concentrations (69.4 ± 3.5 and 57.6 ± 1.3% compared to 
75.3 ± 0.9 and 67.7 ± 1.1% for lung and spleen of fed animals, Mean ± S.E.M n = 5) 
which would result in the increased concentration of tissue electrolytes when 
normalised to dry weight. Iron content of unfed animals increased in the liver by an 
average of 6.9 µmol g-1 dry weight compared to fed animals. Interestingly, the 
pattern was reversed in brain tissue with a mean Fe reduction of 10.9 µmol g-1 dry 
weight for unfed animals.  
Trace elements (Cu, Zn) were also affected by food deprivation. For instance, Zn 
concentrations were elevated in all analysed tissues taken from unfed animals 
(Table 3 - ANOVA or Kruskal Wallis, P < 0.05). Cu concentrations were significantly 
increased in the spleen, liver and jejunum tissues (Table 5-4). In contrast, whole 
blood electrolyte levels exhibited a different distribution pattern (Fig. 5-5 Panel A-H) 
in unfed animals compared to fed animals. Whole blood Na+, Ca2+, Zn and Cu 
concentrations decreased significantly (t-test or Mann Whitney U P < 0.05) in unfed 
animals. Notably, average whole blood Na+ and Ca2+ concentrations decreased from 
223.2 and 6.6 µmol mL-1 for fed animals to 132.6 and 3.0 µmol mL-1 for unfed 
animals. Whole blood concentrations of Mg2+, K+ and Fe were not significantly 
affected by food deprivation (Fig. 5-5, Panel A-H).  
 
5.4.5 Proximate composition 
Mean values ± S.E.M (n = 5) for % moisture, % lipid, % crude protein, % 
carbohydrate and % ash in the remaining carcasses are summarized in Table 5-4. 
Acute starvation caused a significant increase in carcass % moisture and ash 
230 
 
content (t-test or Mann Whitney U, P < 0.05). The percentage moisture in the 
carcass increased from an average 68.08 ± 0.52% in fed animals to 73.03 ± 0.07% 
for starved animals. % Ash (mineral content) increased from 1.91 ± 0.01 for fed 
animals to 4.87 ± 0.01 for unfed animals. In contrast carcass % Lipid and % 
carbohydrate were significantly reduced in unfed animals (t-test or Mann Whitney U, 
P < 0.05). Average carcass gross energy was significantly less in unfed animals 
(Means ± S.E.M, n = 3; 21.2 ± 0.17 compared to 25.9 ± 0.13 MJ kg-1 for fed animals). 
This was probably due to the diminished carbohydrate and lipid stores in the starved 
animals. Carcass % protein remained unaffected by acute starvation (Table 5-3). 
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Fig.  5-4: Concentration of Ti nmol g
-1
 dry weight in young (23 day old) rat organs following 48 h food deprivation or fed ad libitum until sampling. Values are 
means ± S.E.M (n = 5 for each group). Letters represent significance between organs within treatments. * represents significance between treatments within 
tissues. ANOVA or Kruskal Wallis for between tissues and student’s t-test or Mann Whitney U for between treatments within tissues (P < 0.05). 
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Table ‎5-3: Tissue moisture and electrolyte concentrations in 23 day old female Wistar rats fed ad libitum or starved for 48 h prior to 
sampling  
 
Values are means ± S.E.M (n = 5 for each group) and are expressed as µmol g
-1
 dry weight. Different letters represent differences within treatments (starved (S) or Fed (F) 
between organs within columns. * indicate significant difference between treatments within organ columns and electrolytes (ANOVA, Kruskal Wallis, t-test or Mann Whitney U 
test, P < 0.05). 
 
 
 
 
Tissue electrolytes µmol [Metal] g -1 dry weight 
Treatment Organ % moisture Na
+ 
K
+ 
Ca
2+ 
Mg
2+ 
Fe
 
Cu
 
Zn
 
F Brain 78.3 ± 0.2
a
 188.8 ± 4.2
a
 238.4 ± 5.4
a
 7.9 ± 0.4
a
 14.6 ±0.3
a
 15.3 ± 4.5
a
 0.32 ± 0.07
a
 1.07 ± 0.02
a
 
S Brain 76.4 ± 0.26
a
 288.7 ± 11.9
a
* 297.5 ±  13.9
a
* 32.8 ± 20.5
a
 22.0 ± 0.7
a
* 4.3 ± 0.9
a
* 0.27 ± 0.01
a
 1.82 ± 0.09
a
* 
F Lung 75.3 ± 0.9
a
 261.6 ± 24.6
b
 135.8 ± 10.5
b
 11.3 ± 1.0
a
 9.8 ± 0.6
b
 15.4 ± 4.4
a
 0.11 ± 0.01
b
 1.42 ± 0.24
b
 
S Lung 69.4 ± 3.5
b
* 390.9 ± 62.8
b
* 201.7 ± 7.6
b
* 21.2 ± 1.2
b
* 17.0 ± 0.9
b
* 17.6 ± 2.6
b
 0.14 ± 0.03
b
 2.27 ± 0.09
b
* 
F Muscle 55.0 ± 5.8
b
 81.9 ±  10.1
c
 134.8 ± 30.1
bc
 8.8 ± 0.9
a
 14.1 ± 3.2
abc
 4.7 ± 2.7
b
 0.08 ± 0.01
b
 0.67 ± 0.11
c
 
S Muscle 49.5 ± 4.4
c
* 225.4 ±  16.0
a
* 202.2 ± 4.4
b
 39.6 ± 16.3
a
* 26.6 ± 1.1
c
* 3.4 ± 0.6
a
 0.10 ± 0.00
b
 1.53 ± 0.06
a
* 
F Spleen 67.7 ± 1.1
b
 100.9 ± 5.0
c
 245.3 ± 13.5
a
 8.7 ± 0.5
a
 18.4 ± 0.7
c
 12.3 ± 3.3
a
 0.09 ± 0.00
b
 1.46 ± 0.07
b
 
S Spleen 57.6 ± 1.3
bc
* 234.8 ± 28.7
a
 291.7 ± 17.4
a
 21.6 ± 1.2
b
* 25.4 ± 1.1
c
*  16.1 ± 1.2
b
 0.14 ± 0.01
b
* 2.29 ± 0.13
b
* 
F Liver 69.0 ± 0.3
ab
 84.0 ± 4.5
c
 136.7 ± 4.9
b
 3.1 ± 0.3
b
 13.7 ± 0.5
a
 7.2 ± 1.1
a
 0.42 ± 0.05
a
 1.41 ± 0.06
b
 
S Liver 67.0 ± 1.0
b
 200.2 ± 8.3
ac
* 186.4 ± 7.8
b
* 4.9 ± 0.3
c
* 24.1 ± 1.2
ac
* 14.2 ± 2.2
b
* 0.82 ± 0.11
c
* 3.54 ± 0.38
c
* 
F Jejunum 74.3 ± 0.9
a
 286.6 ± 31.8
b
 139.5 ± 17.7
bc
 33.9 ± 5.8
c
 19.6 ± 1.8
c
 4.1 ± 0.9
b
 0.11 ± 0.01
b
 1.52 ± 0.11
b
 
S Jejunum 76.5 ± 0.4
a
 536.2 ± 52.5
b
* 244.7 ± 5.2
c
* 49.4 ± 14.8
a
 33.6 ± 1.5
d
* 2.7 ± 0.1
a
 0.22 ± 0.01
ab
* 3.70 ± 0.24
c
* 
F Kidney 66.6 ± 1.7
b
 129.2 ± 20.9
c
 100.5 ± 17.7
c
 6.7 ± 1.1
ab
 11.2 ± 2.2
ab
 20.6 ± 14.8
ab
 0.18 ± 0.03
ab
 0.92 ± 0.17
abc
 
S Kidney 69.6 ± 0.6
b
 204.4 ± 59.0
ac
* 174.2 ± 39.1
bc
 10.7 ± 2.4
c
 18.3 ± 3.9
abc
 24.6 ± 7.1
b
 0.29 ± 0.06
ab
 2.21 ± 0.52
ab
* 
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Fig.  5-5: Whole blood electrolyte concentrations for rats starved for 48 h or fed ad libitum until sampling. Values are means ± S.E.M (n = 5 for each group) and are expressed 
as µmol mL
-1
 Metal * indicates significance between treatments (student’s t-test P < 0.05). Panels A-H represent whole blood concentrations of Na
+
, Mg
2+
, K
+
, Ca
2+
, Fe, Cu, 
Zn and Ti respectively. 
Table ‎5-4: Proximate remaining carcass composition of 23 day old rats expressed as % wet weight 
 Fed Starved 
% Moisture 68.08 ± 0.52 73.03 ± 0.07* 
% Ash 1.91 ± 1.91 4.87 ± 0.01* 
% Protein 17.22 ± 0.33 17.39 ± 0.04 
% Lipid 10.63 ± 0.07 3.74 ± 0.03* 
% Carbohydrate 2.15 ± 0.33 0.97 ± 0.12* 
Values are means ± S.E.M (n = 5 for each group) and are expressed as % of wet eviscerated carcass. 
* 
* 
* 
* 
* 
A B C D 
E F G H 
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5.5 Discussion 
This pilot study is to our knowledge one of the first reports demonstrating changes in 
tissue Ti and electrolyte concentrations in rats of different ages, feeding on a 
commercially available standard rodent diet in comparison to rats acutely deprived of 
food. The present study demonstrated that the Ti concentrations in the blood and 
internal organs of young rats showed transient increases when the animals were fed 
a normal diet containing an incidental amount of Ti in comparison to unfed rats of the 
same age. No such differences were demonstrated in the tissues of older rats 
subjected to the same treatment. Moreover, older rats had lower Ti tissue 
concentrations than younger rats, regardless of the feeding status. Consequently, 
food intake and the age of the animals is likely to influence their Ti status with 
respect to initiating regulatory toxicity tests with bulk or nano forms of TiO2 . 
 
5.5.1 Effect of age and feed status on tissue Ti concentrations 
The first pilot experiment investigated the effects of acute starvation on Ti and 
electrolyte concentrations in tissues that have been identified as primary target 
tissues for bulk and NP TiO2 accumulation in rodents following intravenous 
exposures (Patri et al. 2009; van Ravenzwaay et al. 2009; Shinohara et al. 2012) 
and secondary targets following oral exposures (Jani et al. 1994; Tassinari et al. 
2014).  
This first pilot study shows that younger fed rats have higher mean Ti concentrations 
in the spleen liver and kidney per gram dry weight compared to fed older rats (Fig. 5-
3). The standard rodent feed had a mean Ti concentration of 3.28 mg g-1. Assuming 
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rats consume 5 g per 100 g of body weight (Bogdanske et al. 2011) they are 
exposed to 164 mg kg-1 bw day-1 Ti through their normal diet. In spite of this chronic 
oral exposure to high levels of Ti, fed older animals had considerably lower spleen 
and kidney Ti concentrations than fed young rats suggesting an organ dilution effect 
(Jovanovic et al. 2012) which would also imply low bioavailability and absorption of 
Ti from oral dietary exposures or that the rate of Ti absorption is matched by Ti 
depuration.  
Unfortunately there is no clear pattern in the literature of this age effect on 
accumulation of Ti from TiO2 NP or bulk exposures. For example Tassinari et al. 
(2014) showed 60 day old rats exposed to 2 mg kg-1 bw day-1 for 5 days had 
significant increases in spleen Ti concentrations; Geraets et al. (2014) showed 63 
days old rats exposed to 8.6 mg kg-1 bw day-1 for 5 days demonstrated no effects; 
Cho et al. (2013) demonstrated no effects in 133 day old rats exposed to 1000 mg 
kg-1 bw day-1 for 13 weeks; Jani et al. (1994) showed 98 day old rats exposed to12.5 
mg kg-1 day-1 for 10 days demonstrated increased liver spleen and lung Ti 
concentrations. A number of factors may be responsible for the discrepancies in the 
data, for example, rat strain, particle size, time of particle administration, feed status 
and duration of administration. It is difficult to tease apart the confounding variables 
which would allow for a true comparison between studies. 
Spleen and kidney Ti tissue concentrations reported in this present study for fed 
young rats (23 days old) are higher than those reported in the Cho et al. (2013) study 
controls, but, the tissue Ti values reported for 6 month old rats in this present study 
are lower. Interestingly, the animals in Cho et al. (2013) study were 4 months old at 
the time of sampling and the tissue Ti values reported for the control animals fall in 
between the values reported for 23 day old and 6 month old animals in this present 
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study. For example Cho et al. (2013) reported tissue Ti values of 0.4 and 0.4, µg g-1 
wet weight, equivalent to 42 and 42 nmol g-1 dry weight for spleen and kidney 
(figures are calculated from an assumed tissue moisture content of 80% and 
converted to nmol for convenience) and in this present study Ti tissue concentration 
values for fed 23 day old rats were 143 and 61 nmol g-1 dry weight, whilst for fed 6 
month old rats the values were 21 and 20 nmol g-1 dry weight for spleen and kidney, 
respectively. This correlation may be a fortuitous; nevertheless, it is curious to see 
that tissue Ti concentrations appear to reduce with increasing age when comparing 
the results herein with other researcher’s work. Historically it has been demonstrated 
that tissue metal concentrations for some metals (iron, copper) in young animals 
tend to be higher than older animals (Kello and Kostial 1977; Kostial et al. 1978) and 
the evidence presented herein suggests that Ti follows this pattern (at least in the 
kidney liver and spleen). 
It is unclear why young animals have higher tissue Ti concentrations than older rats 
although there is a number of possible explanations based on our knowledge of 
physiological processes in young developing mammals. Young animals are likely to 
have a higher body burden of metals as a result of placental transfer (Kostial et al. 
1978). This has been supported by Takeda et al. (2009) who showed 
subcutaneously administered TiO2 in pregnant mice is transferred to the offspring. 
Another explanation could be ascribed to the higher metabolic rate young animals 
have compared to older animals (Roberts and Rosenberg 2006). Studies have 
demonstrated higher intestinal absorption rates and higher body retention in young 
animals (<1 month) for some metals e.g. Pb, Fe (Forbes and Reina 1972) Ce (Inaba 
and Lengemann 1972) TiO2 (Wang et al. 2013), and this has been attributed to 
increased intestinal pinocytic activity in the GIT of developing animals (Lecce 1972; 
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Martinsson and Johnsson 1975). Finally, ration size per kg of tissue decreases with 
age, therefore, young animals are ingesting relatively more Ti containing food. 
Further research needs to examine the links between age and intestinal permeability 
to Ti/TiO2 following oral exposures.  
 
5.5.2 Tissue and whole blood Ti concentrations in young rats compared to 
acutely food deprived animals 
Young rats demonstrated statistically significant increases (ANOVA or t-test, P < 
0.05) in [Ti] in whole blood, brain, lung, spleen and jejunum compared to unfed rats 
of the same age. Given this, the data suggest that dietary Ti is absorbed and 
depurated quickly in young rats.  
The increase in lung Ti concentrations following murine oral exposures to TiO2 (oral 
gavage of a TiO2 solution of bulk and NP) has been reported in a number studies 
(NP- Wang et al. (2007); Cho et al. (2013); bulk- Jani et al. (1994)). This may occur 
through incidental production of an aerosol stimulated by the gnawing action of the 
rat when feeding or simply due to the high blood flow infiltrating the lungs (intestinal 
absorption of Ti could end up in the lungs - Wang et al. 2007). The anatomy of the 
lung may play a role in preferentially accumulating particles of TiO2. The high level of 
blood flow coupled with the intricate capillary network could act as a filter trapping 
particles (Li and Huang 2008). Elevated brain [Ti] may also be explained via 
incidental production of an aerosol. Wang et al. (2007) demonstrated intranasal 
instillation of TiO2 NPs can enter the CNS via the olfactory system and accumulate in 
the brain or possibly via oral exposures (Wang et al. 2007); however, changes in 
blood brain barrier permeability associated with brain development in young rats 
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cannot be ruled out (Cremer et al. 1976). Jejunum levels of Ti are expected to be 
higher in fed animals due to undigested Ti containing food incidentally bound to the 
tissue.  
Whole blood Ti concentrations varied in relation to feed status in young rats. In this 
pilot study mean blood [Ti] decreased by more than 50% in unfed young rats 
compared to fed rats suggesting rapid removal or redistribution of Ti. Geraets et al. 
(2014) demonstrated a similar rapid decline in rats intravenously administered 9.8 
mg kg-1 bw TiO2 NPs (< 30 min). After 24 h no Ti was detected in the blood (Geraets 
et al. 2014). Similar results were demonstrated by Fabian et al. (2008) who 
intravenously administered 5 mg kg-1 bw TiO2 NPs. Unfortunately the mechanisms of 
Ti depuration are subject to debate and appear to be influenced by methods of 
administration. For example, Cho et al. (2013) detected high concentrations of Ti in 
the faeces following chronic oral exposure and this is also supported by Jani et al 
(1994) who calculated that 6.5% (12.5 mg kg-1 TiO2 per day for 10 days 500 nm 
diameter primary particle size) of the dose is absorbed in rat small intestine whilst 
the rest is excreted through the bowel (Jani et al., 1994). Xie et al. (2011) 
demonstrated intravenously injected rutile TiO2 radiolabelled with 125 I injected into 
mice and rats at 1 and10 mg kg-1 bw was mainly found in the urine indicating renal 
excretion. Whether renal excretion is responsible for already present systemic Ti and 
faecal excretion is merely a by product of a lack of absorption needs more research.  
Once Ti is in the blood stream it is expected that levels of Ti would increase in 
organs such as the liver spleen and kidney. Surprisingly, there was no statistically 
significant increase in liver or kidney Ti concentrations in fed young animals. The 
reasons are unclear although this has been demonstrated in others work. For 
example, Geraets et al. (2014) showed repeated oral exposures of between 10.9 – 
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12 mg TiO2 kg
-1 bw day-1 for 5 days in female rats had no effect on kidney and liver 
[Ti]. Similar results were demonstrated by Cho et al. (2013) who administered a 
considerably larger dose of 1041.5 mg kg-1 bw day-1 TiO2 for 13 weeks and 
demonstrated no changes in kidney and liver tissue Ti concentrations. 
In contrast, Wang et al (2007) demonstrated considerable increase in kidney and 
liver tissue Ti concentrations in mice two weeks post exposure following a single oral 
administration of 5 g kg-1 (25 and 80 nm diameter) TiO2 particles. This is likely 
related to the massive dose administered to the animals resulting in overloading the 
gut.  
Mean spleen [Ti] was elevated in fed young animals although this was not regarded 
as significant in the 2nd pilot experiment. Interestingly, Tassinari et al. (2014) orally 
exposed 60 day old rats to TiO2 NPs for 5 days at a concentration of 2 mg kg
-1 bw 
day-1 and reported significant average Ti increases of 0.046 µg g-1 wet weight 
equivalent to 4.9 nmol g-1 dry weight in the spleen; however, Geraets et al (2014) 
demonstrated no changes in rats of similar ages (63 days) exposed to 8.6 mg kg-1 
bw day-1 TiO2 NPs for 5 days. It is surprising that the natural variation in 60 day old 
control animals in the Tassinari et al. (2014) study was so low. For example, in this 
present study, the standard error for mean spleen Ti concentrations for fed 3 month 
old rats was 15 nmol g-1 dry weight and for fed young rats (23 days) between 20-30 
nmol g-1 dry weight . 
Regrettably, many of the studies mentioned above (Wang et al. 2007; Cho et al. 
2013; Geraets et al. 2014; Tassinari et al. 2014) state that all experimental animals 
were allowed to feed normally before and during the oral exposure experiments on 
standard laboratory feed, which was not characterized for [Ti], or in the case of the 
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Cho et al. (2013) study, explicitly stated that the [Ti] of the diet was unknown. This 
makes it difficult to draw any reasonable conclusions about TiO2 ADME considering 
TiO2 is present in food at mg kg
-1 levels and if used as a food colouring the 
concentration will be considerably higher. This makes the concentrations used in low 
dose trials negligible in comparison to background exposures, which could be 20 - 
50 times greater than the exposures being tested (Based on the Ti concentration of 
feed analysed in this present study).  
 
5.5.3 Effect of food deprivation on tissue and blood electrolytes in young rats 
Acute food deprivation caused significant increases in Na+, K+, Mg2+ and Ca2+ tissue 
electrolyte concentrations and decreases in whole blood Na+ and Ca2+ 
concentrations compared to fed young rats. This is indicative of water movement 
from the tissue into the blood and is supported by the reduced carcass tissue 
moisture compared to fed animals (Table 5-4). A speculative explanation for these 
results may be related to starvation induced polydipsia (water consumption was not 
monitored during the study). Increasing water consumption is a well-documented 
reaction to food deprivation for some rodent species (Newcomer et al. 1987). The 
effect of increased water consumption causes a transient reduction in blood osmotic 
pressure, which is either quickly corrected by urine production (i.e., routine renal 
homeostasis of the drinking response), or in persistent situations, other solutes such 
as amino acids can be added to the blood to raise osmotic pressure. In animals, the 
release of amino acids from the tissues to the blood as osmolytes is a well-
documented strategy. These can include proline, tyrosine, phenylalanine, leucine 
isoleucine and valine (Rankin and Davenport 1981). These amino acids diffuse into 
the blood down the concentration gradient thereby increasing blood osmotic 
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pressure. Water would be expected to follow this efflux of proteins out of the cell via 
solute drag (Van Bruggen et al. 1982), ultimately dehydrating the tissues and diluting 
extracellular whole blood electrolytes. Solute drag has been shown to exert 
considerable force on water movement (Van Bruggen et al. 1982) and could easily 
explain the moisture concentration asymmetry demonstrated in this present study. 
Whole blood Mg2+ K+ and Fe would not be expected to change because these 
elements are primarily regulated inside red cells (e.g. bound to haemoglobin or Mg 
ATP complexes) (Flatman 2002). This is in agreement with observations in this 
present study.  
 
5.5.4 Weight loss and changes in proximal composition in starved juvenile 
rats  
Weight loss is amplified in smaller endotherm animals subjected to acute food 
deprivation because they tend to have higher mass specific metabolic rates. 
Younger smaller rats have been shown to lose more mass per day than older larger 
rats subjected to food deprivation (Goodman et al. 1981) and this is in agreement 
with this present study. As expected, lipid and carbohydrate stores are the first to be 
depleted and used for energy metabolism. For example, glucose used in glycolysis 
and lipids used for ß-oxidation in the mitochondria (Murray et al. 2009). Carcass 
crude protein content was unaffected by acute food deprivation in young rats. Protein 
catabolism is considered to be a fuel of last resort and the switch from lipid 
catabolism to protein catabolism is thought to occur when an animal’s lipid 
concentration reaches a critical threshold (Caloin 2004) which did not occur in 48 h 
suggesting the ramifications of food deprivation in this study were physiological and 
not pathological. Relative mineral content increased in the carcass of starved young 
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rats. This increase in mineral content has been reported to occur in starved 
vertebrates by a number of researchers (e.g. Cook et al. 2000; Shoemaker et al. 
2003). The reasons are unclear although Prunescu et al. (2003) hypothesised that in 
the absence of food young animals would maintain or increase micronutrients in the 
body for building or rapidly turning over mineral rich tissues (e.g. bone, blood) 
(Prunescu et al. 2003). 
 
5.5.5 Limitations of the study 
Several limitations to this pilot study need to be acknowledged. The form and size of 
the Ti in the food was unknown. It may have been in the form of illumenite (FeTiO2) 
or leucoxene ore (TiO2.FeO.H2O) or naturally occurring rutile rather than processed 
TiO2. Only the kidney, liver and spleen were analysed for all age groups and feed 
statuses. There was no sham control e.g. animals being fed a Ti free diet. 
 
5.5.6 Conclusion 
This study shows that young rats are susceptible to transient increases in tissue and 
whole blood Ti concentrations when fed a standard laboratory diet containing Ti in 
comparison to unfed rats of the same age. Critically, there is an age effect with older 
rats demonstrating lower tissue [Ti] in liver kidney and spleen following long term 
chronic dietary exposures to relatively large concentrations of Ti in comparison to 
young rats.  
TiO2 particle (NP or Bulk) oral exposure studies need to explicitly analyse and report 
the concentrations and forms (if possible) of the control diet animals are fed, 
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especially, when trying to determine the effect of low dose oral exposures on 
accumulation, absorption and distribution of Ti/TiO2 following TiO2 NP particle 
exposures. There is a risk that conclusions drawn from TiO2 NP oral exposures 
scenarios will misinterpret the ADME of administered Ti against the high background 
concentrations present in some standard laboratory feeds, especially when the 
technology used to determine tissue Ti concentrations is unable to differentiate 
between administered Ti and Ti already present. 
Finally, age effects need to be considered when evaluating risk in the human 
population, considering, food with high [Ti] tends to be found in products that are 
predominantly marketed to children. Higher absorption and accumulation in children 
may lead to increased oral toxicity. More research is required in this field. 
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Chapter 6: General Discussion 
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There is limited information on the mechanisms of TiO2 NP uptake via the 
mammalian intestine and the influence of crystal structure and particle size (bulk and 
nano) on these processes. The overarching hypothesis of this thesis is that TiO2 
particles are bioavailable and can translocate through gut epithelial cells and enter 
the serosal compartment mediated by vesicular energy dependent processes in 
mammalian intestinal epithelium. The physicochemical properties of the particles 
such as particle size and crystal structure will subsequently affect uptake rates and 
accumulation and exert different physiological effects on tissues relative to bulk 
versions of the same material. The body of work presented here has contributed to 
our knowledge of TiO2 bulk and NP uptake and accumulation in mammalian models 
and goes on to offer some suggestions as to the mechanisms involved in this 
process. The data presented heirein can be used to inform hazard and risk 
assessments with regards to oral exposure of TiO2 NPs. 
 
6.1.1 Overview 
In Caco-2 cells, uptake, accumulation and appearance of Ti/TiO2 in the serosal 
compartment were demonstrated, and this was influenced by TiO2 crystal 
morphology (Chapter 2, 3). The nano rutile form was taken up the least irrespective 
of cell maturation status and growth substrate (Chapter 2, 3). The bulk material 
demonstrated the greatest uptake and accumulation rates in cell culture, although 
appearance of Ti/TiO2 from TiO2 particle exposures in the serosal compartment from 
bulk TiO2 exposures was delayed in comparison to nano P25 and nano anatase TiO2 
(Chapter 3). Incubating cells with pharmacological inhibitors caused significant 
changes in the cellular concentrations of Ti/TiO2 at 24 h compared to no drug 
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treatments which implied an active process is responsible for uptake and 
accumulation rather than diffusional processes (Chapter 2). Moreover, differential 
accumulation of different crystal structures of TiO2 in the pharmacological trials 
implies crystal structure influences uptake pathway in Caco-2 cells (Chapter 2). 
In whole rat GIT the work presented herein reports regional differences in Ti/TiO2 
accumulation from both bulk and nano forms of TiO2 by vertebrate mammalian 
intestine (Chapter 4), and demonstrates uptake of Ti/TiO2 from TiO2 particle 
exposures across jejunum segments of rat small intestine using the isolated 
perfused intestine technique (Chapter 4). The main findings are that Ti/TiO2 from 
TiO2 particle exposures (Bulk and nano P25) accumulate in the small intestine and 
large intestine in rats, with the Ti/TiO2 mainly accumulating in the mucosa rather than 
the underlying muscularis. Initial rates of uptake and appearance of Ti/ TiO2 from 
TiO2 particle (bulk and nano) exposures in the serosal compartment are influenced 
by particle size. The nano TiO2 exposures had significantly higher initial Ti flux rates 
(a measure of serosal appearance of Ti from apical exposures) than the bulk 
material (Chapter 4, Table 4-7). Addition of nystatin or vanadate caused the mean 
concentration of tissue Ti to increase for both bulk and nano TiO2 exposures 
suggesting that export of Ti/TiO2 is partly controlled by cholesterol and solute 
transport pathways. These results are in line with the results demonstrated in Caco-2 
cells (Chapter 2).  
Histopathology and ultrastructure analysis (TEM and SEM) of both cells and 
intestinal tissues demonstrated at least some of the administered TiO2 remained in 
particulate form inside vesicles within cells and that TiO2 irrespective of size and 
crystal structure had negligible effects on cell and tissue morphology compared to 
controls (Chapters 2 - 4).  
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In whole organisms, concentrations of Ti in secondary target organs following oral 
exposures of food containing Ti decreased with increasing age. Moreover, feed 
status had a negligible effect on Ti tissue concentrations in older animals. In contrast, 
younger animals demonstrated significant changes in tissue Ti relative to feed status 
(fed animals had higher tissue Ti concentrations) (Chapter 5). No concrete 
conclusions can be drawn from the pilot study in Chapter 5 although a number of 
ideas can be put forward to explain the data. Young animals may have increased 
intestinal permeability to Ti relative to older animals or older animals have more 
developed excretory mechanisms which may explain the disparity in tissue Ti 
concentration between animals of different ages. The latter may be a more likely 
explanation because the perfusion work used intestines of 12 week old rats and this 
data demonstrated uptake of TiO2 occurs in this intestine. Unfortunately, drawing a 
comparison between this whole body work and the in vitro work described earlier is 
difficult due to a number of reasons. For example, the Ti in the feed was not 
adequately characterised. Food matrix effects, food transit times, changes in pH 
along the intestine and digesta composition were not analysed and likely play a role 
in the bioavailability of Ti from dietary exposures. Moreover, in the Caco-2 work and 
intestinal perfusions particles of TiO2 were administered in a manner that facilitated 
direct contact of particles with apical epithelium. 
The work described here significantly contributes to the field in terms of our 
understanding of particle physicochemical properties on uptake and accumulation in 
mammalian intestinal epithelium. For instance, particle crystal structure affects 
accumulation and uptake in intestinal cells. The rates of uptake and tissue 
accumulation in the perfused rat intestine are influenced by particle size and these 
rates are explicitly reported herein. Moreover, this work highlights some 
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methodological considerations with regards to in vivo dietary exposures. Finally the 
work presented herein contributes important information about the uptake hazard of 
bulk and nano TiO2 in mammalian models and can be used to inform risk 
assessment and policy decisions with regards to the hazard presented by oral 
exposure to TiO2 of various size and crystal structures.  
 
6.1.2 Comparison between in vitro methods  
Although in vivo studies are regarded as the “gold standard” for biological relevance 
with regards to TiO2 uptake, systemic distribution, and toxicity; the mechanistic 
analysis of particle uptake is complicated by a considerable number of variables that 
inform on food intake, bioavailability and therefore oral dose (e.g. behavioural effects, 
animal social structure, stress etc.). These factors may in turn trigger, neuro-
endocrine events that might alter blood flow and/or the metabolic activity of the gut 
epithelium. Performing experiments in vitro gives you control over these systemic 
signals in the blood, allowing for many variables to be accounted for and potential 
mechanisms to be tested. 
In this present thesis, different in vitro methods were used to improve our 
understanding of TiO2 uptake mechanisms, rates of Ti transport and the effects of 
TiO2 exposures on biochemical markers and tissue and cell electrolytes in 
mammalian intestinal cells/tissue. Human intestinal Caco-2 cell culture is a useful 
tool to assess uptake and transport mechanisms of Ti/TiO2 from apical exposure of 
TiO2 across a monolayer of enterocyte like cells. Caco-2 cells have the advantage of 
being high throughput and being able to accurately control media/ material 
exposures. Disadvantages include a lack of realism in terms of metal uptake and 
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permeability when compared to an intact intestine. Given this, extrapolating uptake 
and accumulation rates to in vivo from cell line information should be applied with 
caution.  
A more realistic in vitro model for assessing uptake and transport of Ti/TiO2 from 
TiO2 luminal exposures is the perfused intestine method. This is far closer to the real 
condition than those demonstrated by cell lines. Morphologically the structure of the 
gut consists of the four layers of intestinal tissues (mucosa, submucosa, muscularis, 
serosa) and the perfused intestine demonstrates good viability when removed from 
the organism and bathed in an appropriate physiological saline.  
The results from these two in vitro methods (Chapters 2-4) show both similarities and 
differences with regards to particle accumulation and sub lethal physiological effects. 
Similarities include Ti/TiO2 from TiO2 exposures accumulated in the perfused 
intestine tissue and cell monolayer following mucosal/apical administrations. Mean 
tissue and cell Ca2+ concentrations both increased following TiO2 exposures. 
Differences included mature cells grown on inserts (lowest accumulation for any of 
the cell culture experiments) demonstrated Ti concentrations at 4 h that were 15 
times greater than the tissue Ti concentration for both bulk and nano P25 TiO2 
exposures. Overall rates of Ti/TiO2 appearance in the basolateral compartment were 
20 and 13 times higher in cells than perfused intestine for bulk and nano P25 TiO2, 
respectively (Chapter 3, Fig. 3-10). Moreover, the electrolyte concentrations in 
control cells were 26, 14 and 8 times higher for Na+, K+ and Mg2+, respectively, in 
comparison to control intestinal tissue electrolyte concentrations. These differences 
can be attributed to the phenotype of the Caco-2 immortalized cell lines (Chapter 2, 
Section 2.5.1d). Transport of Ti/TiO2 is expected to be higher across a monolayer of 
cells in comparison to four tissue layers which comprise the intestine. Accumulation 
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rates would also be higher due to accelerated rates of membrane turnover 
associated with carcinogenic cells, lack of mucus and gravitational settling of 
particles on the apical membrane. Electrolyte concentrations are also expected to be 
higher because of the increased number of metal ion transporters associated with 
carcinogenic cells (Brookes et al. 2006).  
The overall Ti flux rates in perfused rat intestine (Chapter 4, Table 4-7) presented in 
this thesis are 5 and 3 times greater than overall Ti flux rates demonstrated in the 
mid gut of trout (Al-Jubory and Handy 2012) using the same method, materials and 
administered concentrations of bulk and nano TiO2. Trout mid intestine is 
considerable thicker than rat small intestine and it would be expected that this would 
slow Ti/TiO2 transport from TiO2 exposures from lumen to serosa. Moreover 
endotherms have higher metabolic rates which may increase the rate of energy 
dependent vesicular processes. Interestingly if the values from the trout perfusion 
are compared to the rat perfusion the Q10 for NP uptake is 1.7 and for bulk uptake 
2.3 which would also support the idea that an energy-dependent process is 
responsible for particle uptake rather than diffusional processes. 
 
6.1.3 Uptake and accumulation- Is there a material type affect? 
Both in vitro methods demonstrated in this thesis showed Ti tissue and cell 
accumulation from bulk and nano P25 TiO2 exposures. The tissue/cell TiO2 
accumulation for both forms (bulk and nano P25) was similar in both types of 
experiment and analysis of the basolateral medium/perfusate established the 
appearance of Ti from bulk TiO2 exposures was slower than the appearance of Ti 
from nano P25 exposures (Chapters 3 - 4). It would be expected that slower efflux of 
251 
 
Ti from bulk TiO2 exposures would result in higher tissue accumulation if the rates of 
apical uptake were the same. This occurred in cell culture (Chapter 2-3), but, in the 
perfused intestine this was not the case, suggesting the rate of apical uptake is 
different for the bulk TiO2 relative to the nano P25 TiO2 in the perfused rat intestine 
model. Another plausible explanation for the discrepancies in the data between both 
models could be due to the differences in experimental design. In the cell culture 
experiments the increased settling rate of the bulk material would have increased 
particle contact time with the apical cell surface possibly resulting in the increased 
accumulation observed. However, in the perfusion model the increased settling time 
of the bulk material would have resulted in less contact time with the epithelium 
whilst the more stable suspension of NPs would have resulted in an increased 
particle contact time with the intestinal epithelium. 
 
Uptake and accumulation of Ti metal from TiO2 exposures demonstrated in both in 
vitro methods can be most easily explained by apical uptake of TiO2 particles rather 
than surface bound or dissolved Ti. This is evidenced by the low concentration of 
surface bound tissue Ti represented by the rapid solution dipping experiment 
(Chapter 4, Fig 4-10) and the low dissolution rates of TiO2 demonstrated in 0.1 M 
NaCl solutions (Schmidt and Vogelsberger 2009), intracellular saline solution (Al-
Jubory and Handy 2012) and inside Caco-2 cells (Brun et al. 2014). Moreover, TEM 
and SEM evidence has repeatedly demonstrated intact particles within vesicles in 
cells below the apical membrane (Brun et al. 2014; Gitrowski et al. 2014; Janer et al. 
2014). In this present thesis characterisation of the material in cells was performed 
by X-ray energy dispersive spectrophotometry (EDS) (Chapter 2, Fig. 2-9, 2-10). In 
the gut perfusion, TEM sections of TiO2 exposed tissues showed morphologically 
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similar particles to those characterised in the stock solutions within vesicles and 
these were absent from the controls. Although this is not definitive evidence of 
particles from exposures within tissues a number of previous studies have made 
inferences about putative TiO2 particles within or on tissues without EDS 
measurements based on morphological similarities to stock solutions (Jani et al. 
1994; Galloway et al. 2010; Janer et al. 2014). The evidence suggests that TiO2 Bulk 
and nano enter mammalian cells through an apical endocytosis mechanism.  
 
6.1.4 Mechanisms of TiO2 uptake and accumulation 
The evidence presented in this thesis implies that TiO2 particle uptake occurs 
through vesicular endocytic processes. Sensitivity to pharmacological agents 
suggests diffusion alone cannot be responsible for the Ti accumulation in cells and 
tissues following exposure to TiO2 particles. Chlorpromazine is arguably a selective 
inhibitor of clathrin-mediated endocytosis. Additions of this drug to cells caused a 
reduction in accumulated Ti from bulk and nano anatase TiO2 exposures suggesting 
clathrin mediated endocytosis is at least partially responsible for apical uptake of 
some forms of TiO2. Genistein, a tyrosine kinase inhibitor broadly reduces actin 
cytoskeletal movement, which would be a prerequisite to any endocytic processes 
and has been used as a calveolae-mediated endocytosis inhibitor (Le and Nabi 2003; 
Rejman et al. 2005; dos Santos et al. 2011) caused a significant reduction in Ti 
accumulation for all forms of TiO2 (Chapter 2, Fig. 2-8). The rutile form was 
particularly affected, suggesting that rutile TiO2 NPs are preferentially absorbed 
through calveolae based endocytic processes. Interestingly additions of nystatin a 
putative cholesterol inhibitor caused a marked increase in cell Ti concentrations. This 
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same effect was demonstrated in jejunum tissue exposed to bulk TiO2, suggesting 
apical uptake of TiO2 is cholesterol independent, but basal efflux has a cholesterol-
dependent component (Chapter 2, 4). For example, the initial and overall rates of Ti 
efflux into the serosa for jejunum exposed to nano P25 TiO2 were markedly reduced 
in the presence of nystatin (Chapter 4, Table 4-7). In the presence of vanadate (a p- 
type ATPase inhibitor) significant increases in tissue and cell Ti was demonstrated 
following exposure. This suggests that apical uptake continues, but basal efflux is 
interrupted. Curiously the effect of an ion transport inhibitor on Ti accumulation would 
imply that some of the TiO2 undergoes dissolution and is subsequently incapable of 
efflux from the cell. Information regarding vanadate sensitive ATPases being 
involved in exocytosis is sparse. However, metal transporting ATPases have been 
known to be involved in loading metal ions into vesicles (e.g. Cu Dameron and 
Harrison (1998)) and subsequently trafficked to the serosal membrane (Handy et al. 
2000).  
 
6.1.5 Potential toxicity- Is there a nano effect? 
An initial hypothesis of this thesis considered that TiO2 NPs will exert different 
physiological effects in comparison to the bulk version of the material. In the cell 
culture experiments (Chapter 2, Table 2-2; Chapter 3, Table 3-1) the addition of TiO2 
NPs caused a greater mean increase in intracellular Ca2+ relative to the bulk version 
of the particles following 24 h incubation (although bulk TiO2 exposures caused 
mean cell Ca2+ increases relative to controls). This effect was demonstrated 
irrespective of cell age or growth substrate. In the gut perfusion work this increase in 
tissue Ca2+ was also noted, with NPs causing a larger mean Ca2+ increase than the 
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bulk material (Chapter 4, Table 6). This effect has also been demonstrated in 
perfused trout intestine using the same materials described herein (Al-Jubory and 
Handy 2012). In contrast, the response in vivo is not so clear. For example, 
Ramsden et al. (2009) reported no effects of dietary TiO2 (bulk and nano) on tissue 
electrolytes concentrations (Na+, K+ and Ca2+) in vivo, although brain Na+/K+ ATPase 
activity was reduced by 50% following an 8 week exposure of 10 and 100 mg kg-1 
day-1 nano TiO2. Alternatively, Hu et al. (2010) demonstrated a reduction in brain 
Ca2+/Mg2+ ATPase activity and an increase in brain tissue Ca2+ in mice following 
intragastric administration of anatase NPs (5-50 mg kg-1) every day for 60 days. 
Unfortunately it was not possible to infer whether disturbances to Ca homeostasis 
occurred in vivo in this present thesis (Chapter 5) because there was no sham 
control and the Ti in the feed was not adequately characterised. Tissue and cell Ca2+ 
concentrations are tightly regulated and the evidence presented herein highlights a 
potential concern with regards to dietary TiO2 exposures interfering with calcium 
homeostasis. In light of this, more research on the precise mechanisms of TiO2 
induced changes in electrolyte homeostasis is required.  
In this present work, there was no effect of 1 mg L-1 TiO2 exposures on medium LDH 
activity in Caco-2 cell culture regardless of cell maturity (Chapter 2, Table 2-1; 
Chapter 3, Fig. 3-11), nor in the perfused intestine serosal perfusate and mucosal 
solution (Chapter 4, Fig. 4-4) relative to controls, which is indicative of undamaged 
epithelium. Similar responses have been demonstrated in perfused trout intestine 
(Al-Jubory and Handy 2012). Moreover, there was no effect on cell and tissue 
morphology (Chapters 2, 3 and 4), nor were there any differences in TEER (Chapter 
3, Fig. 3-9) following exposures to all forms of TiO2 (bulk and nano) which suggests 
tight junction integrity remained unaffected. Similar results have been demonstrated 
255 
 
by Koeneman et al. (2010) in cell culture for similar exposure concentrations. In vivo 
the situation is inconsistent. A number of researchers have demonstrated dietary 
exposures to TiO2 NPs causes detrimental changes to a number of secondary target 
organs (GIT/ Liver/ Kidney Wang et al. (2007); Kidney Gui et al. (2013); Spleen 
Wang et al. (2011) Spleen /ovaries Tassinari et al. (2014). In contrast, a number of 
researchers have demonstrated no pathological effects associated with oral TiO2 
exposure and tissue accumulation (Jani et al. 1994; Cho et al. 2013; Geraets et al. 
2014). The situation is still unclear and more research needs to be done. 
 
6.1.6 Hazard screening 
Nanotechnology is an area with large potential benefits for consumers, workers, 
patients and the environment. However, it is important that the risk posed by ENMs/ 
NPs are appropriately mitigated in order to take advantage of the benefits of the 
technology (Handy et al. 2008). Within the food sector this same risk benefit balance 
needs to be achieved. Nevertheless, nanotechnology and ENMs may expose 
humans and the environment to new risks that are as of yet largely unknown. The 
lack of information about the impacts of such technologies on public safety, and the 
potential toxicity of ENMs require a precautionary stance to be adopted in the 
absence of suitable regulation (Chau et al. 2007).  
Currently there are many different areas of legislation that apply to the food sector, 
and few of these give specific guidance on ENMs NMs and NPs. The production of 
new ENMs will be subject to the European REACH (Registration, Evaluation, 
Authorization and Restrictions of Chemicals) legislation, and NONS (Notification of 
New Substances) legislation (Hansen 2010). There are no provisions in REACH 
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referring explicitly to ENMs, but they are intended to be covered by the “substance” 
definition in REACH (European-Commission 2008). Under this legislation 
manufacturers and importers will have to submit a dossier for substances that they 
manufacture or import at or above 1 tonne a year. At or above 10 tonnes the 
registrant will be required to produce a chemical safety report (European-
Commission 2008). There are some concerns that small manufacturers of ENMs 
may not reach the 1 tonne threshold in REACH, and that some ENMs will be made 
of existing chemical substances that already have a CAS number (Handy and Shaw, 
2007). REACH therefore needs modification to include new physical forms of 
existing chemicals. Top down substances are nanomaterials that are made by 
grinding/milling an existing bulk chemical to the nano scale (<100 nm). Other 
legislation which is applicable to the use of nanotechnology in the food sector does 
not refer to the issue of particle size (Table 6-1).   
Table ‎6-1: Food legislation that needs altering to account for NPs 
EU 
Regulation/ 
Directive 
 
What does it 
cover? 
What are the gaps? Website 
EU 258/97 
EU novel foods 
regulation 258/97 
Foods and novel food 
ingredients not 
consumed before the 
15/05/1997 
Does not cover material that 
has an established history of 
food use 
Does not cover particle size 
 
http://europa.eu/legislation_summaries/con
sumers/consumer_safety/l21119_en.htm 
EU 178/2002 
The general 
safety article 
of the EU Food 
Law 
Regulation 
 
Food traceability 
 Food safety 
Too loose http://ec.europa.eu/food/food/foodlaw/ 
traceability/index_en.htm 
 
EC 97/618 
Framework for 
scientific 
assessment of 
novel 
foods 
 
Scientific assessment 
procedures for 
Regulation 
(EC) No 258/97 
Doctrine of substantial 
equivalence a concern 
http://eur-lex.europa.eu/smartapi/cgi/ 
sga_doc?smartapi!celexapi!prod!CELEX 
numdoc&lg=EN&numdoc=31997H0618 
&model=guichett 
Directive 89/107 
EU Food 
Additive Use 
Directive 
 
Food additive List of permitted additives 
Does not specifically cover 
particle size 
http://europa.eu.int/eur-lex/lex/ 
LexUriServ/site/en/consleg/1989/ 
L/01989L0107-20031120-en.pdf 
EU 94/36 
Regulation on 
colours for 
use in foodstuff 
Colours for use in food 
stuff 
List of permitted colours. 
Does not specifically cover 
particle size 
http://eur-lex.europa.eu/smartapi/cgi/ 
sga_doc?smartapi!celexdoc!prod!CELEX 
numdoc&numdoc=31994L0036&model 
=lex&lg=en 
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EU 1935/2004 
EU Food 
Packaging 
Regulation 
Must comply with food 
labelling laws. 
Must not be misleading. 
Active ingredients must 
comply with 89/107. 
 
Does not cover particle size http://eur-lex.europa.eu/ 
LexUriServ/site/en/oj/2004/l_338/ 
l_33820041113en00040017.pdf 
Directive 91/414 
Directive 79/117 
EC Regulation 
No 
396/200 
 
 
 
Pesticide regulations 
covering plant based 
products. 
 Needs to cover 
nanoformulations 
http://ec.europa.eu/food/plant/ 
protection/index_en.htm 
Directive 
98/8/EC, 
Directive 
76/769/EEC. 
 
Regulations covering 
biocidal products 
Needs to cover 
nanoformulations 
http://ec.europa.eu/environment/ 
biocides/index.htm 
Regulation (EC) 
No 1907/2006 
REACH 
Regulation applying to 
the manufacture, placing 
on the market and use 
of substances on their 
own, in preparations or 
in articles 
Too loose.  
 
Does not cover nano material 
from already accepted bulk 
substances. 
http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?ur
i=COM:2008:0366:FIN:en:PDF 
(European-Commission 2008; Miller and Senjen 2008) 
 
This present thesis highlights the uptake hazard of TiO2 via oral exposure scenarios 
and could be used to partially inform policy makers on risk assessments. For 
example, the legislation needs to be modified to account for particle size because 
the data presented herein demonstrated the uptake hazard of TiO2 NPs into the 
serosal compartments is greater than the bulk material (Chapter 4, Table 4-7) and 
should be considered in risk assessments. The crystal structure of the material 
needs to be taken into account. The Caco-2 work (Chapter 2-3) suggests the rutile 
form would present less of an uptake hazard than the anatase form and this should 
be accounted for in legislation. Moreover, legislation does not take into account 
vulnerable groups such as children who may have higher exposure risk and 
therefore uptake risk in comparison to adults. Further investigations on the effects of 
TiO2 on food related risk assessments and NP hazards are advisable.  
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6.1.7 Future work  
A number of areas require further investigations, and some suggestions are 
indicated below. 
 Research into the mechanisms underpinning the alteration of electrolyte 
homeostasis is required. Particularly with respect to changes in calcium. The 
first stage would be to assess the form of Ca2+ (free or bound) responsible for 
the detected increases. This could be explored using Fura 2 dye and confocal 
microscopy in conjunction with TiO2 exposures.  
 In intestinal cell culture, SiRNA could be used to specifically knock out 
proteins associated with particular endocytic (e.g. caveolin, dynamin) 
pathways which may allow for a more precise evaluation of the mechanisms 
mediating particle uptake rather than using pseudo-specific pharmacological 
inhibitors.  
 More in depth pharmacological investigations in the perfused intestine. For 
example chlorpromazine (a clathrin mediated endocytosis inhibitor) and 
genistein (a tyrosine kinase inhibitor) have been shown to reduce 
accumulation in cell culture and it is uncertain whether this would occur in the 
more physiologically relevant perfused intestine model.  
 Assessing the effect of TiO2 crystal structure on uptake and accumulation in 
the perfused intestine model and definitively demonstrating the form of the Ti 
in the serosal compartment (intact particle or ion) thereby extending the work 
from cell culture to a more physiologically relevant model  
 Assessing how food matrix affects impact on TiO2 NP bioavailability. NPs are 
unlikely to be ingested alone; rather, they will be incorporated into a food/ 
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liquid matrix which will influence abiotic factors which in turn will affect particle 
behaviour and perhaps, bioavailability.  
 Chronic in vivo dietary exposures exploring the effect of TiO2 particle size, 
crystal structure and animal age on GIT uptake, systemic accumulation and 
pathologies. TiO2 containing products are preferentially consumed by children 
and the metals literature has demonstrated increased toxicological sensitivity 
in young animals in comparison to adults.  
Research in all these areas will inform hazard assessment and bring us one a step 
closer to understanding mechanisms underpinning uptake and potential toxicity of 
TiO2 NPs.  
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